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CHAPTER I 
 
INTRODUCTION 
 
Cytoarchitectural foundations of forebrain circuit organization and function: focus on the 
neocortical minicolumn 
 
Planning, calculation, and the assimilation of current sensory input and emotional 
states with prior experience are among the most sophisticated functions of the 
mammalian forebrain, and no forebrain structure has been more sculpted by evolution 
than the neocortex to facilitate these exquisitely complex forms of information 
processing.  Remarkably, over the last 100 million years, the surface area of this 
laminated tissue has expanded by a factor of ~1,000 in the human as compared to the 
mouse, while the lamination architecture itself has remained relatively unchanged (Rakic, 
2009).  From this observation and advances in the understanding of neocortical ontogeny 
has emerged the concept of the minicolumn- a radially organized, minimal component of 
neocortical information processing whose numerical expansion is positively correlated 
with increasingly sophisticated forebrain function throughout mammalian evolution.      
The neocortical minicolumn has been championed by Mountcastle as the basic 
information processing module within the neocortex (Mountcastle, 1997).  These 
functional units are comprised of 100-150 neurons arranged in a vertical column that 
spans the six horizontal neocortical laminae (Fig. 1A), and they are innervated by 
specific input modalities (Mountcastle, 1997; Markram, 2008).  In primary sensory 
cortex, excitatory, glutamatergic pyramidal neurons within layer 2/3 of the minicolumn 
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receive modality-specific, ascending thalamic information via feed-forward connections 
from the granule cells in layer 4.  Within these neurons, this information is integrated 
with coincident cortical inputs and thalamic feedback, allowing for higher-order,  
 
 
 
associative processes such as attention (Jones, 2002; Rubio-Garrido et al., 2009).  Layer 
2/3 pyramidal neurons predominantly project their intra-columnar axons to pyramidal 
neurons in layer 5 to propagate the descending flow of information through the 
minicolumn.  Layer 5 pyramidal neurons, in turn, distribute resultant minicolumnar 
outputs to other cortical areas and important subcortical forebrain centers including the 
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striatum and thalamus.  A schematic summarizing basic excitatory connectivity within 
the neocortical minicolumn can be viewed in Figure 2. 
From a qualitative observation of pyramidal cell dendritic morphology alone (Fig. 
3), one can infer that these neurons are able to integrate information entering the  
 
 
 
minicolumn at different vertical levels.  Dendritic compartmentalization is an important 
morphological feature that supports this capacity.  For example, using a high-resolution 
4 
 
approach, Petreanu and colleagues revealed that afferents from both ascending peripheral 
sources and descending central sources impinge upon discrete but overlapping domains 
of the pyramidal cell dendritic arbor, according to layer-specific patterns (Petreanu et al., 
2009).  At the molecular level, varied distributions of voltage-dependent ion channels can  
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influence local dendritic excitability and affect input-output relationships in neurons 
(Hausser et al., 2000).  For example, a recent study implicated a down-regulation of 
Kv4.2 K
+
 channels in the potentiation of local dendritic branch strength (Losonczy et al., 
2008), and modeling studies indicate that nonuniform ion channel distributions best 
explain the backpropagation of action potentials within the basal dendritic arbors of 
pyramidal neurons (Nevian et al., 2007; Acker and Antic, 2009).  Collectively, these 
findings indicate that minicolumnar pyramidal neurons may be able to simultaneously 
process and store unique combinations of circuit-level information within specific 
dendritic domains.     
How does cytoarchitecture contribute to the cohesive activation of excitatory 
neurons and the vertically constrained flow of information within the minicolumn?  First, 
axo-dendritic overlap is maximal among excitatory neurons located directly above or 
below one another within a minicolumn.  Second, columnar boundaries of axo-dendritic 
overlap predict functional connectivity (Shepherd et al., 2005).  Third, the inputs to a 
mincolumn, whether ascending or descending, tend to be highly focused (Mountcastle, 
1997; Mountcastle, 2003; Markram, 2008).  However, neurons in neighboring 
minicolumns are certainly not completely disconnected from each other, either 
anatomically or functionally, allowing for the spread of activation among them.  
Inhibitory interneurons are integral in controlling excitation both across and within 
minicolumns.  
Minicolumnar inhibitory interneurons mediate inhibitory neurotransmission by 
releasing gamma-amino butyric acid (GABA) onto their target neurons.  They are fully 
intercalated within all layers of the neocortex (Fig. 1A; Fig. 2) and they exhibit diverse 
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axonal morphologies, which relate to their ability to mediate inhibition across (lateral 
inhibition) or within (intrinsic inhibition) minicolumns (Markram et al., 2004).  For 
example, parvalbumin-expressing basket interneurons in the superficial cortical layers are 
particularly suited to mediate inhibition across mincolumns, considering their 
horizontally aligned axonal arbors and perisomal targeting of pyramidal neurons (Fig. 2).  
The lateral extent and the efficacy of this inhibition are dictated by the axonal arbor width 
and the ratio of pyramidal neurons to other interneurons contacted, respectively (Krimer 
and Goldman-Rakic, 2001).  Layer II calbindin- and calretinin-expressing double-
bouquet interneurons also facilitate lateral inhibition.  However, they do so via vertically 
oriented axonal arbors, which effectively form an inhibitory curtain within the neuropil 
surrounding each minicolumn (DeFelipe et al., 1990; Buxhoeveden and Casanova, 2002; 
Yanez et al., 2005) (Fig. 2).  In addition to different patterns of synaptic connections, 
interneuron subtypes within a minicolumn also exhibit different thresholds for excitation. 
Therefore, the amplitude and frequency of an incoming excitatory stimulus will 
determine the subset of interneurons that become activated within the minicolumn and, 
thus, the quality of the information processed therein (Porter et al., 2001; Markram et al., 
2004). 
  The minicolumn is the basic unit of neocortical information processing, and 
groups of minicolumns enable increasingly complex computations.  Provided they share 
common inputs and are linked by short-range horizontal connections, as many as 70-80 
neighboring minicolumns can be locally and cohesively activated.  These so-called 
macrocolumns (Fig. 1B) provide an anatomical basis for information processing modules 
in sensory and association cortices that share similar functional properties (Mountcastle, 
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1997; Mountcastle, 2003).  Long-range axonal projections connect functionally related 
macrocolumns in distant neocortical areas and also link them to lower centers (Fig. 1C).  
In this way, information processed in local circuits throughout the forebrain can be bound 
together to support the most sophisticated cognitive functions.   
 
The developmental basis of neocortical circuit formation: from neurogenesis 
to synaptic pruning and in-between 
 
Neurogenesis and migration of minicolumnar neurons  
The cytoarchitectural framework of the neocortical minicolumn is determined 
developmentally by modes of neurogenesis and neuronal migration in the dorsal 
forebrain that are conserved across all mammals.  Both symmetrical and asymmetrical 
divisions of radial glial progenitor cells within the proliferative zones of the dorsal 
pallium are essential to neocortical neurogenesis.  During the earliest phases of 
neurogenesis, symmetrical divisions predominate and amplify the radial glial progenitor 
cell pool (Takahashi et al., 1996; Takahashi et al., 1997; Kornack and Rakic, 1998).  
Subsequently, each radial glial precursor undergoes iterative asymmetrical divisions to 
generate a lineage of daughter neurons that migrate along their radially oriented processes 
to populate the overlaying layers of the incipient neocortex in an inside-out fashion.  That 
is, more recently born neurons populate increasingly superficial neocortical layers 
(Angevine and Sidman, 1961; Sidman and Rakic, 1973).  Because each radial glial 
progenitor cell seeds only one or a few minicolumns, they are referred to as radial 
ontogenetic units (Rakic, 1988).  It logically follows then that numbers of asymmetric 
radial glial divisions dictate the radial extent of the minicolumn, and thus, the thickness 
of the neocortex, while numbers of symmetric divisions dictate the available pool of 
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radial ontogenetic units, and thus, the surface area of the neocortex.  Therefore, 
mechanisms enhancing symmetric radial glial progenitor cell divisions have likely 
evolved to support the massive expansion of neocortical surface area in higher mammals 
(Rakic, 1988; Kornack and Rakic, 1998; Rakic, 2009). 
   Approximately 85% of neurons in the neocortical minicolumn arise from the 
dorsal pallial mechanisms of neurogenesis and radial migration described above, and they 
are exclusively excitatory projection neurons.  The remaining 15% are local inhibitory 
interneurons, which take a far more circuitous path to their minicolumnar residences.  It 
was once thought that inhibitory and excitatory neurons migrate in tandem to the cortex 
from within a common region of the dorsal pallial proliferative zone, but this concept 
began to unravel during the past two decades.  Initial dye labeling and time-lapse 
microscopy experiments in developing ferret brain slices showed some postmitotic 
neurons to migrate orthogonally to radial glia processes across very long distances within 
the cortical intermediate zone (O'Rourke et al., 1992).  Further experiments in the rodent 
brain confirmed that these tangentially migrating cells originate in the ganglionic 
eminences (GE) of the ventral forebrain (de Carlos et al., 1996).  Finally, Anderson and 
colleagues demonstrated the restricted expression of Dlx 1/2 transcription factors in the 
GE, the ablation of which prevented the tangential migration of nearly all GABA-ergic 
interneurons to the neocortex (Anderson et al., 1997).  In rodents, these findings meshed 
well with previous data that cortical and subcortical proliferative zones contain 
immiscible progenitor cell populations (Fishell et al., 1993; Neyt et al., 1997); since they 
are not generated amongst the precursors of cortical pyramidal cells, inhibitory 
interneurons necessarily take a tangential migration from the GE to the dorsal pallium in 
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order to form local circuits within columns of cortical pyramidal cells (Fig. 4).  More 
recent studies in the developing human forebrain have demonstrated a conserved mode of 
tangential migration for interneurons, albeit from expanded zones of origin, which 
include the dorsal pallium in addition to the GE (Letinic et al., 2002).  
 
 
 
 
Axon and dendrite outgrowth and guidance: morphological scaffolding for intrinsic 
and extrinsic minicolumnar connections 
 
Following neurogenesis, the initiation of neuronal migration coincides with 
relatively undifferentiated minicolumnar neurons establishing polarity, the precursor to 
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developing their characteristic dendritic and axonal morphologies, and consequently, the 
assembly of the initial framework for intrinsic and extrinsic minicolumnar connectivity.  
Connectivity between any two neurons, minicolumnar or otherwise, depends on the 
interaction between their presynaptic (i.e., axonal) and postsynaptic (i.e., dendritic) 
elements, which are developmentally specified.  Growing, differentiating neurons 
initially extend a symmetrical array of short neurites from their cell bodies, each of which 
possesses a highly dynamic growth cone structure at its distal end.  A single neurite is 
then specified to become the neuron’s sole axon.  This selective transformation requires 
changes in cytoskeletal actin and microtubule stability that result in a dramatic increase in 
both neurite growth rate and growth cone size (Bradke and Dotti, 1999; Gonzalez-Billault 
et al., 2001; Witte et al., 2008).  An equally selective, though less dramatic, increase in 
neurite growth rate may also underlie the specification of an apical dendrite among 
basilar dendrites in the arbors of neocortical pyramidal neurons (Horton et al., 2006).  
Though still unclear, the inductive mechanisms of neuronal polarity are at least partly 
cell-autonomous in nature, as even dissociated neurons cultured at low-density develop 
axons and asymmetrical dendritic arbors (Dotti et al., 1988; Horton et al., 2006).              
Newly specified axons and dendrites undergo further outgrowth and branching, 
which is carefully organized to yield characteristic pyramidal neuron and interneuron 
morphologies.  Numerous soluble and extracellular matrix- or membrane-bound 
molecules serve as growth and/or guidance cues for developing axons and dendrites.  
While neurons could conceivably receive growth signals broadly across their axonal and 
dendritic membranes, attractive and repulsive guidance signals are sensed by their growth 
cones (O'Donnell et al., 2009).  Guidance molecule receptors at the growth cone cell 
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membrane are poised to transduce directional cues into intracellular signaling cascades 
that, whether attractive or repulsive, culminate in the local recruitment or dispersion of 
actin and microtubles, respectively (Quinn and Wadsworth, 2008).  Such asymmetrical 
rearrangements of the cytoskeleton effectively steer the growing axon or dendrite through 
the developing forebrain. 
There is a great diversity of families of membrane-bound and secreted axon 
guidance molecules expressed by mammalian species (Chilton, 2006; O'Donnell et al., 
2009), which reflects the complexity of establishing precise connections between neurons 
that are separated by great distances within the developing forebrain.  Even in the 
smallest mammalian forebrain, long-projecting axons navigate tortuous paths that are 
thousands of microns long, and they make numerous intermediate guidance “decisions” 
en route to reaching their targets.  For example, commissural corticocortically projecting 
pyramidal neurons in layer 2/3 likely depend upon attractive Netrin-1 signaling through 
DCC receptors for outgrowth and guidance toward the midline, as Netrin-1 knockout 
mice exhibit agenesis of the corpus callosum and other forebrain commissures (Serafini 
et al., 1996).  At the midline, glial populations both superior to (i.e., the indusium 
griseum) and inferior to (i.e., the glial wedge) the callosum secrete repulsive guidance 
cues, which callosal axons avoid by coursing through the body of this incipient tract 
toward their target areas in contralateral cortex (Fig. 5).  These molecules include Slits, 
which are sensed by Robo receptors expressed on the callosal axon growth cones (Shu et 
al., 2003), and even Wnts signaling through noncanonical pathways (Yoshikawa et al., 
2003).   
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Comparatively little, however, is known about the cues that guide callosal axons 
to their targets within homotopic neocortical areas once they cross the midline (Lindwall 
et al., 2007).  Our current understanding of inter-areal and intra-areal targeting 
mechanisms is primarily based on studies of the thalamocortical and corticothalamic 
projection systems.  Aspects of inter-areal targeting are likely to be set up by axon sorting  
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events before potential target areas are even encountered.  Dufour and colleagues 
demonstrated complementary gradients of Ephrin-A5 ligand and EphA4/EphA5 receptor  
expression within the thalamus and ventral forebreain, respectively, which proved to 
dictate both the path of thalamocortical axons to the neocortex and their inter-areal 
targeting therein.  For example, because Ephrin-A5 is a repulsive guidance cue, anterior 
dorsal thalamic neurons that express high Eph receptor levels project their axons through 
the anterior ventral forebrain where Ephrin-A5 levels are low, and consequently, target 
anterior neocortical areas (Dufour et al., 2003).  Recent studies showing that serotonin 
can modulate Netrin-1-mediated thalamocortical trajectories through the ventral forebrain 
indicate that the sorting of long-projecting forebrain axons is a highly complex and 
regulated process (Bonnin et al., 2007).   
Ephrin/Eph systems also play a role in intra-areal targeting.  Remarkably, in the 
study described above, Dufour and colleagues also showed that a neocortical Ephrin-A5 
expression gradient emerges perinatally to complement the expression of EphA4/EphA5 
receptors in the somatosensory thalamus and preserve the somatotopic organization of the 
thalamocortical afferents (Dufour et al., 2003).  Deletion of ephrin-A5 results in the 
misguidance of specific thalamic axons to cortical areas which they normally do not 
target (Uziel et al., 2002).  Reciprocal intra-areal targeting of corticothalamic projections 
within the thalamus was shown to depend on neocortical gradients of yet another Ephrin-
A5 receptor, EphA7.  However, unlike EphA4/EphA5 disruptions, manipulations of 
EphA7 were shown not to affect corticothalamic axon sorting or guidance en route to the 
target (Torii and Levitt, 2005).  
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The axon guidance events discussed thus far serve to organize connectivity in the 
tangential neocortical domain- that is, the specific neocortical areas, and therein, the 
specific minicolumns or groups of minicolumns to be innervated.  How then is 
connectivity organized in the radial neocortical domain, across the vertical structure of 
the minicolumn?  Studies of the ascending thalamocortical projection to layer 4 have 
yielded the majority of progress toward answering this question.  The initial step in the 
process concerns the ability of the thalamocortical axons to breach the neocortical-
subcortical boundary.  Upon arriving at the neocortex, thalamocortical axons interact 
with a transient population of neurons called subplate neurons, which are located just 
inferior to the deepest neocortical layers (Lund and Mustari, 1977; Rakic, 1977; Shatz 
and Luskin, 1986).  Subplate neurons themselves project axons to layers 4 and 1 of the 
neocortex (Friauf et al., 1990); it has been suggested that they pioneer a path used by 
thalamocortical axons to invade the neocortex in the radial dimension (Allendoerfer and 
Shatz, 1994).  Consistent with this hypothesis is the observation that ascending axons 
from visual thalamus pass over their preferred target regions when the subplate neurons 
beneath visual neocortex are specifically ablated (Ghosh and Shatz, 1992).  
  Stop signals are thought to instruct the invading thalamocortical axons to cease 
their radial progress through the cortical laminae once they reach layer 4.  The exact 
nature of these signals has yet to be elucidated, but it is known that thalamocortical axons 
are likely sensing a change in the levels of a guidance cue across layers (i.e., a gradient), 
rather than the absolute presence or absence of one.  In culture, thalamocortical axons 
will only stop and connect with layer 4 neurons if their growth is oriented perpendicular 
to the cortical laminae; thalamocortical axons that encounter layer 4 parallel to the 
15 
 
cortical laminae will grow within it without stopping (Yamamoto, 2002).  Importantly, 
lamina-specific targeting and lamina-specific growth and connectivity may not be 
interdependent processes.  For example, Ephrin-A5 knockout mice exhibit normal 
laminar targeting, but severely reduced axonal branching, of thalamocortical afferents 
within layer 4 (Uziel et al., 2002). 
Dendrite guidance is also essential to establishing forebrain connectivity, and this 
process is regulated by some of the same guidance molecules that regulate axon 
guidance.  For example, Whitford and colleagues demonstrated that Slit signaling 
through Robo receptors can promote the outgrowth and branching of cortical neurons in 
culture (Whitford et al., 2002).  Another study showed that Semaphorin-3A expression in 
superficial layers of neocortex may attract the apical dendrites of pyramidal neurons and 
orient them perpendicularly to the pial surface (Polleux et al., 2000).  Axon and dendrite 
growth and guidance can be differentially mediated by conserved classes of signaling 
molecules, presumably because of distinct downstream signal transduction mechanisms 
that are specific to each cellular compartment (Jan and Jan, 2003).  Similarly, distinct 
pyramidal neuron subtypes may signal divergently downstream of dendritic neurotrophin 
receptor activation, perhaps explaining the opposing effects BDNF and NT-3 on dendritic 
growth and branching in different neocortical layers (McAllister et al., 1997).  
   Through a developmental process known as “tiling”, neurons with similar 
functional properties communicate with each other through their dendritic arbors to 
ensure a complete but nonredundant occupation of receptive space in nervous system 
tissues.  Specifically, contact-mediated and/or short-range guidance cues emitted from a 
dendrite are thought to repel the growth of any encroaching dendrites if they are from the 
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same functional class.  This rule applies to dendrites that originate from either the same 
neuron (i.e., isoneural repulsion) or different neurons (i.e., heteroneural repulsion) (Jan 
and Jan, 2003).  Though best studied in drosophila and the mammalian retina (Wassle et 
al., 1981; Grueber et al., 2002; Grueber et al., 2003; Huckfeldt et al., 2009), tiling could 
also underlie the function of neocortical circuits.  For example, for a given visual 
stimulus feature such as orientation, layer 4 granule cells in primary visual cortex exhibit 
shifts in receptive field properties at a periodicity that conforms to the physical 
dimensions of the minicolumn (Mountcastle, 1997); dendritic tiling could support a 
morphological basis for this phenomenon by minimizing the overlap of dendritic arbors 
that originate from orientation-sensitive granule cells in neighboring minicolumns. 
 
Synaptogenesis and activity-dependent refinement of minicolumnar connectivity 
 
Carefully orchestrated outgrowth and guidance events succeed in bringing 
specific axonal and dendritic elements into close proximity so that the appropriate 
intrinsic and extrinsic connections of the neocortical minicolumn can be made.  
Synaptogenesis is the process by which focal junctions are made between these elements 
to facilitate the transmission of information between them.  The axonal, or presynaptic, 
side of the junction consists of calcium-sensitive protein complexes, which trigger the 
fusion of neurotransmitter vesicles with the cell membrane upon receipt of anterogradely 
propagated information from the cell body, encoded as an electrical impulse (Kandel et 
al., 2000).  Released neurotransmitter diffuses freely across a narrow synaptic cleft to be 
bound by ionotropic receptors at a postsynaptic dendritic site.  Neurotransmitter binding 
allows the selective flow of ions through these receptors, thus transducing the chemical 
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signal into an electrical current and propagating the flow of information through the 
postsynaptic neuron (Kandel et al., 2000).  Biochemical and ultra-structural studies have 
revealed complex networks of membrane and scaffolding proteins, which are integrated 
with the cytoskeleton through equally complex networks of linker proteins, both pre- and 
postsynaptically (McGee and Bredt, 2003; Okabe, 2007; Siksou et al., 2009).  The 
observation of such an elaborate architecture evokes some basic questions about synapse 
development: 1) how is synaptic contact initially made? 2) is synaptogenesis induced 
from the pre- or postsynaptic side? 3) can any axonal or dendritic site form a synapse? 
and 4) how are synapses stabilized? 
 Synaptic contact between developing axons and dendrites is either initiated 
passively, through en passant contacts of their overlapping branches, or directly, through 
the extension of long, thin filapodial branches or their growth cones (McAllister, 2007).  
These initial contacts are extremely transient in nature, and very few become stabilized as 
synaptic sites (Niell et al., 2004).  At least two reasons could explain why some contacts 
yield synapses and others do not: 1) highly specific mechanisms of axon and dendrite 
guidance are at play, which allow stereotyped circuit partners to seek each other out using 
soluble cues and/or cell adhesion molecules that stabilize contact and allow the 
recruitment of synaptic proteins, and/or 2) synaptogenesis occurs at those contacts where 
an a priori organization of either pre- or postsynaptic elements transcellularly induces the 
recruitment of their respective counterparts.  Regarding the former postulate, there is 
abundant evidence that transynaptic, bidirectional signaling between cell adhesion 
molecules supports selective synaptogenic events (Barbe and Levitt, 1992; Fannon and 
Colman, 1996; Graf et al., 2004).  Evidence supporting the latter postulate has recently 
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been obtained from experiments utilizing time-lapse imaging of fluorescently tagged pre- 
and postsynaptic proteins in culture models of synaptogenesis.  For example, Sabo and 
colleagues demonstrated that vescicles containing machinery for neurotransmitter vesicle 
release pause and cycle repeatedly with the axonal cell membrane, and that stable 
contacts with dendritic filopodia were preferentially made at these pause sites (Sabo et 
al., 2006).  A similar experimental design was also used to show that stationary clusters 
of postsynaptic proteins, including the scaffolding protein Neuroligin-1, transcellularly 
recruit actively recycling neurotransmitter vesicles to directly apposed foci in contacted 
axons (Gerrow et al., 2006).  Collectively, these findings indicate that synaptogenesis can 
be induced both pre- and postsynaptically, and that specific axonal and dendritic sites 
become “predestined” to form synapses (Fig. 6A,B) (McAllister, 2007). 
What factors contribute to the stabilization and maturation of a newly formed 
synapse?  In purely descriptive, morphological terms, the maturation of a nascent 
excitatory synapse requires the transformation of axonal elements into presynaptic 
terminals and dendritic elements into dendritic spines.  Marked increases in pre- and 
postsynaptic protein localization are necessary, but beyond the initial recruitment of the 
presynaptic release machinery and postsynaptic neurotransmitter receptors, the precise 
blueprint for constructing (or deconstructing) a mature synapse is unknown (McAllister, 
2007).  What is known is that synapse maturation correlates with increases in synaptic 
size and strength (i.e., the efficacy of neurotransmission), whereas opposing changes 
occur in a synapse that is being eliminated or “pruned”.  In all nervous systems, including 
the mammalian forebrain, the total synaptic population at any single time-point is 
comprised of strong/stabilizing and weak/destabilizing types of synapses, with the 
19 
 
 
 
relative capacity for change toward either type described as “plasticity”.  Robust periods 
of plasticity in the developing mammalian forebrain are essential to translating 
experience-driven neuronal activity into changes in connectivity that will support 
adaptive behavioral responses in a maturing individual (Hensch, 2003; Knudsen, 2004).   
Ocular dominance plasticity is by far the best characterized example of adaptive 
plasticity within columnar modules of the mammalian neocortex.  In the primary visual 
cortex of carnivores and primates, thalamocortical axons transducing right-eye and left-
eye visual information target segregated populations of layer 4 granule cells in arrays of 
adjacent macrocolumns (Katz and Crowley, 2002).  The thalamocortical inputs 
representing each eye typically impinge upon neocortical territories of equivalent size, 
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but this can change dramatically should an eye become deprived of visual input during 
developmental periods of heightened neocortical plasticity.  In their seminal work, Hubel 
and Wiesel demonstrated that monocular deprivation (MD) in cats, when applied within a 
critical 3-4 week period postnatally, results in a large increase in the proportion of visual 
cortical neurons responding to inputs from the intact (i.e., dominant) eye and a 
concomitant decrease in that responding to deprived eye inputs (Hubel and Wiesel, 1970; 
Sawtell et al., 2003).  Moreover, they reported that the recovery of deprived eye vision 
subsequent to the removal of the (MD) was minimal if it occurred beyond the critical 
period.  This does not mean that mature, adult animals lack a capacity for cortical 
plasticity.  In fact, though mechanistically distinct from juvenile plasticity, adult ocular 
dominance plasticity has recently been demonstrated in mice (Sawtell et al., 2003; Hofer 
et al., 2006).  Plasticity later in life, however, is most certainly constrained by the 
outcomes of preceding critical periods (Knudsen, 2004).  For example using the feline 
MD paradigm, Shatz and Stryker showed expansions in the dominant eye thalamocortical 
projection and corresponding retractions in the deprived eye projection, indicating that 
the poor deprived eye recovery seen in mature animals after the cessation of MD is in 
large part due to there being too few remaining connections to strengthen (Shatz and 
Stryker, 1978).  The rearrangement of thalamocortical projections subsequent to MD 
exemplifies a very common theme in the development of connectivity.  That is, patterned 
activity strengthens strong connections and results in a further weakening or elimination 
of weak connections.  However, decreased activity does sometimes result in paradoxical, 
homeostatic increases in growth and connectivity, and vice versa.  Such responses may 
be most relevant to earlier developmental periods when pre- and postsynaptic elements 
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are still making initial contact (Lund et al., 1991; McAllister et al., 1996; Tripodi et al., 
2008).        
 
Forebrain circuit abnormalities in neurodevelopmental disorders: focus on 
autism spectrum disorders 
 
Down’s syndrome, Rett Syndrome, autism spectrum disorders (ASD) and 
virtually all neurodevelopmental disorders are defined by deficits in higher-order 
forebrain functions that unfold as an individual develops.  Because appropriate forebrain 
function depends on the integrity of the underlying forebrain circuitry, it is accepted that 
neurodevelopmental disorders share in common an aberrant or insufficient establishment 
of forebrain connectivity.  Presumably, the ontogeny of disrupted forebrain connectivity- 
that is, when, how, and which specific circuits are affected- dictates the presentation of 
clinical phenotypes that characterize each neurodevelopmental disorder.  
 Connectivity-based etiological hypotheses for ASD are rooted in the earliest 
clinical history of the disorder.  In 1943, Kanner first published a clinical description of 
the related disorders we now know as ASD, which led to the identification of a defining 
triad of core features that includes impaired social interaction, communication deficits, 
and repetitive and restricted interests and behaviors (Kanner and Eisenberg, 1957; 
American Psychiatric Association. and American Psychiatric Association. Task Force on 
DSM-IV., 2000).  Kanner’s descriptions also evoked conceptualizations relating to the 
causes of the disorder.  For instance, he noted in affected individuals, “the inability to 
experience wholes without full attention to the constituent parts”, which seems to 
comport with Frith’s weak central coherence theory that states that individuals with ASD 
tend to process detailed situational elements without recognizing relationships between 
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them (Happe and Frith, 1996).  For example, as compared to typically developing or 
intellectually disabled children, individuals with ASD are expert at remembering random 
word strings, but poor at recalling meaningful sentences of a similar length (Tager-
Flusberg, 1996).  Recognition of this cognitive style prompted a testable hypothesis 
concerning the state of forebrain circuitry in ASD.  Namely, that local connectivity (e.g., 
synapses within or between nearby minicolumns) is enhanced at the expense of long-
range connectivity (e.g., synapses linking distant, functionally related minicolumns to 
each other or other forebrain structures) (Fig. 1F). 
 Recent functional data support predictions of global hypo-connectivity in 
forebrain circuits in ASD.  Functional magnetic resonance imaging (fMRI) during either 
face processing or sentence comprehension tasks revealed reduced prefrontal activation 
relative to other cortical areas in the brains of individuals with autism (Just et al., 2004; 
Koshino et al., 2008).  More recent magnetoencephalographic analyses of high-
functioning children with ASD showed they have enhanced parietal lobe synchrony and 
decreased prefrontal lobe synchrony relative to typically developing children during the 
performance of executive function tasks (Perez Velazquez et al., 2009).  Collectively, 
these and other studies indicate that long-range circuits between the frontal cortices and 
other brain regions are functionally disconnected in ASD (Geschwind and Levitt, 2007). 
High-resolution structural imaging and postmortem anatomical analyses have 
been applied to assess morphological correlates of local hyper-connectivity and global 
hypo-connectivity in ASD.  Morphological evidence of abnormal local circuitry in ASD 
has come almost exclusively from post mortem anatomical studies, which show 
minicolumns to be narrower and more numerous in several cortical areas within autistic 
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brains (Casanova et al., 2002) (Fig. 1D,E).  This pathological feature is consistent with 
the local bias in neocortical activation in ASD as revealed by fMRI, and it also portends 
structural abnormalities at the single cell level, including reduced pyramidal dendritic 
arbor size, which lend themselves to further postmortem study (Amaral et al., 2008).  
Volumetric MRI and diffusion tensor imaging (DTI) of the corpus callosum indicate 
fewer and less organized interhemispheric connections in ASD.  Studies employing MRI-
based volumetry have revealed varying decreases in callosal volume along the rostro-
caudal extent of the structure (Piven et al., 1997; Just et al., 2007; Frazier and Hardan, 
2009; Hardan et al., 2009), consistent both with disruptions in long-range connectivity in 
ASD and the heterogeneity of the disorder (Geschwind and Levitt, 2007).  In general, 
these callosal volumetric deficits are corroborated by DTI data, which show increased 
ratios of radial to longitudinal diffusion within this fiber tract in affected individuals 
(Alexander et al., 2007; Keller et al., 2007).  Structural studies of the corpus callosum in 
ASD have thus far predominated, but fMRI data indicate that similar studies of 
intrahemispheric long-range projections also are warranted (Folstein and Rutter, 1977; 
Steffenburg et al., 1989; Just et al., 2007).          
 
ASD-associated genes: understanding etiological mechanisms at the level of 
forebrain connectivity 
 
Heritability and heterogeneity are two defining characteristics of ASD.  Strong 
genetic heritability in ASD is evident from traditional twin studies, which have 
demonstrated concordance values between 50-91% for monozygotic twins and 0% for 
dizygotic twins (Folstein and Rutter, 1977; Steffenburg et al., 1989).  However, in both 
general and extreme populations, bivariate concordance among individual traits of the 
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ASD triad (e.g., social impairment and communication impairment or social impairment 
and restrictive and repetitive behaviors and interests) has proven to be modest, indicating 
that distinct groups of genes may influence each trait (Ronald et al., 2006a; Ronald et al., 
2006b).  This is consistent with heterogeneity in both the severity of core deficits and the 
comorbidity of disorders such as mental retardation and seizures in ASD (Geschwind and 
Levitt, 2007).  Understanding how different groups of ASD risk genes yield the 
developmental disruptions in forebrain connectivity that result in distinct subtypes of 
ASD is an outstanding challenge.   
Two genetic models, which do not exclude each other, may be useful in 
conceptualizing etiological mechanisms of ASD that account for the heterogeneity of the 
disorder.  First, risk genes may selectively confer vulnerability to developing circuitry 
that relates to a specific ASD core deficit.  In this case, enhanced vulnerability to ASD 
would require the inheritance or de novo occurrence of risk genes related to each of the 
three core features of the disorder; vulnerability to a specific subtype of ASD would 
depend on the degree of risk incurred for one core deficit relative to the others as well as 
the co-occurrence of exacerbating genetic and/or environmental factors that might 
otherwise more broadly impact forebrain connectivity.  A second model dictates that 
large groups of ASD-associated gene variants and mutations may, through epistatic 
relationships, converge on signaling pathways that generally impact the social and 
emotional circuits that are affected in autism.  Phenotypic heterogeneity in this model 
results from the pleiotropic functions of the risk genes in various other pathways (Bill and 
Geschwind, 2009).  Finally, both models allow for the introduction of even further 
heterogeneity related to the timing of the genetic insult.  For example, in the context of 
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the first model, two risk genes may specifically impact circuits related to social 
interaction but do so during distinct developmental epochs.  If the expression of one gene 
is related to neurogenesis and expression of the other is related to a later process such as 
synaptogenesis, the qualitative nature of their impact on that circuitry may be quite 
different.  
Regardless of the genetic model that is favored, significant progress in 
understanding the etiology of ASD will surely come from directly relating the 
neurobiological functions of ASD risk alleles to the development of circuits that are 
disrupted in the disorder.  Progress in this endeavor is only just beginning to be realized.  
Rare mutations found to be enriched in ASD compared to controls, such as NLGN3, 
NLGN4, NRXN1, NRXN3, and SHANK3, are particularly exciting because of their 
clearly established roles in synaptogenesis and the maintenance of synaptic connectivity 
(Varoqueaux et al., 2006; Tabuchi et al., 2007; Hung et al., 2008; Gibson et al., 2009).  
However, to date, expression studies of these genes (Lim et al., 1999; Varoqueaux et al., 
2006) have not provided the resolution required to understand their potential relationships 
to the development of forebrain circuits affected in ASD.  Moreover, because the 
mutations are rare, expressed by only a few individuals with ASD, it is unlikely that the 
mutations are associated with specific subtypes of ASD. Further confusing the issue is the 
fact that the rare mutations of these genes have been associated with both mental 
retardation and ASD in the same family (Laumonnier et al., 2004).  Thus, although the 
findings provide clues to neurobiological etiology, the contribution of these specific 
genes broadly to ASD, which affects 1 in 150 children, is minimal. 
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An example of a strong link between an ASD risk allele and potential etiological 
mechanisms has come from studies of the PTEN locus.  In 2005, Butler and colleagues 
found rare loss of function mutations in the PTEN gene to associate with a subset of 
individuals with ASD and comorbid macrocephaly (Butler et al., 2005).  Remarkably, 
subsequent studies in a mouse model of postnatal, forebrain-specific PTEN loss of 
function revealed ethologically relevant deficits in social behavior as well as 
macrocephaly that was due to increased dendritic and axonal arborization (Kwon et al., 
2006).  Excitement concerning this finding, however, is tempered by the fact that germ-
line PTEN mutations are rare (>1 in 10,000) and relevant to only a few ASD cases.  
Etiological mechanisms that are more broadly relevant to ideopathic cases of ASD will 
necessarily come from studies of common ASD risk alleles.                    
 
The emergence of the Met receptor tyrosine kinase as an ASD risk gene 
 
Allelic variants of the gene encoding the MET receptor tyrosine kinase (MET) 
have recently been identified as ASD risk factors, in the truest sense of the term.  Over 
the past three years, four independent studies, using 7 independent family cohorts, have 
demonstrated the association of two allelic variants of the MET gene with ASD 
(Campbell et al., 2006; Campbell et al., 2008; Jackson et al., 2009; Sousa et al., 2009). 
The rs1858830-C and rs38845-A ASD-associated MET alleles are remarkably common, 
with population frequencies ranging from approximately .35-.55.  Also, each allele 
results from a single nucleotide variation in the 5’ regulatory region of the gene, which 
suggests that they influence ASD risk at the level of gene expression.  Thus far, in vitro 
assays have shown the rs1858830-C allele to recruit different transcriptional complexes 
to the MET promoter than its ASD-protective rs1858830-G allele counterpart; with the 
27 
 
result being reduced MET transcriptional efficiency (Campbell et al., 2006).  This finding 
is consistent with the reported 2-fold decrease in neocortical MET expression in ASD 
postmortem cases (Campbell et al., 2007).  Moreover, two other genes encoding genes in 
the Met signaling pathway carry common alleles associated with ASD (Campbell et al., 
2008).  Considering that ASD is a neurodevelopmental disorder, a very basic mechanistic 
hypothesis concerning the relationship of MET and ASD risk has emerged: decreased 
MET expression during development increases the chance that forebrain circuit miswiring 
events characteristic of ASD will occur.  Because the process of wiring together forebrain 
connections during development is extremely complex, further refinement of this 
hypothesis will require a detailed understanding of the MET gene products (i.e., MET 
proteins) and their molecular functions.  A current synopsis of MET protein function in 
the context of neurodevelopment is presented below.  General experimental directives for 
elucidating mechanistic relationships between MET signaling and ASD etiology and risk 
are also presented. 
 The human MET gene encodes the transmembrane MET receptor tyrosine kinase.  
This signaling enzyme is initially translated as an inactive precursor of approximately 
190 kD that, via furin-dependent proteolysis, is cleaved into an  (45 kD) and chain 
(145 kD) within late endosomes en route to the cell membrane (Komada et al., 1993).  
Disulfide bridges subsequently form between the - and -chains to yield a mature, 
heavily glycosylated transmembrane protein capable of transducing extracellular signals 
into intracellular signaling events.  Specifically, MET signaling commences upon the 
binding of its polypeptide ligand, hepatocyte growth factor (HGF), in the extracellular 
space.  Although HGF is a soluble protein, its local concentration, and therefore, its 
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availability to bind Met can be influenced by extracellular matrix molecules such as 
heparin sulphate (Kemp et al., 2006).  HGF binding induces MET receptor 
oligomerization and the autophosphorylation of intracellular tyrosine residues that serve 
as multi-substrate docking sites for signaling adaptor proteins (Ponzetto et al., 1994).  
These adaptor proteins in turn facilitate the activation of several major signaling cascades 
including the PI3K, Erk, and P38 systems (Stefan et al., 2001; Xiao et al., 2001).  The 
nature of MET signaling is extremely context- and cell type-dependent and reflects the 
pleiotropic functions of this receptor in cellular development.  
Although first discovered as a proto-oncogene (Cooper et al., 1984), MET was 
soon after found to be involved in a variety of normal cell developmental processes 
including cell proliferation, migration, differentiation, and survival.  MET signaling also 
influences development at the tissue-level.  For example, the formation of duct systems 
within the developing pancreas, kidney, and liver is dependent upon MET signaling 
(Rosario and Birchmeier, 2003; Zhang and Vande Woude, 2003).  Duct formation is 
based on the process of epithelial tubulogenesis, which requires the organization of 
complex interactions among many polarized cells.  The exquisite coordination of 
interactions among polarized cells is also a dominant theme in the development of 
forebrain connectivity, and in vitro studies have recently implicated MET signaling in 
this process as well. 
MET signaling in cells grown in vitro has been shown to potentiate virtually 
every aspect of neurodevelopment that is required to establish connections between 
forebrain neurons.  Nearly all of this work has been done on neurons and tissues 
harvested from rodent species where, by convention, the gene and mRNA molecules are 
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designated as “Met” and the protein is designated as “Met”.  HGF stimulation enhances 
the motility of olfactory and neocortical interneurons (Powell et al., 2001; Garzotto et al., 
2008) as well as that of gonadotropin hormone releasing neurons of the hypothalamus 
(Giacobini et al., 2007), indicating that Met signaling may regulate the migration of 
forebrain neurons.  Met signaling also has been shown to promote the axonal outgrowth 
of thalamic neurons (Powell et al., 2003) and the dendritic outgrowth of neocortical and 
hippocampal pyramidal neurons (Gutierrez et al., 2004; Lim and Walikonis, 2008) in 
vitro.  Finally, evidence that Met may influence the actual formation (Tyndall and 
Walikonis, 2006; Tyndall et al., 2007) and function (Akimoto et al., 2004) of synaptic 
connections between forebrain neurons has recently been demonstrated in dissociated 
hippocampal neurons and acute hippocampal slices, respectively.  As discussed above, 
deficits in any of these processes can yield pathological alterations in forebrain patterning 
and circuitry.  However, incorporating such a wide range of potential deficits into a 
conceptualization of MET-associated ASD risk is a daunting task- especially when the 
neurodevelopmental capacity of MET signaling to influence forebrain connectivity in 
vivo is largely unknown.  
Comprehensive spatiotemporal MET expression mapping in the developing 
forebrain will provide an essential foundation upon which to build an understanding of 
MET signaling in the context of typical forebrain development as well as ASD 
susceptibility.  Because neurodevelopment occurs in a logical, stereotyped sequence (e.g., 
migration necessarily occurs before synaptogenesis), knowing when the receptor is 
expressed during rodent and primate forebrain development will help to identify the 
processes to which MET signaling is most relevant.  Knowing the spatial patterns of 
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MET expression during forebrain development is also crucial.  Although the in vitro 
literature seems to indicate that MET is expressed in every neuronal subtype in the 
forebrain, stressful environments, perhaps like those in tissue culture systems, are known 
to induce and/or enhance MET expression (Honda et al., 1995; Su et al., 2007).  Thus, the 
distribution of the receptor in vivo may be much more restricted.  In fact, an enriched 
association of the rs1858830-C allele with social and communication phenotypes of ASD 
was recently discovered (Campbell et al., 2009), suggesting that MET signaling may be 
especially important for the development of forebrain circuits governing social and 
emotional dimensions of behavior.  If this is true, a further prediction would be that 
comparative studies of MET receptor distribution in the developing forebrain will reflect 
species-specific requirements for communication and social interaction.   
MET expression mapping studies also will serve to focus functional studies aimed 
at elucidating the consequences of developmental MET signaling disruptions on forebrain 
circuit development in vivo.  For example, MET is likely expressed in both axonal and 
dendritic compartments, so forebrain neurons which do not express the receptor, but 
receive MET-expressing axonal afferents, would constitute a useful population in which 
to study isolated circuit-level influences of MET signaling.  Mouse models that allow for 
the genetic ablation of Met signaling from specific populations of forebrain neurons will 
of course be essential to these studies.  Such models also will provide an in vivo platform 
for studying Met signaling mechanisms that are pertinent to forebrain circuit 
development, as the protein complexes that allow Met to engage specific downstream 
pathways should be intact. 
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Abstract 
The establishment of appropriate neural circuitry depends upon the coordination 
of multiple developmental events across space and time.  These events include 
proliferation, migration, differentiation, and survival - all of which can be mediated by 
hepatocyte growth factor (HGF) signaling through the Met receptor tyrosine kinase.  We 
previously found a functional promoter variant of the MET gene to be associated with 
autism spectrum disorder, suggesting that forebrain circuits governing social and 
emotional function may be especially vulnerable to developmental disruptions in 
HGF/Met signaling.  However, little is known about the spatiotemporal distribution of 
Met expression in the forebrain during the development of such circuits.  To advance our 
understanding of the neurodevelopmental influences of Met activation, we employed 
complementary Western blotting, in situ hybridization and immunohistochemistry to 
comprehensively map Met transcript and protein expression throughout perinatal and 
postnatal development of the mouse forebrain.  Our studies reveal complex and dynamic 
spatiotemporal patterns of expression during this period.  Spatially, Met transcript is 
localized primarily to specific populations of projection neurons within the neocortex and 
in structures of the limbic system, including the amygdala, hippocampus and septum.  
Met protein appears to be principally located in axon tracts.  Temporally, peak expression 
of transcript and protein occurs during the second postnatal week.  This period is 
characterized by extensive neurite outgrowth and synaptogenesis, supporting a role for 
the receptor in these processes. Collectively, these data suggest that Met signaling may be 
necessary for the appropriate wiring of forebrain circuits with particular relevance to 
social and emotional dimensions of behavior.   
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Introduction 
The Met receptor tyrosine kinase is a pleiotropic, α,β-heterodimeric 
transmembrane protein that was first discovered as a proto-oncogene (Cooper et al., 
1984), and soon after found to be involved in a number of normal physiological 
processes.  The Met receptor and its endogenous ligand, hepatocyte growth factor (HGF), 
are expressed in the developing and adult nervous systems, and signal to mediate multiple 
neurodevelopmental and neurophysiological processes, including peripheral and central 
neuron survival (Hamanoue et al., 1996; Zhang et al., 2000), migration (Powell et al., 
2001; Giacobini et al., 2007; Garzotto et al., 2008), axon guidance (Ebens et al., 1996; 
Caton et al., 2000; Powell et al., 2003), dendritic arborization (Gutierrez et al., 2004; Lim 
and Walikonis, 2008), and synapse maturation and activity (Akimoto et al., 2004; Tyndall 
and Walikonis, 2006; Tyndall et al., 2007).  Deficits in any of these processes can yield 
pathological alterations in brain patterning and circuitry.  It is of particular note, 
therefore, that the human orthologue, MET, is located on chromosome 7q31, a region 
implicated in autism spectrum disorder (ASD) (IMGSAC, 1998; Ashley-Koch et al., 
1999; Barrett et al., 1999; Yonan et al., 2003), and a large family-based genetic analysis 
determined that an allelic variant in the 5’ promoter region of MET is associated with 
ASD, increasing risk approximately 2.25 fold (Campbell et al., 2006).  Furthermore, 
postmortem tissue analyses revealed an approximately two-fold reduction in MET protein 
expression in the temporal neocortex of ASD subjects compared to unaffected controls 
(Campbell et al., 2007). 
Roles for Met in the development of the diencephalon and telencephalon have 
been demonstrated in vitro.  In the diencephalon, Met signaling is required for migration 
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of gonadotropin hormone-releasing hormone-1 neurons from the nasal placode to the 
hypothalamus (Giacobini et al., 2007), and HGF has both growth-promoting and 
chemoattractive influences on axons from thalamic explants (Powell et al., 2003).  In the 
telencephalon, Met disruption diminishes the elaboration of dendritic arbors in cortical 
organotypic cultures (Gutierrez et al., 2004), while HGF enhances dendritic outgrowth 
and excitatory synaptic development of dissociated hippocampal neurons (Tyndall and 
Walikonis, 2006; Nakano et al., 2007; Tyndall et al., 2007; Lim and Walikonis, 2008), 
and stimulates the motility of developing interneurons from basal forebrain explants 
(Powell et al., 2001). 
 These in vitro studies illustrate the developmental capacities of Met, but the 
extent to which they represent the neurodevelopmental roles of Met in vivo is unclear.  To 
date, only two in vivo studies have attempted to examine the consequences of direct Met 
signaling manipulations in the context of mammalian forebrain development (Martins et 
al., 2007; Ohya et al., 2007).  To place the human genetic studies in perspective and to 
advance our understanding of the putative neurodevelopmental influences of Met 
activation, we used complementary Western blotting, in situ hybridization and 
immunohistochemical approaches to comprehensively map Met transcript and protein 
expression throughout late embryonic and postnatal development of the mouse forebrain 
(E17.5– P35).  We also examined protein expression patterns in mutant mice in which 
Met was conditionally deleted from structures originating from the dorsal pallium.  We 
show here that Met is expressed by discrete subtypes of long-projecting neurons of the 
forebrain, particularly, though not exclusively, of dorsal pallial origin, and that Met 
protein is enriched in the developing axons of these cells.  Moreover, we demonstrate that 
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the peak of Met expression in these cell populations coincides with principal periods of 
axon outgrowth and synaptogenesis, supporting a functional role for Met signaling in the 
development of forebrain connectivity. 
 
Materials and Methods 
Breeding and genotyping mice 
 C57BL/6J mice were purchased from the Jackson Laboratory (Bar Harbor, ME, 
USA). Conditional Met mutant mice (Emx1cre/Metfx/fx) were generated by mating mice 
homozygous for a Met allele, in which exon 16 is flanked by loxP sites (Huh et al., 2004) 
(Metfx/fx, courtesy of Dr. Snorri Thorgeirsson, NIH/Center for Cancer Research, 
Bethesda, MD) to Emx1-cre mice (Gorski et al., 2002) (courtesy of Dr. Kevin Jones, 
University of Colorado, Boulder, CO) that were also heterozygous for the floxed allele 
(Emx1cre/Metfx/+). Both Metfx/fx and Emx1cre/Metfx/+ breeding lines were back-crossed 
onto the C57BL/6J background for greater than 10 generations, and their progeny (i.e., 
Emx1cre/Metfx/fx and littermate control mice), were genotyped via polymerase chain 
reaction (PCR).  The PCR primer sets were as follows: Emx1cre forward 5’-
TTCGGCTATACGTAACAGGG-3’ and reverse 5’-TGCATGCAACGAGTGATGAG-
3’; Metfx forward 5’-GCAACTGTCTTTTGATCCCTGC-3’  and reverse 5’-
TGTCCAGCAAAGTCCCATGATAG-3’.  For the Emx1cre reaction, DNA samples are 
submitted to an initial denaturation step of 5 minutes at 94oC, then 35 amplification 
cycles [(denaturation: 94oC for 45 seconds), (annealing: 55oC for 30 seconds), 
(elongation: 72oC for 1 minute)], and then a final elongation step of 5 minutes at 72oC.  
The expected PCR product size is 350 bp.  For the Metfx reaction, DNA samples are 
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submitted to an initial denaturation step of 5 minutes at 94oC, then 35 amplification 
cycles [(denaturation: 94oC for 45 seconds), (annealing: 60oC for 1 minute), (elongation: 
72oC for 2 minutes)], and then a final elongation step of 5 minutes at 72oC.  The expected 
PCR product size is 500 bp for the wild type Met allele and 580 bp for the Metfx allele.      
            A cross-sectional approach was employed to assess patterns of Met transcript and 
total Met protein expression in the developing mouse forebrain.  For each experimental 
methodology described, forebrains from at least 3 mice from at least two independent 
litters were analyzed at each developmental time point of interest.  In the case of 
immunohistochemical studies requiring comparisons of Emx1cre/Metfx/fx and littermates, 
at least 3 experimental pairs from independent litters were analyzed per time point.  
           All research procedures using mice were approved by the Institutional Animal 
Care and Use Committee at Vanderbilt University and conformed to NIH guide-lines. All 
efforts were made to minimize animal suffering and to reduce the number of animals 
used.  
In situ hybridization 
In situ hybridization was performed as previously described (Campbell and 
Levitt, 2003), with modification.  Two cDNA probe templates specific to the mouse Met 
gene were generated by RT-PCR: a 1,387 bp fragment corresponding to nucleotides 
2665-4051 of NM_008591 and a 1,404 bp fragment corresponding to nucleotides 37-
1440 of NM_008591.  Antisense and sense cRNA probes were transcribed from these 
templates with incorporation of 35S-CTP.  
Pregnant dams were deeply anesthetized with isofluorane, fetuses were harvested 
and the dissected brain rapidly removed, frozen in isopentane, and stored at -80o C until 
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cryosectioning at 20 µm.  Cryosections were thaw-mounted onto Superfrost Plus glass 
slides (Fisher) and stored at -80oC.    
Slide-mounted sections were postfixed in buffered 4% paraformaldehyde for 15 
minutes, washed in 0.1 M phosphate-buffered saline (PBS) for 5 minutes, acetylated with 
0.25% acetic anhydride in 0.1M triethanolamine-HCl/0.15 M NaCl with 0.16%HCl for 
10 minutes, and washed in 2X standard saline citrate (SSC; 0.15 M NaCl, 0.015 M 
sodium citrate) for 1 minute.  Tissue was then dehydrated in graded alcohols (50%, 70%, 
95%, 100%; 1 minute incubation each), delipidated in chloroform (two 5 minute 
incubations), and incubated in 100% and 95% ethanol (1 minute each).  Slides were dried 
at 37oC for at least 2 hours. 
Each slide was hybridized with 3 ng radiolabeled probe in 100 µl hybridization 
buffer (50% formamide, 0.75 M NaCl, 20 mM 1,4-piperazine diethane sulfonic acid, 10 
mM EDTA, 10% dextran sulfate, 5X Denhardt’s solution, 50 mM DTT, 0.2% sodium 
dodecyl sulfate, 100 µg/ml sonicated salmon sperm DNA, and 10 µg/ml yeast tRNA) per 
slide.  Hybridization was performed at 55°C for 16 hours in a humid chamber. 
Following hybridization, coverslips were removed in 4X SSC plus 390mM 2-
mercaptoethanol and slides were incubated in this solution for 15 minutes at room 
temperature followed by 4X SSC without 2-mercaptoethanol for 15 minutes at room 
temperature.  Sections were then treated with 1:1 formamide/buffer (0.6M NaCl, 40 mM 
Tris base, 2 mM EDTA, 0.06% HCl) at 60oC for 30 minutes and washed in room 
temperature 2X SSC for 5 minutes.  Sections were then treated with 20ug/ml RNase A in 
0.5 M NaCl, 10 mM Tris, pH 8.0, and 1 mM EDTA at 37oC for 30 minutes.  The slides 
were then washed in graded salt solutions (2X, 1X, and 0.5X SSC each for 5 minutes at 
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room temperature, and 0.1X SSC at 65oC for 30 minutes).  Slides were cooled to room 
temperature in 0.1X SSC for 5 minutes and dipped in 60% ethanol with 0.33 M 
ammonium acetate.  Slides were dried at 37oC for 3-6 hours and exposed to X-ray film 
(Biomax MR; Eastman Kodak, Rochester, NY) for 3-15 days.  A subset of sections were 
prepared for emulsion dipping, following the protocol noted in (Campbell and Levitt, 
2003) and exposed for 3-6 days prior to development. 
Immunohistochemistry 
 The primary antibody used for Met immunohistochemical study was mouse anti-
Met (Met, B-2; sc-8057; lot No. C2807; Santa Cruz Biotechnology, Santa Cruz, CA; 
immunogen: peptide corresponding to amino acids 1330-1379 of mouse Met (NCBI# NP 
032617)).  Using immunoblotting methods, the antibody recognizes the recombinant Met 
protein (Santa Cruz), and a minor band at 170 kD and a major band at 140 kD in brain 
tissue homogenates (see below).  These bands represent pre-processed and processed 
forms, respectively, of the Met receptor.  Only the pre-processed band was detected in 
homogenates prepared from mouse neocortex in which the Met gene was deleted from 
the dorsal pallium (data not shown). A mouse monoclonal antibody, 1G9, generated in 
the laboratory against adult mouse hippocampal homogenates, cross-reacts specifically 
with phosphorylated neurofilament-H (NF-H) (Pennypacker et al., 1991), and was used to 
stain developing axons. 
         Postnatal mice were deeply anesthetized with sodium pentobarbital (60 mg/kg i.p.) 
prior to transcardial perfusion with room temperature phosphate-buffered 4% 
paraformaldehyde (pH 7.3) containing 1.3% L-lysine and 0.24% sodium periodate.  After 
postfixation overnight at 4oC, brains were cryoprotected via sequential 12-hour 
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incubations in 10%, 20%, and 30% sucrose in PBS, pH 7.5.  Fetal brains were harvested 
and immersion-fixed overnight at 4oC prior to cryoprotection.  
          Fetal and P0 fixed brains were frozen in embedding medium (Triangle Biomedical 
Sciences; Durham, NC) over liquid nitrogen vapors and stored at -80oC until sectioned 
with a cryostat at 20 µM.  Sections were collected on gelatin-subbed slides and stored at -
80oC until processed.  Fixed brains from P7 through P35 were frozen, cut at 40 µM with 
a sliding microtome (Leica, Bannockburn, IL) and free-floating sections were stored in a 
cryopreservative solution at -20oC until processed. One series of sections from selected 
brains were stained with Cresyl Violet as previously described (Hockfield, 1993).   
           For Met immunohistochemical processing, both cryostat and free-floating sections 
were rinsed in PBS and then incubated for 5 minutes in 0.5% H202 in PBS to quench 
endogenous peroxidases.  The sections were then rinsed in PBS before 25 min incubation 
in 0.1 M Tris-glycine (pH 7.4). Several more PBS rinses preceded a 1.5 hr incubation in 
unlabeled donkey anti-mouse IgG (Fab; Jackson Immunoresearch, West Grove, PA) to 
block endogenous mouse immunoglobulins. Sections were further blocked in several 
rinses of Blotto-T (4% Carnation dried milk in PBS containing 0.2% Triton-X-100).  
Blocked sections were incubated in primary mouse anti-Met antibody diluted 1:250 in 
Blotto-T.  Cryosections were incubated for 2-4 hours at room temperature; free-floating 
sections were incubated for 48-72 hours at 4oC.  Following washes in Blotto-T, sections 
were incubated for 1 hour at room temperature in 1:1000 biotin-SP-conjugated donkey 
anti-mouse IgG (Jackson Immunoresearch) diluted in Blotto-T.  Sections then were 
rinsed several times in PBS and processed by the ABC Elite histochemical method 
(Vector, Burlingame, CA).  Met-specific antibody complexes were visualized by 
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incubating the sections for 2-4 minutes at room temperature in 0.05% 3’3’-
diaminobenzidine (DAB) with 0.015% H202.  The stained sections were rinsed in PBS, 
and free-floating sections were mounted on gelatin coated slides.  Finally, sections were 
dehydrated with ethanol, cleared with xylene, and coverslipped in DPX (Fisher, 
Pittsburgh, PA) for microscopic analysis.  Phosphorylated NF-H staining was performed 
using a similar immunohistochemical protocol for free-floating sections, but with the 
following specific parameters: 1) The 1G9 primary antibody was diluted 1:200 in Blotto-
T, 2) biotin –SP-conjugated donkey anti-mouse IgM secondary antibodies were diluted 
1:1,000 in Blotto-T, and 3) antigen/antibody complexes were visualized using standard 
ABC reagents (Vector), followed by DAB histochemistry.  
Western blotting 
 The following primary antibodies were used for Western blotting studies: rabbit 
anti-Met (Met; # 07-283; lot No. 27208; Millipore (Upstate), Billerica, MA; immunogen: 
peptide corresponding to amino acids 1361-1379 of mouse Met (NCBI# NP 032617)), 
mouse anti-Met (Santa Cruz, sc-8057), mouse anti-alpha-tubulin loading control (alpha-
tubulin, Ab-1; # CP06; lot No. D16509-5; Oncogene Research Products, San Diego, CA; 
immunogen: native chick brain microtubules), mouse anti-GAPDH loading control 
(GAPDH; #AM4300; lot No. 08608176A; Ambion, Austin, TX; immunogen: purified 
rabbit muscle GAPDH).  
          Mice were deeply anesthetized with sodium pentobarbital (60 mg/kg i.p.) prior to 
decapitation and brain removal.  Harvested brains were immediately immersed in room 
temperature Hanks’ balanced salt solution (Sigma, Saint Louis, MO).  With the aid of an 
MZ-6 stereozoom microscope (Leica), the cerebral cortex from each hemisphere was 
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divided evenly midway along the antero-posterior axis to generate two tissue samples.  
The underlying striatum also was rapidly dissected before all samples were snap-frozen 
on liquid nitrogen and stored at -80oC.  
           P0 through >P90 cortical and striatal samples were prepared by homogenizing 
frozen tissue samples in a glass tissue homogenizer (Wheaton, Millville, NJ) with ice-
cold homogenization buffer (50 mM Tris HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 
0.1% SDS, 0.5% deoxycholate,  0.5mM DTT , 2 mM EDTA, pH 8.0, 2 mM EGTA,  
0.2mM PMSF) containing a protease inhibitor cocktail (Sigma), 50 mM activated 
Na3VO4, 100 nM microcystin, and 0.5 nM cypermethrin.  E16 tissue was sonicated 
briefly in the same buffer.  Tissue homogenates were cleared by a 16,000 x g 
centrifugation for 20 minutes at 4oC, and protein concentrations of the supernatants were 
determined using the Dc protein assay (Bio-Rad, Hercules, CA).  
 Protein samples (35 µg protein per lane) were fractionated by SDS-PAGE and 
transferred to supported nitrocellulose membranes.  The membranes were then blocked 
for 1 hr at room temperature in Blotto (3% Carnation dried milk in PBS) before being 
incubated with primary antibodies.  Polyclonal rabbit anti-Met antibodies and alpha-
tubulin antibodies were diluted 1:2500 and 1:100,000, respectively, in Blotto containing 
0.05% Tween-20.  Monoclonal mouse anti-Met antibodies were diluted 1:500 in Blotto 
alone, and GAPDH antibodies were diluted 1:200,000 in Blotto + 0.02% Tween-20.  The 
membranes were then rinsed repeatedly in PBS and incubated for 1.5 hr at room 
temperature with anti-rabbit and anti-mouse horseradish peroxidase-conjugated 
secondary antibodies (Jackson Immunoresearch).  Following several more rinses in PBS, 
the membranes were reacted with enhanced chemiluminescence reagents (GE/Amersham 
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ECL) and detected with autoradiography film (GE/Amersham hyperfilm).  
Autoradiographic films were imaged with a high resolution scanner and subjected to 
densitometric quantification using IMAGE-J.   
Digital illustrations 
 Microscopy was performed with the aid of an Axioplan II microscope (Zeiss, 
Jena, Germany), and micrographs were acquired with a Zeiss AxioCam HRc camera 
(Zeiss) in Axiovision 4.1 software (Zeiss).  No image alteration other than re-sizing was 
performed. Figures were prepared digitally in Microsoft Office Powerpoint 2003 
(Microsoft Incorporated, Redmond, WA). 
Abbreviations used in the figures 
3V 3rd ventricle 
AB accessory basal amygdaloid nucleus 
aca anterior commissure, anterior 
aci anterior commissure, intrabulbar 
acp anterior commissure, posterior 
AD anterodorsal thalamic nucleus 
AV anteroventral thalamic nucleus 
alv alveus 
AOM anterior olfactory nucleus, medial 
AOL anterior olfactory nucleus, lateral 
B basal amygdaloid nucleus 
BST bed nucleus of stria terminalis 
CA1 cornu ammonis 1 of hippocampus 
CA3 cornu ammonis 3 of hippocampus 
cg cingulum 
Cg cingulate cortex 
COa anterior cortical amygdaloid nucleus 
COp posterior cortical amygdaloid nucleus 
cp cerebral peduncle 
CP cortical plate 
CPu caudate putamen (striatum) 
DG dentate gyrus 
dhc dorsal hippocampal commissure 
DL dorsolateral thalamic nuclei 
ec external capsule 
En endopiriform nucleus 
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fi fimbria of hippocampus 
GrDG granule layer of dentate gyrus 
hbc habenular commissure 
HDB nucleus of the diagonal band, horizontal limb 
ic internal capsule 
IP interpeduncular nucleus 
L lateral amygdaloid nucleus 
LEnt lateral entorhinal cortex 
LGP lateral globus pallidus 
LHb lateral habenula 
LM lateral mammillary nucleus 
LSD lateral septal nucleus, dorsal part 
LSI lateral septal nucleus, intermediate 
LSV lateral septal nucleus, ventral part 
LV lateral ventricle 
M medial amygdaloid nucleus 
MHb medial habenula 
MM medial mammillary nucleus 
Mol molecular layer of hippocampus 
MPO medial preoptic nucleus 
MS medial septal nucleus 
mt mammillothalamic tract 
mtg mammillotegmental tract 
NLOT nucleus of lateral olfactory tract 
opt optic tract 
Or oriens layer of hippocampus 
Pir piriform cortex 
Py pyramidal cell layer of hippocampus 
Rad stratum radiatum of hippocampus 
RSG retrosplenial granular cortex 
S subiculum 
SHy septohypothalamic nucleus 
SI substantia innominata 
sm stria medullaris 
SP subplate 
st stria terminalis 
SuM supramammillary nucleus 
SVZ subventricular zone, striatum 
SVZC subventricular zone, cortex 
vhc ventral hippocampal commissure 
VL ventrolateral thalamic nuclei 
VTM ventral tuberomammillary nucleu
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Results 
Temporal patterns of Met expression during forebrain development 
Met signaling has been implicated in vitro in diverse neurodevelopmental 
processes in the forebrain, including cell migration (Powell et al., 2001; Giacobini et al., 
2007; Garzotto et al., 2008), neurite outgrowth (Powell et al., 2003; Gutierrez et al., 
2004; Lim and Walikonis, 2008), and synaptogenesis (Madhavan and Peng, 2006; 
Tyndall and Walikonis, 2006; Nakano et al., 2007), each of which occurs in vivo during 
well defined, though overlapping, temporal windows.  As a first step in identifying the 
neurodevelopmental processes for which Met signaling may be most relevant in vivo, we 
utilized Western blotting to assess Met receptor protein expression levels in three 
forebrain regions across development.  Anterior cortex, posterior cortex, and striatum 
exhibit strikingly similar temporal patterns of Met expression (Fig. 1).  Total Met protein 
levels in these regions are relatively low from peak to late periods of neurogenesis 
(E16.5).  There is a marked increase in expression levels during the perinatal period (P0), 
corresponding to a time when most cortical and striatal neurons have finished their 
migration and are actively extending both axonal and dendritic processes (Parnavelas and 
Uylings, 1980; Miller and Peters, 1981; Miller, 1986; Tepper and Trent, 1993; Tepper et 
al., 1998).  Met protein expression increases dramatically between P0 and P7 (Fig. 1), 
peaking at a period coincident with extensive neurite outgrowth and the onset of 
synaptogenesis (Blue and Parnavelas, 1983; Micheva and Beaulieu, 1996; De Felipe et 
al., 1997).  This is followed by a gradual decrease in Met expression during the peak 
period of synaptogenesis (Aghajanian and Bloom, 1967; Dyson and Jones, 1980; Blue 
and Parnavelas, 1983; Markus and Petit, 1987; Micheva and Beaulieu,  
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1996; De Felipe et al., 1997) (P14, P21).  Met levels continue to decrease through the 
onset of puberty (P35) to reach a low baseline of expression in the adult (P90).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Western blotting analysis of Met protein expression during forebrain development in wild type 
mice.  The temporal profile of Met expression is strikingly similar regardless of the forebrain region 
assayed: protein levels are relatively low embryonically (E16), but increase dramatically during perinatal 
development (P0) to reach a peak at P7.  Levels remain high through the second postnatal week (P14), but 
decline dramatically thereafter (P21) to relatively low levels in the adolescent (P35) and adult (>P90).  Note 
that peak periods of Met expression overlap with principal periods of neurite outgrowth and synaptogenesis 
in the mouse forebrain. Samples from each forebrain region were probed on separate blots and optimal film 
exposure times were independently determined.   
 
 
 The Western blotting data are consistent with a hypothesized role in vivo for Met 
signaling during multiple neurodevelopmental events, but especially neurite outgrowth 
and synaptogenesis.  To gain complementary, spatially-resolved data regarding Met 
receptor expression, we undertook detailed in situ hybridization and 
immunohistochemistry studies.  We also present immunohistochemical mapping data 
using tissue from Emx1cre/Metfx/fx mice, in which the targeted deletion preferentially 
ablates the processed, membrane-bound form of the Met receptor from all cells arising 
from the dorsal pallium, including the projection neurons of the cerebral cortex, 
hippocampus, and select amygdaloid nuclei, by E10.5 (Gorski et al., 2002). Unlike 
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constitutive Met knockout mice, which exhibit early embryonic lethality (Bladt et al., 
1995), Emx1cre/Metfx/fx mice are indistinguishable from wild type mice with regard to 
survival and reproductive capacity.  Gross analyses also show Emx1cre/Metfx/fx mice to 
have normal cortical lamination and thickness, and normal fiber tract development 
(Supplemental Fig. 1).   Thus, this targeted deletion provides an opportunity to 1) 
establish Met antibody specificity and 2) define more accurately the cellular origin of 
Met expression in axons and neuropil elements.   The results of the in situ hybridization 
and immunohistochemical mapping studies are organized by neuroanatomical region in 
two epochs: 1) during (E17.5-P16) and 2) after (P21-P35) the rise and peak of Met 
expression in the forebrain.  By convention, and to distinguish between mRNA and 
protein products, we italicize when referring to the transcript (“Met”) and do not italicize 
when referring to the protein (“Met”). 
 
Expression of Met in developing projection neurons of the cerebral cortex (E17.5-P16) 
 We readily observed Met transcript to be present in the somites as well as the 
primordial heart, kidney, and liver as early as E11.5.  However, using the specific 
hybridization conditions noted above, we did not reliably observe Met in the forebrain 
until E15, when low levels in the cerebral cortex were first detected.  Therefore, detailed 
Met expression analyses prior to E15 are most relevant to the periphery and extra-
forebrain regions of the central nervous system, and thus, are beyond the focus of the 
present study.  At all postnatal ages examined, there was little, if any, Met detected in 
developing or mature fiber tracts.  In contrast, Met protein localization revealed dense 
staining of developing axons in forebrain tracts (see below). 
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Supplemental Figure 1.  Qualitative histological and cytoarchitectural analyses in the early postnatal 
forebrain of Emx1cre/Metfx/fx mice.  A and A’: Low-magnification photomicrographs of Cresyl Violet-
stained coronal sections demonstrate grossly similar anatomical structure in wild type (A) and 
Emx1cre/Metfx/fx (A’) forebrains at P8.  B and B’: High-magnification photomicrographs of the boxed 
regions in A and A’ show comparable cortical lamination and cytoarchitecture in wild type and 
Emx1cre/Metfx/fx mice, respectively.  C and C’: Low-magnification photomicrographs of phosphorylated 
neurofilament-H immunoreactivity in coronal sections illustrate the grossly normal development of major 
axon tracts in Emx1cre/Metfx/fx (C’) mice as compared to wild type mice (C) at P7.  Scale bar = 1.1 mm for 
A, A’, C, and C’; 275 µm for B and B’.  
 
 
At birth, Western blot analysis reveals a more than three-fold increase in the total 
level of Met protein in the posterior cortex compared to the anterior cortex (Fig. 2E).  
This finding is corroborated by both in situ hybridization and immunohistochemical 
staining (Fig. 2A,C).  Thus, Met expression in the dorsal pallium exhibits a posterior 
(high) to anterior (low) gradient, which is most evident in the cortical plate.  Met is also 
expressed in the subplate, but is relatively uniform throughout its posterior-anterior 
extent.  Immunohistochemical staining reveals that Met expression in the cortex is 
localized to more posterior white matter tracts underlying the cortical plate (Fig. 2C).  By 
P7, the posterior-anterior gradient of cortical Met expression abates (Fig. 2B,D,E).   
The radial distribution of Met expression in the cortex can be observed more clearly in 
the coronal plane.  At birth, there is an emerging bi-laminar pattern of labeling (Fig. 3A-
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C), which becomes more evident by P7 (Fig. 3D-F).  At the transcript level, Met 
expression is most dense in layers II/III and in deeper layers V and VI, but essentially 
absent in layer IV (Fig. 3D,E).  Met protein is also expressed in a bilaminar pattern, with 
maximal signal in the deepest portion of the cortex, where it appears to be localized to the 
coalescing fibers of subcortically and cortico-cortically projecting axons from throughout 
the cortex (Fig. 3F).   The paucity of Met expression in layer IV is most evident in 
primary sensory cortices, particularly the somatosensory barrel fields; this is not 
surprising given the low levels of Met transcript in the dorsal thalamus (see below), and 
its absence in layer IV itself.  Though the bilaminar pattern of Met transcript expression 
remains similar at P14 compared to P7,  Met immunoreactivity at the later time point is 
substantially reduced (Fig. 3G-I).  
 
Cortically Projecting Fiber Tracts (P0 – P16) 
 
Immunohistochemical analysis during the first two weeks postnatal reveals Met 
protein expression in several fiber tracts, including the corpus callosum, cingulum, 
anterior commissure, internal capsule, and external capsule, which arise from cerebral 
cortical neurons expressing Met transcript.  The level of Met expression in these tracts is 
dynamic over this period, as described below. 
Corpus Callosum  
During the perinatal period, the corpus callosum exhibits intense Met staining, though 
expression is limited in its rostro-caudal extent (Fig. 4A,B).  At the most anterior level, 
staining of callosal fibers is sparse, but increases in density posteriorly.  At P7, the 
corpus callosum exhibits dense staining throughout its rostro-caudal extent (Fig. 4C,D).   
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Figure 2.  A transient tangential gradient of Met transcript and protein expression in the early postnatal 
neocortex.  In situ hybridization analysis of Met in sagittal sections of wild type forebrain reveals a strong 
posterior (high) to anterior (low) gradient of signal in the neocortex, which is present at E18.5 (A), but 
normalizes by P7 (B).  DIC photomicrographs of Met immunoreactivity in wild type sagittal sections show 
increased axonal labeling (arrows) in the posterior neocortex at E17.5 (C), but distributed axonal (arrows) 
and neuropil labeling throughout the anteroposterior extent by P7 (D).  Semiquantitative Western blotting 
confirms the protein gradient revealed by immunohistochemistry; Met protein levels are found on average 
to be approximately three-fold greater in posterior versus anterior neocortex at P0 but not P7 (E). Error bars 
in E represent reflect standard error of the mean, N = 3 in each group. Scale bar = 925µm for A, 1.75mm 
for B, 550 µm for C and 1.1 mm for D. 
 
 
By P14, and even more evident at P16, Met immunoreactivity in this tract becomes less 
Fig. 4E-H), and an additional pattern is observed; Met immunoreactivity is present in 
more dorsally situated axons at rostral levels (Fig. 4E,G), whereas stained fibers are 
localized ventrally at more caudal levels (Fig. 4F,H).  These staining patterns may reflect 
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unique patterns of maturation of distinct subpopulations of cortico-cortical projection 
neurons during this time period. 
 
 
Figure 3.  Laminar patterning of Met transcript and protein expression in the neocortex.  A, D, G: 
Autoradiographic images of Met transcript in coronal sections from wild type mice, scanned from film.  B, 
E, H:  DIC photomicrographs of coronal sections from wild type mice after processing for autoradiography 
and emulsion-dipping.  C, F, I: DIC photomicrographs of Met immunoreactivity in coronal sections from 
wild type mice.  At birth, low levels of Met transcript (A,B) and protein (C) are present throughout the 
extent of the neocortex, but a bi-laminar pattern of expression is emerging.  By P7 (D,E,F), laminar 
patterning is apparent, with a distinct absence of Met signal in layer IV.  This pattern of transcript 
expression is maintained at P14 (G,H), but immunohistochemical signal is reduced at this age (I).  Scale 
bar = 1.55mm for A,D,G; 275µm for B,C,F,I; 550µm for E,H. 
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Figure 4.  Met protein expression in the corpus callosum.  DIC photomicrographs show Met 
immunoreactivity in coronal sections from wild type mice.  At P0 (A, B), Met immunoreactivity is 
observed in the caudal portion of the corpus callosum, but not in the rostral region.  By P7 (C, D), Met 
expression is intense throughout the rostro-caudal extent of the tract.  Expression remains high, but 
gradually declines at P14 (E,F) and P16 (G,H).  Note that at P14 and P16, Met immunoreactivity is 
enriched in dorsally situated axons at rostral levels (arrows) and ventrally situated axons at caudal levels 
(arrowheads).  Scale bar = 275µm for all panels. 
 
 
Cingulum  
Met immunoreactivity is observed in the cingulum during postnatal development, 
particularly at P7 (Supplemental Fig. 2D).  This tract contains corticothalamic and 
thalamocortical projections that originate and terminate, respectively, in the cingulate 
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cortex, is a major pathway connecting the cingulate cortices and anterior thalamic nuclei 
to parahippocampal structures, and carries interhemispherically projecting axons of 
 
 
 
Supplemental Figure 2.  Met transcript and protein expression in the cingulate cortex and cingulum.  A-C: 
Autoradiographic images of cingulate cortex at E18.5, P7, and P14 show Met transcript expression.  DIC 
photomicrographs of Met immunoreactivity demonstrate expression of the protein in the wild type (D), but 
not in the Emx1cre/Metfx/fx (E) cingulum at P7.  By P16 (F), expression is virtually absent in the wild type 
cingulum.  Scale bar = 1.1mm for A-C; 275µm for D-F. 
 
 
neurons in association cortices (White, 1959; Domesick, 1970; Mufson and Pandya, 
1984; Shibata, 1993).  Comparison of matched sections from wild type and 
Emx1cre/Metfx/fx conditional null mice reveals an absence of cingulum staining in the 
mutant mice (Supplemental Fig. 2E), indicating that cortical efferents, not afferents, 
express Met in this tract.  This is consistent with Met transcript expression in neurons of 
the cingulate cortex (Supplemental Fig. 2A-C), and its absence in primary dorsal 
thalamic nuclei, throughout the same developmental period.  As observed in the corpus 
callosum, there is reduced Met immunostaining in the cingulum at later ages (P16, 
Supplemental Fig. 2F).   
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Anterior Commissure 
The anterior commissure and the neurons that give rise to its axons exhibit 
substantial Met protein and transcript expression, respectively (Fig. 5).  Met 
immunohistochemical labeling is apparent in both the anterior and posterior limbs of the 
anterior commissure, though staining is much more intense in the posterior limb, as 
demonstrated in coronal sections (Fig. 5D-F).  The heavily Met-expressing axons of the 
posterior limb can be seen in horizontal sections coursing out of the posterior temporal 
cortices (Supplemental Fig. 3A).  Staining is much lighter in fibers 
of the anterior limb, which emanate from the olfactory bulbs and anterior temporal 
cortices (Supplemental Fig. 3B) (Gurdjian, 1925; Brodal, 1948; Jouandet and 
Hartenstein, 1983).  Comparison of anterior commissure staining between wild type and 
Emx1cre/Metfx/fx mice confirms that the Met-expressing axons are mostly of dorsal pallial 
origin (Fig. 5D’-F’).  We note, however, the presence of some residual Met-
immunostained fibers in the P0 and P7 Emx1cre/Metfx/fx posterior limb (Fig. 5D’).  These 
fibers likely originate in the ventral endopiriform cortex, a region in which Met is not 
deleted due to low rates of Emx1-driven Cre recombination (Gorski et al., 2002).  
Met staining in the anterior commissure is reduced dramatically by P16 (Fig. 5F), despite 
continued transcript expression in the piriform cortex (Fig 5C).  Little, if any, protein is 
detected in the structure’s anterior limb, whereas low levels of expression persist in the 
posterior limb.  Comparison between staining patterns in the wild type and 
Emx1cre/Metfx/fx tissue indicates that this residual expression in the posterior limb is 
authentic (Fig. 5F’). 
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Internal Capsule   
From P0 through P7, Met protein expression is apparent in the fasciculated fibers 
of the internal capsule (Fig. 6A,C).   The virtual absence of Met immunoreactivity in 
  
 
   
  
Figure 5.  Met transcript and protein expression in the piriform cortex and anterior commissure.  A-C:  
Autoradiographic images of piriform cortex at E18.5, P7, and P14 show Met transcript expression.  DIC 
photomicrographs show Met immunoreactivity in coronal sections from wild type (D,E,F) and 
Emx1cre/Metfx/fx (D’, E’, F’) mice.  In the wild type sections, Met is expressed in both the anterior and 
posterior limbs of the commissure, though the staining is more intense in the posterior limb.  Met 
immunoreactivity is largely depleted in both limbs in the Emx1cre/Metfx/fx sections, owing to their dorsal 
pallial origin.  We note residual staining in the P0 and P7 posterior limb (D’,E’), likely due to a 
contribution from fibers originating in the ventral endopiriform cortex in which Emx1-mediated Cre 
recombination rates are low.  Scale bar = 825µm for A-C; 275µm for D-F and D’-F’. 
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Supplemental Figure 3.  Differential Met protein expression in the anterior commissure.  DIC 
photomicrographs illustrate Met immunohistochemistry in the posterior and anterior limbs of the anterior 
commissure in horizontal sections from P7 wild type mice.  Heavily stained axons within the posterior limb 
course between posterior piriform cortices (A).  In a more dorsal section, lightly stained axons within the 
intrabulbar and anterior subdivisions of the anterior limb emanate from the olfactory bulbs and anterior 
piriform cortex (B).  Scale bar = 550 µm for A and B. 
 
 
these fibers in Emx1cre/Metfx/fx mice at P0 and P7 (Fig. 6A’,C’), together with very low 
Met expression in primary sensory and motor nuclei in the dorsal thalamus, indicates that 
cortical efferents, rather than thalamocortical fibers, are labeled.  Futhermore, in wild 
type animals, Met staining in the cerebral peduncle is minimal (Fig. 6B,D,G,H), 
suggesting that cortico-tectal, -bulbar and -spinal fibers contribute little to the  Met 
staining.  Therefore, corticothalamic and corticostriatal projections seem to comprise the 
greatest proportion of Met-immunoreactive axons in the internal capsule.   
By P7, additional, moderately intense Met immunnostaining appears throughout 
the striatal and dorsal thalamic neuropil (Fig. 6C), coinciding with active periods of axon 
branching and collateralization of cortico-striatal and cortico-thalamic axons (Frassoni et 
al., 1995; Nisenbaum et al., 1998; Sheth et al., 1998).  This neuropil staining remains 
(albeit at lower intensity) through P14 and P16 (Fig. 6E,F), although by this time the 
internal capsule fibers are devoid of Met staining.  At all ages, Met expression is absent 
64 
 
 
Figure 6.  Met protein expression in the internal capsule and cerebral peduncle.  DIC photomicrographs 
illustrate Met immunohistochemistry in the internal capsule and cerebral peduncle in coronal sections from 
wild type and Emx1cre/Metfx/fx mice.  Staining of internal capsule fibers is apparent in P0 and P7 wild type 
mice (A,C) but essentially absent in matched sections from Emx1cre/Metfx/fx mice (A’,C’).  At P7, note the 
increase in Met immunoreactivity in the underlying striatal neuropil but the absence of such staining in the 
globus pallidus.  By P14 (E) and P16 (F), the internal capsule fibers are nearly devoid of Met staining, but 
there is remaining immunoreactivity in the striatal neuropil.  The paucity of Met labeling in the cerebral 
peduncle at all ages examined (P0, B; P7, D; P14, G; P16, H) suggests that cortico-tectal, -bulbar, and -
spinal fibers contribute minimally to the Met immunoreactivity in the internal capsule.  (Scale bar = 410µm 
for A,A’,B,C,C’,D; 550µm for E-H.  
 
 
in the neuropil of the globus pallidus, consistent with the lack of Met transcript in the 
caudatoputamen, the primary contributor of afferents to this structure (Preston et al., 
1980; Chang et al., 1981; Wilson and Phelan, 1982).  Met-immunopositive fibers in the 
globus pallidus appear to be corticofugal fibers of passage.   
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External Capsule  
 
The external capsule is a conduit for axons projecting between multiple cortical 
areas and the lateral, and other, subnuclei of the amygdaloid complex (Brothers and 
Finch, 1985; Faulkner and Brown, 1999; Weisskopf and LeDoux, 1999; Heinbockel and 
Pape, 2000; Szinyei et al., 2000).  This tract contains fibers that are densely stained for 
Met during the first two postnatal weeks (Supplemental Fig. 4).  As expected, there is a 
near-complete absence of Met expression in the external capsule in Emx1cre/Metfx/fx mice 
(Supplemental Fig. 4A’).  By P16, consistent with a decrease in Met expression in both 
the cortex and amygdala, only low levels of Met staining are observed in the external 
capsule (Supplemental Fig. 4B). 
 
Expression of Met in developing projection neurons of the hippocampus (E18.5-P16) 
In the hippocampus, Met transcript is expressed by pyramidal cells of the 
subiculum, CA1 and a subdomain of CA3 from birth through P14 (Fig. 7A-C).  As in the 
cerebral cortex, Met protein expression in hippocampal neurons is localized to long 
projection neurons.  At P0 and P7, immunohistochemical staining of Met reveals intense 
labeling of axons in the alveus and fimbria/fornix (Fig. 7D,E), which are comprised in 
part of the extrinsically projecting axons of the hippocampus.  Specifically, Met 
immunostaining is dense in the precommissural and postcommissural divisions of the 
fornix (Fig. 7J,K), which project to the septum and hypothalamus, respectively.  The 
dorsal and ventral aspects of the hippocampal commissural division of the fornix also 
express Met protein (Fig. 7I,J).  All fornix divisions in the Emx1cre/Metfx/fx mouse are 
devoid of Met protein (Fig. 7M,N,O), demonstrating that Met-expressing axons in this 
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fiber tract originate from dorsally derived hippocampal pyramidal neurons, rather than 
from the various subcortical targets to which they are reciprocally connected.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure 4.  DIC photomicrographs illustrate Met immunohistochemistry in the external 
capsule (arrows) in coronal sections.  At P7, Met immunoreactivity is present in the external capsule in 
wild type (A), but not Emx1cre/Metfx/fx (A’), mice.  By P16, Met staining is not observed in the external 
capsule of wild type (B) or Emx1cre/Metfx/fx (B’) mice.  Scale bar = 400µm for all panels. 
 
 
Throughout development, Met transcript is conspicuously absent in the dentate 
granule neurons of the hippocampus (Fig. 7A-C).  Consistent with this, axons projecting 
from these cells to CA3 via the mossy fiber pathway are not Met-immunoreactive.  In 
contrast, Met immunolabeling is observed in the stratum moleculare of wild type (Fig. 
7H), but not Emx1cre/Metfx/fx, mice (Fig. 7L), mostly likely representing perforant path 
fibers originating from layer II entorhinal cortex (Steward and Scoville, 1976; Dolorfo 
and Amaral, 1998; van Groen et al., 2002).  The lighter immunostaining observed in the 
strata radiatum and oriens of CA1 and CA3 also is absent in Emx1cre/Metfx/fx mice (Fig. 
7H,L), consistent with Met-expression in the terminal fields of a subpopulation of  
bilaterally projecting CA3 neurons (Gottlieb and Cowan, 1973; Swanson et al., 1978).  
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We note, however, that this terminal axon Met staining cannot be differentiated from 
staining in the apical and distal dendrites of CA3, CA1, and subicular pyramidal neurons.  
Similar to the cerebral cortex, Met immunolabeling in the hippocampus and associated 
axon tracts is greatly reduced at P14 and P16 (Fig. 7F,G). 
 
 
Figure 7.  Met transcript and protein expression in the hippocampus.  A-C: Autoradiographic images of Met 
transcript in coronal sections from wild type mice, scanned from film.  At all ages, autoradiographic signal 
is observed in the stratum pyramidale of the subiculum, CA1, and a subregion of CA3. Signal is absent in 
the dentate gyrus (DG).  D-O: DIC photomicrographs of Met immunoreactivity in coronal sections from 
wild type (D-K) and Emx1cre/Metfx/fx (L-O) mice.    D and E: DIC images of Met immunoreactivity from 
wild type mice show robust staining of the alveus and fimbria/fornix at P0 (D) and P7 (E), indicating that 
efferent axons of hippocampal pyramidal cells express Met.  This staining decreases at later ages (P14, F; 
P16, G).  Light staining in the strata oriens and radiatum and heavier staining in the stratum moleculare is 
observed in wild type (H), but not Emx1cre/Metfx/fx (L), mice at P7. Heavy Met staining is present in the 
dorsal hippocampal commissure (I), ventral hippocampal commissure (J), precommissural fornix (J), and 
postcommissural fornix (K).  This staining is completely absent in corresponding axon tracts in the 
Emx1cre/Metfx/fx mouse (M, N, and O).  Scale bar = 1mm for A-C; 275 µm for D-O.  
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Expression of Met in developing projection neurons of the septum (E18.5-P16) 
 
Met transcript expression in the septum is robustly detected perinatally (Fig. 8A), 
with dense labeling restricted to dorsolateral neurons and lighter labeling in the medial 
nucleus.  This pattern persists throughout the first two postnatal weeks (Fig. 8B,C).  Met 
immunolabeling in the dorsolateral septum is considerable, and the pattern of staining is 
equivalent in wild type and Emx1cre/Metfx/fx mice.  This suggests localization to cell 
bodies or terminating afferent axons of a subpallial origin (Fig. 8H,L), but distinguishing 
between cell body and neuropil localization is difficult at the light microscopic level.  In 
contrast, axonal Met immunoreactivity clearly predominates in the intermediate lateral 
and medial septal nuclei (Fig. 8I).  This staining is greatly reduced in the Emx1cre/Metfx/fx 
mouse (Fig. 8M), consistent with a loss of Met-expressing septal afferents of a dorsal 
pallial origin.  Axons of dorsally derived hippocampal pyramidal neurons innervate both 
dorsal and intermediate lateral nuclei, and, to a lesser extent, the medial septal nucleus 
(Swanson and Cowan, 1979; Staiger and Nurnberger, 1991; Phelan et al., 1996), and a 
substantial proportion of these axons express Met (Fig. 7). Therefore, Met-expressing 
hippocampal neurons may selectively target specific septal nuclei. 
Select septal efferents also express Met.  For example, dorsolateral septum 
contributes a robust intra-septal projection to the nucleus of the horizontal diagonal band 
(Swanson and Cowan, 1979; Staiger and Nurnberger, 1991; Phelan et al., 1996), in which 
some terminal fibers appear to be Met-immunopositive in wild type mice.  A lack of Met 
transcript labeling in the nucleus of the horizontal diagonal band, (see Fig. 8A,B,C) and a 
maintenance of Met-immunostained axons in the nucleus of the diagonal band in the 
Emx1cre/Metfx/fx mouse (Fig. 8M) are consistent with this observation.   
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Figure 8.  Met transcript and protein expression in the septum in coronal sections from wild type and 
Emx1cre/Metfx/fx mice.  A-C: In situ hybridization analysis of Met in wild type septum across perinatal 
(E18.5, A) and early postnatal development (P7, B; P14, C).  At all ages, autoradiographic signal is 
observed specifically in dorsolateral and medial subnuclei.  D-G: DIC photomicrographs of Met 
immunoreactivity from wild type mice show labeling throughout the septum (outlined regions) at P0 (D) 
and P7 (E), which is decreased by P14 (F) and hardly detectable above background levels at P16 (G).  At 
P7, all Met staining of the dorsolateral septum (H) and partial staining of the nucleus of the diagonal band 
(I) of wild type mice is preserved in Emx1cre/Metfx/fx mice (L and M).  Stained afferents in the medial and   
intermediate septal nuclei (I) and the anteromedial hypothalamus (K) of wild type mice are absent in 
Emx1cre/Metfx/fx mice (M and O) at P7, indicating a dorsal pallial rather than septal origin for Figure 8—
cont.  these fibers.  Septo-habenular axons do not express Met as evidenced by a lack of staining in the stria 
medullaris in both wild type (J) and Emx1cre/Metfx/fx (N) mice at P7.  Scale bar = 1.35mm for A-C; 550 µm 
for D-O.  
 
          
Neurons in the lateral and medial septal nuclei contribute descending projections 
to the medial preoptic area of the hypothalamus and ascending projections to the 
hippocampus, respectively (Swanson and Cowan, 1979; Chiba and Murata, 1985; Risold 
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and Swanson, 1997), but Met-expressing axons in these regions are undetectable in 
Emx1cre/Metfx/fx mice (Figs. 8O and 7L).  This suggests that the fibers originate from 
projection neurons of the Emx1-expressing lineage, and not septal neurons.  Additionally, 
though septal neurons are known to contribute efferents to the habenula via the stria 
medullaris, these cells predominantly reside in the septofimbrial and triangular nuclei 
(Herkenham and Nauta, 1977; Swanson and Cowan, 1979; Kawaja et al., 1990), where 
Met transcript is not detected (data not shown).  Axons in the stria medullaris are also 
devoid of Met protein expression in both wild type and Emx1cre/Metfx/fx mice (Fig. 8J,N).  
 Though some Met immunohistochemical signal is evident on afferent axons 
within the medial and intermediate lateral nuclei of the septum at P14 and P16 (Fig. 
8F,G), in contrast to earlier ages (Fig. 8D,E), staining is difficult to distinguish from 
background.  There is also a concomitant reduction of Met staining on axons likely to be 
dorsolateral septal efferents to the nucleus of the diagonal band (data not shown).  This 
downregulation of axonal Met expression mirrors that observed in both cerebral cortical 
and hippocampal projection neurons after the second postnatal week.   
 
Expression of Met in developing projection neurons of the amygdala (E18.5-P16) 
 
Of the 13 commonly recognized nuclei within the amygdaloid complex 
(Aggleton, 2000), 5 express Met during postnatal development.  From caudal to rostral, 
these are the posterior cortical amygdala, basal amygdala, lateral amygdala, medial 
amygdala, and the nucleus of the lateral olfactory tract.  Met transcript is detected within 
these nuclei perinatally (Fig. 9A,B,C), at P7 (Fig. 9D,E,F), and at P14 (Fig. 9G,H,I).  
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During this same period, Met protein expression is particularly dense in amygdalofugal 
axons of the stria terminalis.  
At P7, there is intense Met immunostaining in the posterior cortical amygdaloid 
nucleus, from which Met-immunostained axons appear to project anteriorly via the stria 
terminalis (Canteras et al., 1992) (Fig. 10A,B).  More rostrally, Met-expressing axons 
from the basal amygdaloid nucleus appear to join the stria terminalis (Fig. 10C) as it 
courses into the ventral forebrain to target the bed nucleus of the stria terminalis (Fig. 
10E,F).  Met-expressing axons in more medial aspects of the stria terminalis emanate 
from the medial amygdala (Fig. 10C), which contributes dense projections to the bed 
nucleus of the stria terminalis (Canteras et al., 1995).  Intensely labeled axons are also 
present within the decussation of the stria terminalis, coursing beneath the 
precommissural fornix, directly superior to the anterior commissure (Fig. 10F).   
Therefore, in addition to ipsilateral projections, Met appears to be expressed on 
contralateral amygdalofugal projections to the bed nucleus of the stria terminalis, which  
most likely arise from the posterior cortical nucleus (Dong et al., 2001).  The lateral 
amygdala, which contains Met-expressing neurons, projects to prefrontal cortex, other 
amygdaloid nuclei, and the nucleus accumbens (McDonald, 1991b; Aggleton, 2000).  Of 
these, only the prefrontal cortex and posterior cortical amygdaloid nucleus exhibit robust 
Met immunostaining, which is lost in Emx1cre/Metfx/fx mice (Fig. 10A,A’, data not 
shown).  However, because both of these regions receive numerous afferents of dorsal 
pallial origin, it is not possible to trace the origin of Met-expressing axons within these 
two regions to the lateral amygdala.  Though likely, it is not absolutely certain that Met is 
expressed on efferents of the lateral amygdala.  
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Figure 9.  In situ hybridization analysis of Met in the rostro-caudal extent of the amygdala during 
development.  Autoradiographic images of E18.5 coronal sections show signal in the posterior cortical 
amygdala (A), the lateral, basal, and medial amygdala (B), and the nucleus of the lateral olfactory tract at 
the most rostral extent of the structure (C).  Signal is observed in these same amygdaloid nuclei at both P7 
(D, E, and F) and P14 (G, H, and I).  Scale bar = 925µm for all panels.  
 
 
Based on recombination patterns in the Emx1-cre reporter mouse (Gorski et al., 
2002), we expected only those Met-positive axons originating from medial amygdaloid 
neurons to remain immunoreactive in the stria terminalis of the Emx1cre/Metfx/fx mouse.  
Indeed, this appears to be the case (Fig. 10A’-F’).  Interestingly, immunohistochemical 
analysis in the null mouse indicates that only a subpopulation of medial amygdaloid 
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Figure 10.  Met protein expression in the amygdala.  DIC photomicrographs illustrate Met 
immunohistochemistry in coronal sections through the caudo-rostral extent of the amygdala and stria 
terminalis (st) in wild type (A, B, C, D, E, F) and Emx1cre/Metfx/fx (A’, B’, C’, D’, E’, F’) mice at P7.  Met-
expressing neurons in the posterior cortical amygdala (A) project labeled axons anteriorly in the st (B).  
More anteriorly, Met-expressing axons from the basal and medial amygdala (MeA) join the vertical limb of 
the st, course over the internal capsule (C, upper panel D, and E), and terminate in the ipsilateral bed 
nucleus of the stria terminalis (BST) and the contralateral BST via decussation at the midline (dashed line) 
(F).  In Emx1cre/Metfx/fx mice, Met staining persists in a subset of st axons that originate from the MeA 
(arrows in C’, D’, E’, and F’).  Met staining is also present in the nucleus of the lateral olfactory tract in the 
rostral extent of the amygdala in both wild type and Emx1cre/Metfx/fx mice (lower panel D and D’).  Scale 
bar = 550 µm for all panels.  
 
 
efferents express Met; although the medial amygdala projects to both the bed nucleus of 
the stria terminalis and the medial preoptic area of the hypothalamus (Canteras et al., 
1995), only Met-stained axons in the latter are ablated in the Emx1cre/Metfx/fx mouse, 
indicating that these axons arise from neurons derived from the dorsal pallium rather than 
the medial amygdala (Fig. 8O). 
At the most anterior extent of the amygdala, dense Met immunostaining is evident 
in the nucleus of the lateral olfactory tract in both wild type (Fig. 10D) and 
Emx1cre/Metfx/fx mice (Fig. 10D’).  Thus, axonal staining in this nucleus likely arises from 
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a non-Emx1-cre expressing subcortical or intra-amygdaloid region.  Considering the data 
from anterograde labeling studies (Santiago and Shammah-Lagnado, 2004),  and reported 
minor potential for Emx1-cre-mediated recombination within the nucleus of the lateral 
olfactory tract (Gorski et al., 2002), the staining pattern is consistent with the nucleus of 
the lateral olfactory tract receiving Met-immunoreactive input primarily from its 
contralateral counterpart. 
Consistent with other forebrain areas, there is a significant decrease in Met 
expression in the amygdaloid complex after P7.  Specifically, Met immunostaining is 
reduced between P14-16 in the stria terminalis (Supplemental Fig. 5E,F) and various 
targets of amygdaloid projections, including the bed nucleus of the stria terminalis 
(Supplemental Fig. 5G,H), the nucleus of the lateral olfactory tract (Supplemental Fig. 
5C,D), and the posterior cortical amydaloid nucleus (Supplemental Fig. 5A,B).   
 
Expression of Met in developing projection neurons of the diencephalon (P0-P16) 
Met mRNA expression is evident in the thalamic reticular nucleus, but no other 
dorsal thalamic nuclei, at P7 (Fig. 11A) and P14 (Fig. 11B).  However, Met protein is 
expressed in the neuropil in several thalamic nuclei, including the reticular, dorsolateral, 
ventrolateral, and anterior thalamic nuclei.  In most regions, this immunostaining is 
virtually absent in the Emx1cre/Metfx/fx mouse (Fig. 11D), indicating corticofugal 
projections as the primary source of Met labeling.  In contrast, Met immunostaining is 
equivalent in the anterior thalamic nucleus in wild type and Emx1cre/Metfx/fx mice (Fig. 
11E,F), particularly in its anteroventral division, and appears to be localized to axons.  
Continued expression of Met in these processes in the Emx1cre/Metfx/fx mouse is somewhat 
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unexpected, considering that Met is dramatically downregulated in Emx1cre/Metfx/fx 
cingulate cortical neurons, which send projections to the anterior nucleus of the thalamus 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure 5.  Decreased postnatal Met expression in the amygdala.  DIC photomicrographs 
illustrate Met immunoreactivity in coronal sections through the caudo-rostral extent of the amygdala and 
stria terminalis (st) in wild type mice at P14 and P16.  Met staining in the posterior cortical amygdala (A), 
nucleus of the lateral olfactory tract (C), and st before (E)   and after (G) decussation at the midline (dashed 
line), is light at P14 and is further reduced in intensity in these same structures just two days later, as shown 
at P16 (B, D, F, and H).  Scale bar = 550 µm for all panels.  
 
 
 (Supplemental Fig. 2D,E).  However, the mammillary nuclei of the posteromedial 
hypothalamus also contribute a major population of afferents to this structure via the 
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mamillothalamic tract, which, along with the mammillotegmental tract, heavily express 
Met protein (Fig. 12A,B).  Moreover, Met immunoreactivity is present in the 
anteroventral, but not the anterodorsal subnuclei of the anterior thalamus (Fig. 11E,F), 
consistent with the selective patterns of innervation within this nucleus by the medial 
mammillary nuclei (Guillery, 1957; Cruce, 1975; Watanabe and Kawana, 1980; Seki and 
Zyo, 1984).  The medial mammillary nuclei themselves receive prominent input from  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11.  Met transcript and protein expression in the thalamus in coronal sections from wild type and 
Emx1cre/Metfx/fx mice.  A and B: In situ hybridization analysis of Met in wild type thalamus at P7 (A) and 
P14 (B).  Autoradiographic signal is detected specifically in the thalamic reticular nucleus (Rt) at these 
ages.  DIC images of Met immunoreactivity at P7 show that neuropil staining in the Rt and dorsolateral and 
ventrolateral thalamic nuclei in wild type mice (C) is greatly reduced in corresponding regions of 
Emx1cre/Metfx/fx mice (D).  Conversely, neuropil staining in specific anterior thalamic nuclei is equivalent in 
wild type (E) and Emx1cre/Metfx/fx (F) mice.  Scale bar = 900µm for A,B; 550 µm for C, D, E, and F.  
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subicular projection neurons at the septal pole of the hippocampus (Swanson and Cowan, 
1977; Allen and Hopkins, 1989; Gonzalo-Ruiz et al., 1992).  These fibers course via the 
postcommissural division of the fornix to terminate specifically within the medial 
mammillary nuclei, and are Met-immunopositive in wild type (Fig. 12C), but not 
Emx1cre/Metfx/fx, mice (Fig. 12D).  The dense axonal staining observed in the ventral 
tuberomammillary nucleus (Fig. 12C) may be contributed by projection neurons in 
infralimbic cortex, ventral CA1 or the subiculum (Ericson et al., 1991; Canteras and 
Swanson, 1992; Cenquizca and Swanson, 2006).  
 In the anterior hypothalamus, there is no Met expression in the anterodorsal or 
medial preoptic nuclei at any stage of postnatal development, but Met immunoreactivity 
is observed in a sparse, but notable, population of axons in both regions (Figs. 8K and 
12E).  This staining is ablated in the Emx1cre/Metfx/fx mouse (Figs. 8O and 12F).  While 
the data do not definitively elucidate the sources of these Met-expressing fibers, likely 
candidates include CA1 and subicular pyramidal cells at the ventral pole of the 
hippocampus (Canteras and Swanson, 1992; Kishi et al., 2000; Cenquizca and Swanson, 
2006).  An intranuclear source for these stained axons is unlikely, as we do not detect Met 
mRNA in the anterodorsal nucleus or medial preoptic nucleus.  
In the habenula, Met transcript and protein are expressed by projection neurons.  
In situ hybridization analysis from E18.5 to P14 reveals modest Met transcript expression 
of the medial, but not the lateral, nucleus (Fig. 13A,B).  Over this period, the fasciculus 
retroflexus axons coursing between the habenula and interpeduncular nucleus (Akagi and 
Powell, 1968; Herkenham and Nauta, 1977) are also Met-immunoreactive (Fig. 13C,E).  
Light axonal staining in the habenular commissure is also observed (Fig. 13C).  
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Consistent with the subpallial origin of the medial habenula, comparable levels of Met 
protein are observed in the fasciculus retroflexus, habenular commissure, and 
interpeduncular nucleus of the wild type and Emx1cre/Metfx/fx mice throughout postnatal 
development (Fig. 13D,F).  In general, decreased axonal Met staining is observed 
throughout the diencephalon soon after the end of the second postnatal week 
(Supplemental Fig. 6), mirroring the decline in other forebrain regions.  A notable 
exception, however, is the relative preservation of Met staining in the fasciculus 
retroflexus and interpeduncular nucleus (Supplemental Fig. 6C,D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12.  Met protein expression in the hypothalamus.  DIC photomicrographs illustrate Met 
immunoreactivity in coronal sections of the hypothalamus and associated axon tracts in wild type (A, C, 
and E) and Emx1cre/Metfx/fx (B, D, and F) mice at P7.  Intense Met staining in the mammillothalamic and 
mammillotegmental tracts of wild type mice (A) is maintained at equivalent levels in Emx1cre/Metfx/fx mice 
(D).  Notable Met staining on afferents within specific mammillary nuclei (C) and the medial preoptic 
nucleus (E) in wild type mice is absent in Emx1cre/Metfx/fx mice (D and F), indicating a dorsal pallial origin 
for these fibers.  Scale bar = 550 µm for A, B, C, and D; 275 µm for E and F.  
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Expression of Met (P21 – P35) 
It is clear from in situ hybridization analysis that, after P21, Met transcript 
continues to be expressed in the forebrain, though at reduced intensity (Fig. 14A).  Even 
more dramatic reductions in immunohistochemical staining are observed at these later 
postnatal ages, as demonstrated by a lack of differential staining in wild type and 
Emx1cre/Metfx/fx mice (Fig. 14B).  This contrasts with the observation that Met protein is 
detected by Western blot analysis in wild type but not Emx1cre/Metfx/fx cortex (Fig. 14C), 
suggesting that the lack of detectable Met protein expression in tissue sections at P21 
may be due to technical limitations.  For example, subcellular redistribution of Met may 
reduce local protein concentration to levels beneath the threshold for 
immunohistochemical detection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13.  Met transcript and protein expression in the epithalamus in coronal sections from wild type and 
Emx1cre/Metfx/fx mice.  A and B: In situ hybridization analysis of Met in wild type habenula at P7 and P14.  
Autoradiographic signal at both ages is specific to the medial but not the lateral habenula.  DIC 
photomicrographs of Met immunoreactivity show equivalent, dense staining of axons in the habenular 
commissure and fasciculus retroflexus (fr) in wild type (C) and Emx1cre/Metfx/fx (D) mice at P7.  Levels of 
axon staining also are equal within target areas of the fr, such as the interpeduncular nucleus, in wild type 
(E) and Emx1cre/Metfx/fx (F) mice at this age.  Scale bar = 1.9mm for A,B; 275 µm for C, D, E and F.  
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Discussion 
The data in the present study provide a comprehensive map of Met receptor 
mRNA and proteinlabeling in the developing mouse forebrain, revealing a surprisingly 
restricted pattern of expression in functionally related circuits.  The in situ hybridization 
data are consistent with, but significantly extend, findings from previous mapping studies 
(Jung et al., 1994; Thewke and Seeds, 1999).  Previous studies reporting Met 
immunohistochemistry in the forebrain have had a limited neuroanatomical and 
developmental scope (Thewke and Seeds, 1999; Korhonen et al., 2000; Sun et al., 2002; 
Ohya et al., 2007), and the antibody reagents used yielded suboptimal and nonspecific 
labeling in our hands.  We employed a novel immunohistochemical approach to localize 
Met receptor protein, providing compelling evidence that Met is expressed in specific 
developing axonal projections that reach select terminal regions in the forebrain.  
Furthermore, our Met immunohistochemical analyses in the Emx1cre/Metfx/fx conditional 
knockout mouse provide an opportunity to attribute sources of Met labeling within a 
specific forebrain region as pallial or subpallial in origin.  
Our complementary expression mapping tools allowed us to determine that Met 
receptor expression during forebrain development is restricted mainly to specific 
populations of projection neurons within the cortex and some classically defined limbic 
system components.  Moreover, Met protein is localized primarily to the axons of these 
cells during peak periods of axon growth and synapse formation, consistent with a 
putative role for Met in regulating these functions.  These data suggest that circuitry 
underlying socio-emotional processing may be selectively vulnerable to disrupted Met 
signaling or expression during development.  This is consistent with data demonstrating 
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Supplemental Figure 6.  Decreased postnatal Met expression in the diencephalon.  DIC photomicrographs 
illustrate Met immunoreactivity in coronal sections through the diencephalon of wild type mice at P16.  
Previously robust Met staining in the thalamic reticular nucleus and dorsolateral and ventrolateral thalamus 
(A) and mammillothalamic tract (B) is scarcely detectable above background at P16.  Axonal Met staining 
is comparatively preserved in the fasciculus retroflexus (C) and interpeduncular nucleus (D) at this same 
age.  Scale bar = 550 µm for all panels.  
 
 
that a MET allelic variant increases risk for ASD, a disorder with core disruptions in 
social behavior (Campbell et al., 2006). 
 
Restricted cell types express Met in the developing forebrain 
 
The present study identifies specific subsets of projection neurons expressing Met 
transcript and provides evidence that these developing neurons traffic Met protein 
predominantly to their axonal compartments.  This is consistent with the reported growth-
promoting and attractive nature of HGF/Met signaling on axons in the spinal cord and 
thalamus in vitro (Ebens et al., 1996; Powell et al., 2003).  However, here we 
demonstrate in vivo that the peak of axonal Met expression occurs after the initial 
establishment of fiber pathways, suggesting that Met may play a preferential role in 
collateralization and terminal field growth, rather than axon guidance - a distinction that 
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was previously unappreciated.  This hypothesis is further supported by the appearance of 
Met immunoreactivity in the striatal and thalamic neuropil during periods of robust 
corticostriatal and corticothalamic axon collateralization (Frassoni et al., 1995; 
Nisenbaum et al., 1998; Sheth et al., 1998).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14.  Analysis of Met transcript and protein expression in the developing mouse forebrain at P21 and 
P35.  A:  In situ hybridization analysis of Met in coronal sections from wild type mice at P21 and P35 
shows equivalent patterns of expression to those observed in early postnatal development (P0 – P14).  B: 
DIC photomicrographs of coronal sections from wild type (left) and Emx1cre/Metrx/fx (right) mice 
demonstrate that at P21 (shown here) and later, no differences in Met immunoreactivity are observed.  C: 
Western blot analysis of total Met protein in P21 wild type and Emx1cre/Metfx/fx mice.  Levels of Met in wild 
type mice (1,3,5) remain much higher than those in null mice (2,4,6) despite a lack of 
immunohistochemical staining as shown in B.  Scale bar = 1.3 mm for both panels in A; 1.1 mm for both 
panels in B. 
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The general subsidence of Met protein expression in forebrain axons after the end 
of the second postnatal week coincides with a transition from axon outgrowth and 
elaboration to pruning and arbor refinement in most murine forebrain circuits (Stanfield 
et al., 1982; Stanfield et al., 1987; Gomez-Di Cesare et al., 1997; Portera-Cailliau et al., 
2005).  In the corpus callosum and stria terminalis, however, Met expression persists later 
and is detected through P21. This may reflect, relative to other axon tracts, more 
protracted periods of development, which, for the corpus callosum, have been determined 
by measurements of myelination (Jacobson, 1963; Tanaka et al., 2003; Vincze et al., 
2008).   
 Though we found Met to be expressed predominantly by axons of projection 
neurons during forebrain development, our data do not preclude this receptor from being 
expressed at lower levels within dendrites and postsynaptic compartments, and even by 
other neuronal cell types.  For example, though Met mRNA was not evident at any time 
in the ganglionic eminence and maturing striatum, Met protein labeling is seen on 
interneurons in explant cultures from the ganglionic eminence (Powell et al., 2001).  
Additionally, cultured dorsal thalamic neurons respond to HGF (Powell et al., 2003), 
indicating that either in vitro conditions may induce Met expression on neurons that 
normally do not express the transcript and protein during development, or the receptor is 
expressed below the limits of detection on certain cell types in vivo. 
At the subcellular level, a shift to a predominantly synaptic localization after P14 
may result in a more evenly distributed Met receptor population throughout the neuropil, 
which would be less readily detected by immunohistochemistry than axon fascicles and 
tracts, where protein levels are more concentrated.  This may explain the discrepancy 
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between robust biochemical detection of Met protein at P21 and the lack of 
immunostaining in tissue sections.  This interpretation is consistent with 
electrophysiological, biochemical and immuno-electron microscopy studies in the 
hippocampus that indicate Met to be present and functional at excitatory synapses in 
mature animals (Akimoto et al., 2004; Tyndall and Walikonis, 2006). Furthermore, there 
is emerging evidence that Met plays a developmental role in synaptic organization, as 
recent in vitro studies have demonstrated that HGF/Met signaling results in the enhanced 
expression and clustering of synaptic components (Madhavan and Peng, 2006; Tyndall 
and Walikonis, 2006; Nakano et al., 2007).  
By adolescence and into adulthood, Met protein expression is low throughout the 
forebrain.  Despite this dramatic down-regulation, however, patterns of transcript 
expression remain similar across early and late postnatal development, suggesting that the 
same populations of forebrain projection neurons express Met even during late 
developmental periods.  This may reflect additional roles for Met in response to stress.  
For instance, Met is dramatically upregulated in cortical and hippocampal axons in adult 
animals with genetically compromised astrocytic populations (Su et al., 2007).  HGF and 
Met are also upregulated in the cerebral cortex subsequent to a transient ischemic insult, 
though it is not known if Met protein levels specifically increase in cortical axons in this 
case (Honda et al., 1995).  
  In addition, there are reports of Met expression by non-neuronal cells of the CNS, 
including astrocytes, oligodendrocytes and microglia.  Many of these studies report 
expression by these glial subtypes in vitro (Machide et al., 2000; Yan and Rivkees, 2002) 
or in injury or disease states (Lalive et al., 2005; Kitamura et al., 2007; Shimamura et al., 
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2007), which may induce or enhance expression of the transcript and protein.  In a 
developmental context, Ohya and colleagues report that striatal oligodendrocyte 
precursor cells (OPCs) express Met in vivo and respond to intrastriatal injections of HGF 
by remaining in a proliferative, immature state, delaying myelination (Ohya et al., 2007).  
However, we do not observe Met mRNA in cell bodies within either the gray matter or 
fiber tracts of the developing striatum, suggesting that the reported effects of HGF on 
OPC maturation may be axonally derived.  While we cannot eliminate the possibility of 
Met expression by non-neuronal cells in the striatum and other forebrain regions, the 
patterns of labeling are not consistent with such expression during forebrain 
development.   
 
Limbic system correlates of Met expression 
While analysis of the spatio-temporal dynamics of Met expression provides 
insight into its cellular roles during development, analysis at the neural systems level 
lends insight into potential roles for Met signaling in the development of specific 
forebrain circuits.  Patterns of Met expression overlap remarkably with classically 
defined limbic structures and their interconnecting fiber pathways (Broca, 1878; Papez, 
1937; MacLean, 1955).  It seems likely, therefore, that this receptor may be particularly 
important to the establishment of circuits that mediate social and emotional information 
processing.  In the cortex, Met is expressed in multiple areas that have roles in processing 
limbic information, including the cingulate, prefrontal, orbitofrontal, temporal, and 
sensory association cortices.  Additionally, Met is expressed in limbic structures involved 
in learning and memory, including the hippocampal formation and the mammillary 
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bodies of the hypothalamus.  Finally, Met is expressed in amygdaloid subnuclei, which 
attach emotional valence to the processes of learning and memory (Davis and Whalen, 
2001; Phelps and LeDoux, 2005), and the septum, which has roles in emotional 
regulation and the control of impulses (Gray and McNaughton, 1982; Menard and Treit, 
1999).   
Substantial Met expression is also present in axon pathways interconnecting 
principal limbic circuit nodes. For example, Met is expressed heavily in the cingulum, 
fornix, mammillothalamic tract, and internal capsule, all considered to be classic limbic 
pathways (Broca, 1878; Papez, 1937; MacLean, 1955).  Additionally, Met expression is 
observed in the anterior commissure, which transmits information between temporal 
cortical areas, and tracts connecting the amygdala to other forebrain areas including the 
external capsule and the stria terminalis.  Temporally, expression of Met in these fibers 
coincides with the period of maximal axonal outgrowth and collateralization, suggesting 
that Met is involved in these processes, and, therefore, in the development of limbic 
connections.  As a corollary, aberrant Met signaling would likely result in deficient 
formation and subsequent function of these circuits.  This is consistent with the first 
reported association of MET with a human, brain-based disorder, ASD (Campbell et al., 
2006).   
 
A role for Met in neurodevelopmental and neuropsychiatric disorders 
 Given the prevalence of Met in the forebrain structures discussed above, we 
hypothesize that this protein, or elements of its signaling pathway, may play a role in the 
etiology and/or pathophysiology of neurodevelopmental and psychiatric disorders with 
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socio-emotional valence.  Three lines of evidence support this hypothesis.  First, MET, 
the human homolog of Met, has been identified as an ASD susceptibility gene (Campbell 
et al., 2006).  Second, MET protein expression is reduced in the superior temporal gyrus 
of individuals with autism (Campbell et al., 2007), whereas transcripts encoding other 
proteins in the MET signaling pathway are increased significantly.   Third, an analysis of 
MET pathway genes reveals an association of an allelic variant of PLAUR with ASD 
(Campbell et al., 2008).  PLAUR encodes the urokinase plasminogen activator receptor, 
which enhances HGF activation and signaling (Pepper et al., 1992; Mars et al., 1993). 
 At a cellular level, too, our findings suggest that disruption of MET may underlie 
or contribute to the pathophysiology of neuropsychiatric disorders.  It has been suggested 
that many disorders, including ASD and schizophrenia, result from aberrant formation of 
neuronal connections during development (Rubenstein and Merzenich, 2003; Frith, 2004; 
Courchesne and Pierce, 2005; Geschwind and Levitt, 2007; Connors et al., 2008).  The 
timing of expression, and the cellular compartmentalization of Met expression in the 
mouse suggests that the protein may have a larger than previously appreciated role in 
establishing and facilitating the maturation of appropriate connections.  Consequently, 
errant Met signaling is likely to result in disruption of normal patterns of connectivity in 
the forebrain.  Disrupted Met signaling could result from alterations in the regulation, 
timing, or levels of receptor expression.  Ongoing analysis of the Emx1cre/Metfx/fx mouse 
and other models of disrupted Met signaling will help to elucidate the roles of Met in 
developing forebrain connectivity. 
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Abstract 
             Two lines of evidence support the hypothesis that MET receptor tyrosine kinase 
signaling regulates the wiring of socially and emotionally relevant forebrain circuits.  
First, a functional MET promoter variant is associated with the social and communication 
phenotypes of autism spectrum disorders (ASD).  Second, the homologous murine 
receptor, Met, is expressed most heavily in long-projecting axons of the neocortex and 
limbic system during the developmental period when connections between these 
structures are being established.  This study tests the hypothesis that MET forebrain 
expression reflects species-specific specialization of circuits that underlie social 
interaction, a core behavior that is disrupted in ASD.  We compared patterns of Met/MET 
protein expression in the developing mouse and rhesus macaque forebrain.  There was a 
strong temporal conservation of expression during the time of rapid axon pathway 
development and the onset of terminal growth and robust synapse formation.  Moreover, 
expression patterns of Met/MET in limbic-related structures were almost identical in both 
species.  These conserved patterns were in marked contrast to the highly divergent 
expression that was evident in the neocortex.  In mouse, Met was broadly distributed 
throughout neocortex. In the macaque, only selective regions of anterior cingulate, 
inferior temporal, posterior parietal and visual cortices expressed MET, including face 
processing regions.  Overall, the pattern is consistent with the importance of vision in the 
social repertoire of the primate.  These data suggest an evolutionarily conserved, 
developmental function of the MET receptor in wiring together limbic and neocortical 
circuits that facilitate species-appropriate social behaviors.                    
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Introduction 
 Current etiological theories of autism spectrum disorders (ASD), defined in part 
by deficits in social interaction and communication, are based on the concept of 
developmental disruptions in forebrain connectivity (Frith, 2004; Geschwind and Levitt, 
2007; Levy, 2007).  Evidence supporting these theories has largely come from genetic 
susceptibility, correlated clinical phenotypes, and functional imaging studies. The latter 
have revealed altered patterns of brain activity and synchronization in individuals with 
ASD during social information processing and communication tasks (Just et al., 2004; 
Koshino et al., 2008; Acker and Antic, 2009).  However, a mechanistic understanding of 
the development of aberrant social circuitry is currently limited. 
 One approach to elucidating etiological mechanisms of ASD is to study the 
developmental functions of associated, variant genes.  Independent genetic studies of 
ASD have revealed CNVs (Marshall et al., 2008), rare mutations (Campbell, et al, 2006) 
and the association of two common allelic variants (rs1858830-C and rs38845-A) of the 
MET receptor tyrosine kinase gene (Campbell et al., 2006; Campbell et al., 2008; Jackson 
et al., 2009; Sousa et al., 2009).  Moreover, an enriched association of the rs1858830-C 
allele with social and communication phenotypes of ASD was recently demonstrated 
(Campbell et al., 2009).  Because Met signaling in vitro potentiates axon outgrowth, 
dendritogenesis, and synaptogenesis (Ebens et al., 1996; Gutierrez et al., 2004; Madhavan 
and Peng, 2006; Tyndall and Walikonis, 2006; Nakano et al., 2007), a basic mechanistic 
hypothesis relating MET gene function and ASD risk has emerged: decreased MET 
protein expression during development increases the risk of ASD-relevant circuit 
miswiring.  Met is expressed in selective patterns in the mouse forebrain that include 
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circuitry involved in social behavior (Judson et al., 2009), but how this translates to 
relevant at-risk primate circuitry is unknown.   
 Mammalian conspecifics, including primates, exchange information concerning 
fitness, mating status, and other factors influencing individual or group survival.  
Stereotyped forebrain circuitry has evolved to support the cognitive processing that 
underlies this conserved social behavior.  For example, circuits involving the 
hippocampal formation and mammillary nuclei facilitate the encoding of socially relevant 
spatial cues and social recognition (Steckler et al., 1998; Sanchez-Andrade et al., 2005).  
The emotional quality of social stimuli is processed by the amygdala in all mammalian 
species (Phelps and LeDoux, 2005).  The input pathways that route social information to 
these conserved cognitive circuits, however, are divergent across mammalian taxa, 
reflecting the various communication modes utilized within this class of animals (Hauser, 
1996).  Primates, for instance, communicate primarily by issuing physical gestures and 
vocalizations, the receipt of which requires visual and auditory system function, 
respectively.  In contrast, rodents depend more heavily on somatosensation and olfaction 
to communicate.  Appropriate species-specific social behavior, therefore, necessarily 
depends on the wiring together of relevant sensory and cognitive circuitry during 
development.  
 Here we test a prediction of the hypothesis that Met/MET receptor signaling 
regulates the development of socially relevant forebrain circuitry: Met/MET expression 
patterns will reflect species-specific requirements for social interaction.  Specifically, we 
compare Met receptor expression in the mouse forebrain with that of its homologue, 
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MET, in the macaque forebrain across corresponding periods of development related to 
circuit formation.   
 
Materials and Methods 
Preparation of fixed brain sections 
Wild type C57BL/6J mice were either purchased from the Jackson Laboratory 
(Bar Harbor, ME) or harvested from Emx1
cre
/ Met
fx/+  
X Emx1
+
/ Met
fx/fx
 matings using 
previously described mouse husbandry and genotyping strategies (Judson et al., 2009).  
In the latter case, mice with a Met
fx/fx
 or Met
fx/+
 genotype were considered wild type if 
they did not have cre recombinase knocked-in to the 3’ untranslated region of either 
Emx1 allele.  Mice aged between postnatal (P) day 0 and 21 were deeply anesthetized 
with sodium pentobarbital (60 mg/kg i.p.) prior to transcardial perfusion with room 
temperature phosphate-buffered 4% paraformaldehyde (pH 7.3) containing 1.3% L-lysine 
and 0.24% sodium periodate.  After postfixation overnight at 4°C, brains were 
cryoprotected via sequential 12-hour incubations in 10%, 20%, and 30% sucrose in PBS, 
pH 7.5.  Fixed brains were then sectioned as previously described (Judson et al., 2009).  
Briefly, P0 brains were sectioned at 20 M with a cryostat and P7-P21 brains were 
sectioned at 40 M with a sliding microtome (Leica, Bannockburn, IL).  Prior to 
immunohistochemical processing, P0 sections were stored at -80°C on gelatin-coated 
slides and P7-P21 sections were stored at -20°C, free-floating in a cryopreservative 
solution.   
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 Series of pre- and postnatal macaque (Macaca mulatta) brain sections (N = 2, 
each age) were from animals housed at the California National Primate Research Center 
(University of California, Davis, Davis, CA), and were prepared as previously described. 
All research procedures using mice and macaques conformed to NIH guidelines 
and were approved by the Institutional Animal Care and Use Committees at Vanderbilt 
University and the University of California at Davis, respectively.  All efforts were made 
to minimize animal suffering and to reduce the number of animals used. 
Met/MET immunohistochemistry 
Two different monoclonal antibodies were used for Met/MET 
immunohistochemical study: 1) mouse anti-Met (Met, B-2; sc-8057; Lot No. C2807; 
Santa Cruz Biotechnology, Santa Cruz, CA), and 2) mouse anti-Met (Met, 25H2; #3127; 
Lot No. 3; Cell Signaling Technology, Beverly, MA).  Met immunohistochemistry was 
performed as previously described (Judson et al., 2009).  Briefly, free-floating mouse or 
macaque brain sections were rinsed several times in PBS before the following blocking 
procedures were applied: 1) 5 minutes in 0.3% H202 in methanol, 2) 25 minutes in 0.1 M 
Tris-glycine (pH 7.4), and 3) 25 minutes in Blotto-T (4% Carnation dried milk in PBS 
containing 0.2% Triton-X-100).  PBS rinses preceded both the Tris-Glycine and Blotto-T 
blocking steps.  For mouse tissue, an additional 1.5-hour incubation in unlabeled donkey 
anti-mouse IgG (Fab; Jackson Immunoresearch, West Grove, PA) was performed 
immediately before the Blotto-T step in order to block endogenous immunoglobulins.  
After blocking, brain sections were incubated in primary anti-Met antibodies for 48 hours 
at 4°C.  Specifically, sections were incubated in either 1:250 anti-Met (Santa Cruz sc-
8057, mouse sections only) or 1:400 anti-Met (Cell Signaling #3127, some mouse 
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sections and all macaque sections) diluted in Blotto-T.  Following washes in Blotto-T, 
sections were then incubated for 1 hour at room temperature in 1:1,000 biotin-SP-
conjugated donkey antimouse IgG (Jackson Immunoresearch) diluted in Blotto-T.  
Sections were then rinsed several times in PBS and processed by the ABC Elite 
histochemical method (Vector, Burlingame, CA).  Met-specific antibody complexes were 
visualized by incubating the sections for 2–4 minutes at room temperature in 0.05% 3’3’-
diaminobenzidine (DAB) with 0.015% H202. 
Cross-species use of antibodies 
We examined the cross-species reactivity of the two commercially available 
mouse monoclonal antibodies used to immunohistochemically label mouse Met protein 
and homologous monkey MET protein in the present study.  These antibodies were 
generated against synthetic peptides corresponding to evolutionarily conserved 
intracellular domains of the mouse (Santa Cruz #8057; immunogen: peptide 
corresponding to amino acids 1330–1379 of mouse Met [NCBI No. NP 032617) and 
human (Cell Signaling #3127; immunogen: peptide corresponding to C-terminal amino 
acids of human Met [NCBI No. AAA59591) receptors, and they exhibited remarkably 
high species cross-reactivity when substituted for each other in a previously described 
immunohistochemical staining protocol (see ―Met/MET immunohistochemistry‖ 
subsection of Materials and Methods)(Judson et al., 2009).  For example, these antibodies 
yielded indistinguishable staining patterns in comparable regions of the somatosensory 
cortex (Supplemental Fig. 1A,B) and hippocampus (Supplemental Fig. 1C,D) in 
postnatal day (P) 7 mice.   
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Supplemental Figure 1.  Equivalent specificity of commercially available Met/MET antibodies.  DIC 
photomicrographs illustrate Met immunohistochemistry in coronal sections (A and C, Santa Cruz mouse 
anti-mouse Met #8057) and sagittal sections (B and D, Cell Signaling mouse anti-human MET #3127) from 
P7 mice.  Identical staining patterns are obtained with both antibodies as shown in the somatosensory 
cortex (A and B) and the hippocampus (C and D).  II-VI, neocortical layers 2 through 6; CA1, cornu 
ammonis 1 of hippocampus; CA3, cornu ammonis 3 of hippocampus; DG, dentate gyrus; S, subiculum.  
Scale bar = 275 M for all images.  
 
 
Digital illustrations 
Microscopy was performed with the aid of an Axioplan II microscope (Zeiss, 
Jena, Germany), and micrographs were acquired with a Zeiss AxioCam HRc camera 
(Zeiss) in Axiovision 4.1 software (Zeiss).  Low-magnification, montage images of 
macaque brain sections were prepared and linearly adjusted for brightness and contrast 
using Adobe Photoshop (Version 7.0, Adobe, San Jose, CA).  No other image alterations 
other than resizing were performed.  All figures were prepared digitally in Microsoft 
Office Powerpoint 2003 (Redmond, WA). 
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Results 
Conserved temporal patterns of Met/MET expression 
Beginning in late neurogenesis and persisting through the first postnatal week in 
the mouse, neocortical Met expression increases dramatically, and the receptor is readily 
detected by immunohistochemical methods first in the efferent axons, and later in the 
neuropil, of the neocortex (Judson et al., 2009).  By the end of the second postnatal week, 
corresponding with a winding down of axonal outgrowth and the beginning of the peak 
synaptogenic period, neocortical Met expression begins to decline.  In fact, by P21, Met 
is only detected sparsely in the neocortical neuropil (Judson et al., 2009).  Collectively, 
these data are consistent with a preferential role for the receptor in orchestrating aspects 
of forebrain development such as axon terminal arborization and the initiation of 
connectivity between circuit-related neurons.   
To address the possibility of an evolutionary conserved role for the homologous 
MET receptor in the developing forebrain, we performed MET immunohistochemistry at 
corresponding developmental time-points in the macaque.  These included gestational 
day (GD) 100 during late neocortical neurogenesis (Rakic, 1974) and GD150 and P21, 
which mark the rise and plateau, respectively, of the peak synaptogenic phase in the 
macaque (Bourgeois and Rakic, 1993; Bourgeois et al., 1994).  MET 
immunohistochemical staining in the GD100 macaque was restricted to select regions of 
the neocortex.  Here, receptor localization was evident in outgrowing axons of projection 
neurons and, though more broadly distributed across the radial dimension of the cortex, 
closely resembled the pattern of Met-labeling observed in the mouse at P0 (Fig. 1A,D),.  
At the cellular level by GD150, the pattern of MET labeling expanded to include the  
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Figure 1.  Conserved temporal patterns of Met/MET expression in mouse and macaque neocortex.  DIC 
photomicrographs illustrate Met/MET immunohistochemistry in coronal brain sections during 
development.  Labeling is predominantly seen in the outgrowing axons of cortical projection neurons in the 
cortex of the P0 mouse (A) and GD100 macaque (D).  During axon collateralization and the onset of 
synaptogenesis, Met/MET labeling is readily observed in neuropil compartments in both species (B,E).  
Note especially the emergence of heavy expression in the marginal zone (mz) and the relative paucity of 
labeling in neocortical layer IV at this developmental stage.  By three weeks of age (C,F), early periods of 
axon wiring have past in both mice and macaques, corresponding with drastically decreased 
immunohistochemical detection of Met/MET.  Scale bar = 138 M for all images.      
 
 
neocortical neuropil in a manner similar to that observed in the mouse at P7.  Membrane 
staining within the neuropil yielded salient patterns including images of cell bodies in 
negative relief, a noticeable increase in marginal zone labeling, and a relative paucity of 
layer IV labeling in both species during this developmental period (Fig. 1B,E).  Whereas 
cortical neuropil labeling increased toward the onset of peak synaptogenesis, staining in 
forebrain axon tracts that carry corticocortically-projecting axons, such as the anterior 
commissure, concomitantly declined (Fig. 2A,B and D,E).   
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Figure 2.  Conserved temporal patterns of Met/MET expression in major forebrain fiber tracts in the mouse 
and macaque.   DIC photomicrographs illustrate Met/MET immunohistochemistry in coronal brain sections 
during development.  In both the mouse (A) and macaque (D), intense Met/MET staining of corticofugal 
axons within the anterior commissure (ac) is observed at time-points just after the end of cortical 
neurogenesis.  Axon staining within this structure gradually decreases in intensity throughout 
perinatal/early postnatal development in both species (mouse B and C; macaque E and F).  The body of the 
ac, located just inferior to a commissural division of the stria terminalis (arrows), is depicted in mouse 
panels A-C, whereas the temporal limb of the ac is depicted in macaque panels D-F.   Met/MET staining in 
efferent fibers of the hippocampus also decreases developmentally in the mouse (G-I) and macaque (J-L).  
Axons of the postcommissural fornix (f) are shown in cross-section in mouse panels G-I.  The macaque f, 
inferior to the corpus callosum (cc), is depicted in J-L.  Examples of select, intensely stained axon bundles 
are indicated by arrows (J and K).  3V, third ventricle.  Scale bar = 275 M for A-C and G-L; 1.1 mm for 
D-F.     
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Figure 3.  Conserved temporal patterns of Met/MET expression in the corticothalamic projection.  DIC 
photomicrographs illustrate Met/MET immunohistochemistry in coronal brain sections during 
development.  Axonal Met staining is evident in the internal capsule (ic, A) but not corticothalamic 
terminal fields (B, boxed region in A) in the dorsal thalamus in the P0 mouse.  A similar pattern of 
expression is observed in low- (E) and high-magnification (F) images of the pulvinar in the GD100 
macaque.  Corresponding images in the P7 mouse (C and D) and GD150 macaque (G and H) show 
dramatically increased Met-labeling of the thalamic neuropil, concurrent with robust periods of 
corticothalamic terminal arborization in each species.  3V, third ventricle; CA1, cornu ammonis 1 of 
hippocampus; cc, corpus callosum; fi, fimbria of hippocampus; LGP, lateral globus pallidus; S1BF, barrel 
field of primary somatosensory cortex.  Scale bar = 550 M for A and C; 825 M for E and G; 138 M for 
B,D,F, and H. 
 
 
There were comparable temporal dynamics of Met/MET expression within the 
terminal fields of subcortically-projecting neocortical axons.  In the mouse at P0 and in 
the monkey at GD100, Met/MET was expressed in developing principle fiber tracts 
including the internal capsule (Fig. 3A; Supplemental Fig. 2A,B) and anterior 
commissure (Fig. 2A,D), which contain corticofugal projections to the thalamus and 
striatum.  However, there was no apparent neuropil labeling in either the corticothalamic  
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Supplemental Figure 2.  Conserved temporal patterns of Met/MET expression in the corticostriatal 
projection.  DIC photomicrographs illustrate Met/MET immunohistochemistry in coronal brain sections 
during development.  Met- labeled axon fascicles pass through the striatum while the corticostriatal 
neuropil is unlabeled (B, boxed region in A).  A similar pattern of expression is observed in low- (E) and 
high-magnification (F) images of the ventromedial striatum in the GD100 macaque.  Corresponding images 
in the P7 mouse (C and D) and GD150 macaque (G and H) show a dramatic increase in Met-labeling of the 
striatal neuropil, concurrent with robust periods of corticostriatal terminal arborization in each species.  cc, 
corpus callosum; fi, fimbria of hippocampus; LGP, lateral globus pallidus; S1BF, barrel field of primary 
somatosensory cortex; vhc, ventral hippocampal commissure.  Scale bar = 550 M for A and C; 825 M 
for E and G; 138 M for B,D,F, and H. 
 
 
(Fig. 3A,B,E,F) or the corticostriatal terminal fields (Supplemental Fig. 2A,B,E,F) at 
this developmental stage.  Robust Met/MET staining in the thalamic (Fig. 3C,D,G,H) 
and striatal (Supplemental Fig. 2C,D,G,H) neuropil became evident by P7 in the mouse 
and GD150 in the macaque, and, as shown in high-magnification images (Fig. 1B,E; Fig. 
3D,H; Supplemental Fig. 2D,H), the pattern of labeling was reminiscent of that seen in 
the neocortex at this same stage of development.  Finally, as in the mouse, 
immunohistochemical detection of MET was dramatically reduced in major forebrain 
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axon tracts as well as neocortical and subcortical axon terminal fields at P21, the plateau 
of the peak synaptogenic period (Fig. 1C,F; Fig. 2C,F). 
 
Expression of Met/MET in the limbic system 
In both the P7 mouse and GD150 macaque, Met/MET staining was evident throughout 
the anteroposterior extent of the amygdala, but the intensity of the staining varied within 
individual amygdaloid nuclei at each level.  We observed robust neuropil staining in the 
P7 mouse amygdala in the nucleus of the lateral olfactory tract, anteriorly (Fig. 4A), and 
the posterior cortical nucleus, posteriorly (Fig. 4C).  These two nuclei of the olfactory 
amygdala, as per (Swanson and Petrovich, 1998), were apparently devoid of labeling in 
the macaque (data not shown).  More moderate staining in the lateral (LA), basolateral 
(BLA), and basomedial (BMA) nuclei at intermediate levels of the amygdala was 
generally conserved between the two species (Fig. 4B,D-F).  Moreover, there was a 
conserved LA (high) to BMA (low) gradient of Met/MET staining across these 
contiguous deep amygdaloid nuclei, although the difference was more pronounced in the 
monkey.  This pattern suggests that the majority of MET-expressing afferents within the 
basolateral complex of the amygdala have origins in the inferior temporal and perirhinal 
cortices of the macaque (Stefanacci et al., 1996; Stefanacci and Amaral, 2002).      
The efferent projections of the immunolabeled neurons in select amygdala nuclei 
in both species expressed Met/MET.  The stria terminalis (st), which is the principle fiber 
tract carrying amygdalofugal axons within the mammalian forebrain, was densely labeled 
in the mouse at P7 at the level of the anterior commissure (Fig. 5A).  At a comparable 
anteroposterior level, we observed MET labeling of relatively modest intensity within  
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Figure 4.  Conserved Met/Met expression in amydaloid and hippocampal afferents.  DIC photomicrographs 
illustrate Met/MET immunohistochemistry at various anteroposterior levels of the amygdala and 
hippocampus in coronal brain sections from the P7 mouse and GD150 macaque.  Though Met expression is 
widespread in the mouse amygdala during axon collateralization, subnuclei such as the nucleus of the 
lateral olfactory tract (NLOT, A) and the posterior cortical nucleus (PCo, C) exhibit exceptionally heavy 
Met-labeling as compared to basolateral (BLA), basomedial (BMA), and central (Ce) amygdaloid 
subnuclei (B).  In the macaque, MET staining is enriched in the BLA and especially the lateral (LA) 
subnucleus (D and E) as compared to the BMA and amygdalohippocampal (AHi) subnuclei (E and F), 
indicating that, as in the mouse, MET is expressed by select amygdaloid afferents during development.  In 
both the developing mouse (G-I) and macaque (J-L) forebrain, Met/MET staining is observed in entorhinal 
cortical efferents within the molecular layer (identified by perforated boundary).  However, MET labeling 
in the macaque is focused in the molecular layer region overlaying the stratum radiatum at the 
subiculum/CA1 boundary (arrows in J, K, and L).  Staining is enriched in posterior (mouse H and I; 
macaque K and L) as opposed to anterior (mouse G; macaque J) levels of the molecular layer in both 
species.  AA, anterior amygdaloid nucleus; CA1, cornu ammonis 1 of hippocampus; CA3, cornu ammonis 
3 of hippocampus; CA4, cornu ammonis 4 of hippocampus; DG, dendtate gyrus; ec, external capsule; or, 
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Figure 4—cont.  stratum oriens of hippocampus; pyr, pyramidal cell layer of hippocampus; rad, stratum 
radiatum of hippocampus; S, subiculum; st, stria terminalis.  Scale bar = 275 M for A-C and G-I; 770 M 
for D-F and J-L.  
 
 
 
Figure 5.  Conserved Met/MET expression in amygdaloid and hippocampal efferents.  DIC 
photomicrographs illustrate Met/MET immunohistochemistry in fiber tracts and axon terminal fields in 
coronal forebrain sections from the P7 mouse and GD150 macaque.  A and D: Examples of Met staining in 
the stria terminalis (green asterisk), posterior limb of the anterior commissure (blue asterisk), 
precommissural fornix (orange asterisk), and mammillary bodies (red asterisk) in the developing mouse 
forebrain.  Asterisks of the same color mark corresponding MET-stained structures in the macaque during a 
similar developmental period (B,C,E, and F).  3V, third ventricle; LV, lateral ventricle.  Scale bar = 550 
M for all images.    
 
 
this fiber tract in the GD150 macaque (Fig. 5E).  Despite this apparent quantitative 
difference in st staining, it was evident at more posterior levels of the tract that only 
select populations of amygdalofugal axons are stained in each species (Supplemental 
Fig. 3B,E).  Moreover, decremental staining was observed within these axon 
subpopulations with increasing developmental age (Supplemental Fig. 3A-C and D-F), 
mirroring the conserved temporal pattern of expression for corticocortical and 
corticofugal axon tracts.  Efferent amygdala fibers also course within the external capsule  
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Supplemental Figure 3.  Conserved temporal patterns of Met/MET expression in axons of the amygdala but 
not the indusium griseum in the mouse and macaque.  DIC photomicrographs illustrate Met/MET 
immunohistochemistry in coronal brain sections during development.  Select bundles of presumably 
amygdalofugal axons are heavily stained (white asterisks) within the stria terminalis (st) in the mouse at P0 
(A) and P7 (B), but this labeling is greatly diminished by P21 (C).  Black asterisks indicated unstained 
axons within this tract (A-C).  A similar temporal pattern of staining is observed in medially coursing axons 
(black arrowheads, D-F) of the macaque st.  Met-stained fibers are absent bilaterally in the mouse indusium 
griseum (arrows, IG) at P0 (G), P7 (H), or P21 (I) time-points.  However, distinct, heavily labeled IG axon 
bundles are readily observed in the macaque at GD100 (J).  This staining is dramatically reduced by 
GD150 (K) and undetectable by P21 (L cc, corpus callosum; Cd, tail of the caudate; ic, internal 
capsule. Scale bar 275 M for all images. 
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and the anterior commissure, both of which are heavily stained in the mouse (Fig. 5A; 
Fig. 8A,C, and E) and macaque (Fig. 5B; Fig. 8G,H) forebrain at this developmental 
age. 
Patterns of Met/MET expression within the mouse and macaque hippocampus 
were generally conserved.  The molecular layer of the dendate gyrus and CA fields of the 
hippocampus, throughout the anteroposterior extent, contained Met/MET 
immunoreactivity in both the P7 mouse (Fig. 4G-I) and GD150 macaque (Fig. 4J-L), 
consistent with Met/MET expression in hippocampal afferents from entorhinal cortex in 
both species. However, there were two key differences in this expression feature between 
the mouse and the macaque: 1) the intensity of Met/MET staining in the molecular layer 
was relatively stronger in the mouse compared to the macaque, and 2) while staining 
appeared to be evenly distributed throughout the mouse molecular layer, it was 
concentrated in regions of the molecular layer apposed to the stratum radiatum near the 
subiculum/CA1 boundary in the macaque.  
Met/MET labeling was intense at P7 in the mouse and GD150 in the monkey in 
the fiber tracts that contain, and the target regions that receive, hippocampal efferent 
projections.  For example, immunnostaining was observed in the precommissural fornix 
(Fig. 5A,C) and the hippocampal commissure (Supplemental Fig. 4I,L).  However, a 
subset of axon fascicles in the indusium griseum (IG), a structure considered an extension 
of the hippocampus (Wyss and Sripanidkulchai, 1983), was densely labeled in the 
macaque (Supplemental Figs. 3J; 4D-F ) but not the mouse (Supplemental Figs. 3G-I; 
4A-C and G-I).  Moreover, the staining was much less intense at GD150 than GD100, 
and was undetectable by P21 (Supplemental Fig. 3J-L).  As shown in coronal sections  
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that include the postcommissural fornix, a similar temporal dynamic of MET expression 
was observed in hippocampal efferents of the macaque (Fig. 3J-L), a pattern that also 
was evident in the mouse (Fig. 3G-I).  One of the most robust projections of the 
hippocampus via the postcommissural fornix is that to the medial mammillary bodies.  
Met/MET labeling was extremely dense in the medial mammiallary bodies in both the P7 
mouse (Fig. 5D) and GD150 macaque (Fig. 5F), consistent with high expression levels of 
the receptor in axons of this hippocampal efferent pathway.  Collectively, these data 
demonstrate that Met/MET is expressed transiently at high levels in afferents and 
efferents of the amygdala and hippocampus during early periods of circuit wiring in the 
mouse and macaque forebrain, followed by a significant reduction later postnatally. 
 
Comparative analysis of tangential patterns of neocortical Met/MET expression 
Mice and primates depend differentially on specific sensory modalities for 
communicating with conspecifics.  Thus, we extended our analysis to interspecies 
comparisons of Met/MET expression within sensory and associative neocortical areas 
during forebrain circuit development.  As shown in low-magnification images 
representing the anteroposterior extent of the P0 mouse forebrain (Fig. 6A-D), Met 
immunohistochemical staining was broadly distributed across the tangential domain of 
the mouse neocortex, with particularly robust labeling throughout the extent of the major 
axon tracts carrying corticocoritical and corticofugal projections, including the corpus 
callosum, anterior commissure, and internal capsule.  This broad tangential distribution of 
neocortical Met expression was more readily apparent in a similar anteroposterior array 
of Met-stained sections at P7 (Fig. 7A-D), when neuropil expression of the receptor  
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Figure 6.  Divergent spatial patterns of neocortical Met/MET expression in the developing mouse and 
macaque forebrain.  DIC photomicrographs illustrate the anterior (A) to posterior (D) progression of 
Met/MET immunohistochemistry in coronal forebrain sections from the P0 mouse and GD100 macaque.  
Notably, all major fiber tracts that carry corticofugal projections as well as the subplate exhibit intense Met 
staining in the mouse forebrain (inset images, A-D).  Robust MET expression in the macaque is largely 
confined to the subplate underlying cortices inferior to the superior temporal sulcus (sts) and in select 
corticofugal fiber tracts of the incipient temporal lobe including, most notably, the anterior commissure (ac, 
B) as well as the external (ec) and extreme (ex) capusules anteriorly (A).  Additional staining in the 
cingulum (cg, A-D) likely reflects MET expression in the efferent fibers of the posterior cingulate cortex, 
whereas labeled axons of the corpus callosum (cc, A-D) may originate in the posterior cingulate and/or 
cortices inferior to the intraparietal sulcus (ips).  24, cortical area 24; 25, cortical area 25; Aq, cerebral 
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Figure 6—cont.  aquaduct; Cd, caudate; ips, intraparietal sulcus; lf, lateral fissure; LV, lateral ventricle; Pu, 
putamen; Pul, pulvinar; vhc, ventral hippocampal commissure.  Scale bar = 3.15 mm for all macaque 
images; 3.6 mm for inset mouse images.    
 
 
proved to be at its peak.  Moreover, the patterns of staining within major subcortical, 
corticofugal terminal fields reflected the widespread Met expression in the neocortical 
neuropil and fiber tracts containing corticofugal efferents (e.g., the internal capsule).  As 
shown at P7, Met-labeled neuropil was evident both throughout the striatum (Fig. 
8A,C,E) and within many nuclei of the thalamus (Fig. 8B,D,F). 
In contrast, there was a remarkably restricted pattern of MET expression in the 
macaque neocortex at GD100 and GD150.  MET labeling was largely absent in the 
frontal lobes, except for low expression in medial areas that included the anterior 
cingulate and subgenual cortices (Figs. 6A; 7A).  While still modest in staining intensity, 
there was a progressive increase in the intensity of MET labeling at increasingly posterior 
levels of the cinguate cortex (areas 24 and 23).  This pattern was marked most saliently 
by staining in the cingulum at GD100 and in the cortical neuropil at GD150 (Figs. 6A-D; 
7A-D).  The most robust staining for MET at GD100 was evident in the subplate and 
neocortical white matter underlying extrastriate visual and auditory cortices of the 
temporal, inferior parietal, and occipital lobes across anteroposterior levels of the 
macaque forebrain (Fig. 6B-D).  By GD150, expression had expanded to include the 
neuropil within these selective neocortical regions (Fig. 7B-D).  Staining patterns at 
GD150 also were highly complex within these regions, especially in the temporal lobe.  
Labeling was most intense inferior to the superior temporal sulcus (sts) in high-order, 
unimodal visual areas, which contain neurons that are responsive to complex stimuli 
including scenes, objects, and primate faces (Baylis et al., 1987; Tsao et al., 2006)      
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Figure 7.  Divergent spatial patterns of neocortical Met/MET expression in the developing mouse and 
macaque forebrain.  DIC photomicrographs illustrate the anterior (A) to posterior (D) progression of 
Met/MET immunohistochemistry in coronal forebrain sections from the P7 mouse and GD150 macaque.  
While Met expression in the mouse (inset images, A-D) is broadly distributed throughout the tangential 
domain of the neocortex, MET expression in the macaque is largely restricted to the temporal cortices 
(white and black asterisks, B-D) and midline cortices including the anterior cingulate cortex (cortical area 
24, A-C; area 23, D) and subgenual cortex (area 25, A).  MET is also differentially expressed within the 
macaque temporal lobe; staining is strong inferior to (white asterisks, B-D), and of modest intensity 
superior to (black asterisks, B-D), the superior temporal sulcus (sts).  Axon staining within the cingulum 
(cg, A-D), anterior commissure (ac, B), and posterior regions of the corpus callosum (cc, C and D) reflect 
the restricted populations of neocorticocortical projection neurons that express MET.  Aq, cerebral 
aquaduct; Cd, caudate; cs, central sulcus; ec, external capsule; ex, extreme capsule; lf, lateral fissure; LV, 
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Figure 7—cont.  lateral ventricle; ox, optic chiasm; Pu, putamen; Pul, pulvinar; vhc, ventral hippocampal 
commissure.  Scale bar = 4.6 mm for all macaque images; 4.2 mm for inset mouse images.   
 
 
 
Figure 8.  Met/MET expression in neocortical efferents in the developing mouse and macaque forebrain.  
DIC photomicrographs illustrate Met/MET immunohistochemistry in forebrain sections from the P7 mouse 
and GD150 macaque.  Widespread Met labeling is observed in the neuropil of the caudatoputamen (CPu) 
(A, C, and E) and lateral thalamus (B,D, and F) in coronal (A and B), sagittal (C and D), and horizontal (E 
and F) brain sections of the develping mouse forebrain, consistent with widespread Met expression in long-
projecting axons of the neocortex.  The distribution of MET-labeled neocortical efferents in the developing 
macaque striatum is much more restricted, as robust staining is observed only in the nucleus accumbens 
(NAc) and fundus striari (Fstr) (G), and the ventral putamen (Pu) and caudate (Cd) (H).  Restricted areas of 
lighter striatal MET staining are observed in the dorsal Cd (I).  MET-labeled neocortical efferents to the 
macaque thalamus are predominantly restricted to the reticular nucleus (Rt) (J), lateral (LPul) and inferior 
(IPul) pulvinar nuclei (J) and limbic thalamic nuclei including the anteroventral nucleus (AV) (I).  3V, 
third ventricle; AD, ; cp, cerebral peduncle; DLG, dorsolateral geniculate nucleus; EGP, external globus 
palidus; ec, external capsule; eml, external medullary lamina; f, fornix; fi, fimbria of hippocampus; fr, 
fasciculus retroflexus; HDB, horizontal limb of the diagonal band; ic, internal capsule; IGP, internal globus 
palidus; LD, laterodorsal thalamic nucleus; LGP, lateral globus palidus; LV; lateral ventricle; LSI, 
intermediate lateral septal nucleus; MGD, medial geniculate nucleus, dorsal part; MPul, medial pulvinar 
nucleus; mt, mammillothalamic tract; ot, optic tract; Po, posterior thalamic nuclear group; PV, 
paraventricular thalamic nucleus; SC, superior colliculus; SNR, substantia nigra pars reticulata; st, stria 
terminalis; VAL, ventral anterior thalamic nucleus, lateral part; VLM, ventrolateral thalamic nucleus, 
medial part; VPM, ventral posteromedial thalamic nucleus.  Scale bar = 550 M for A-F; 2.48 mm for G-J. 
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(Fig. 7B-D).  Less intense MET staining was present superior to the STS in polysensory 
and associative auditory cortices within the superior temporal gyri (Fig. 7B-D) and 
inferior parietal lobes (Fig. 7C,D). 
The limited tangential extent of MET expression in the developing macaque 
neocortex was reflected in the restricted subsets of forebrain fiber tracts and cortical 
efferent target areas in the striatum and dorsal thalamus that contained MET-stained 
axons.  Dense MET labeling in the anterior commissure was evident, consistent with 
receptor expression in cortico-cortically projecting neurons within the temporal lobes 
(Figs. 6B; 7B).  MET staining also was present in the external and extreme capsules 
within the ventral forebrain, which presumably distribute MET-expressing axons 
ipsilaterally among interconnected temporal cortices and to highly specific regions of the 
striatum (Figs. 6A; 7A;  8G,H).  Ventral striatal areas, including the nucleus accumbens, 
fundus striari, and the ventral putamen and tail of the caudate nucleus, constituted the 
most notable target areas of MET-labeled axons (Fig. 8H,I).  There also was very light 
and spatially limited staining in the dorsal caudate nucleus (Fig. 8G,I), with all other 
striatal areas consistently devoid of MET staining (Fig. 8G-I).  This pattern of staining is 
highly divergent from the mouse.   
 There also was MET expression in a small subgroup of presumed corticothalamic 
efferents, consistent again with the highly restricted staining in the neocortex.  For 
example, moderate staining in the laterodorsal superficial (data not shown) and 
anteroventral (Fig. 8I) thalamic nuclei are consistent with the observation of MET 
expression in the cingulate cortices.  The most robust MET staining in the dorsal 
thalamus was found in subnuclei of the pulvinar.  Specifically, the staining was 
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concentrated in the inferior and lateral subdivisions of the pulvinar, with much reduced 
labeling in the medial subdivsion (Fig. 8J).  This pattern reflects the foci of MET 
expression in the temporal and inferior parietal lobes.  Finally, like in mouse, the 
posterior reticular nucleus has MET-labeled neuropil in the monkey (Fig. 8J).  All other 
thalamic nuclei in the developing macaque were devoid of MET staining. 
 
Interspecies conservation of anatomical expression gradients 
 Despite the general observation of widespread Met expression in the mouse 
neocortex and highly restricted neocortical MET expression in the macaque, there was a 
clearly conserved anterior (low) to posterior (high) expression gradient in cortically-
associated structures in both species.  This gradient was best appreciated in 
anteroposterior images of the corpus callosum from the P0 (Supplemental Fig. 4A-C) 
and P7 (Supplemental Fig. 4G-I) mouse and the GD100 (Supplemental Fig. 4D-F) and 
GD150 (Supplemental Fig. 4J-L) macaque.  There also was a similar gradient in the 
hippocampus in both species (Fig. 4G-H and J-L).  Finally, in the macaque, increased 
posterior staining was readily apparent in the cingulate cortex, as previously mentioned 
(Figs. 6A-D; 7A-D), as well as the thalamic reticular nucleus (Fig. 8J).   
 
Discussion 
Here we present comparative forebrain expression mapping data that are 
consistent with an evolutionarily conserved role for the Met/MET receptor tyrosine 
kinase in the wiring of circuits governing social and emotional dimensions of behavior.  
We propose a shared function for mouse Met and the macaque homologue, MET, in  
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Supplemental Figure 4.  Conserved anterior (low) to posterior (high) gradient of Met/MET expression in 
the tangential domain of neocortex.  DIC photomicrographs illustrate Met/MET immunohistochemistry in 
coronal forebrain sections from the developing mouse and macaque.  Met immunoreactivity is observed to 
gradually intensify in increasingly posterior regions of the mouse corpus callosum (cc) at both P0 (A-C) 
and P7 (G-I), consistent with increased Met expression within projection neurons of the posterior 
neocortex.  An even sharper gradient in MET immunoreactivity is seen in this fiber tract at corresponding 
time-points in macaque development including GD100 (D-F) and GD150 (J-L).  A similar anterior (low) 
to posterior (high) gradient of axonal MET expression is a unique feature of the developing macaque 
indusium griseum (IG) and is largely a phenomenon of the GD100 time-point (D-F).  dhc, dorsal 
hippocampal commissure; f, fornix; vhc, ventral hippocampal commissure.  Scale bar = 275 M for A-C 
and G-I; 620 M for D-F and J-L.  
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forebrain circuit wiring, which is supported by the striking temporal and subcellular 
similarities in expression that we observed in these species.  In both the mouse and 
macaque, Met/MET was enriched in the axons of projection neurons within the 
neocortex, hippocampus, and amygdala as early as the end of neurogenesis.  Prior to the 
plateau phase of peak synaptogenesis, receptor expression expanded within the cortical 
and subcortical neuropil, coinciding with the robust collateralization of these axons 
within their terminal fields.  These data suggest a presynaptically-derived influence of 
Met/MET signaling in the initial establishment of forebrain circuits important for social 
and emotional behavior.  Consistent with this, we have recently demonstrated that the 
ablation of Met signaling from corticostriatal axons results in cell-nonautonomous 
changes in the dendritic morphology of medium spiny neurons (M. Judson, K. Eagleson, 
P. Levitt, unpublished observations).   
 Despite the remarkable similarity in subcellular receptor distributions discussed 
above, it should be noted that our Met/MET immunohistochemical stain provides 
inadequate resolution to distinguish either the staining of axonal versus dendritic 
elements, or to differentiate between multiple sources of axonal afferents, within the 
neuropil.  We previously circumvented this issue in the mouse by additionally analyzing 
wild type patterns of Met transcript expression as well as Met staining patterns in a dorsal 
pallium-specific conditional Met knockout mouse.  This approach allowed us to 
determine that nearly all Met staining in the subcortical neuropil is localized to axonal 
afferents of a dorsal pallial origin.  In order to determine the extent to which this finding 
applies to similar MET staining patterns in the macaque forebrain, we would ultimately 
need to analyze developmental MET transcript expression.  There is, however, 
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considerable indirect evidence supporting the preferential localization of MET to 
dorsally-derived axonal compartments in the subcortical neuropil.  For example, the 
ventral (high) to dorsal (low) gradient of MET staining in the temporal cortex is reflected 
with remarkable fidelity in the ventrolateral (high) to dorsomedial (low)) gradient of 
staining in the pulvinar, constistent with the topographical organization of temporal 
corticothalmic axon projections within this nucleus (Romanski et al., 1997; Yeterian and 
Pandya, 1997; Shipp, 2003).  
 
Spatial patterns of Met/MET expression reflect species-specific modes of social 
communication 
 
This study has revealed two themes concerning spatial patterns of Met/MET 
expression and its putative developmental role in the wiring of socially relevant forebrain 
circuitry: 1) receptor expression is highly conserved within limbic structures that are 
essential for social cognition and memory, including the hippocampus, amygdala, and 
cingulate cortices, and 2) receptor expression patterns diverge within sensory and 
associative neocortical areas according to species-specific requirements for the 
perception of socially relevant stimuli.  Evidence supporting the first theme comes from 
the observation of shared Met/MET expression in the structures and fiber pathways that 
constitute core limbic circuitry (Papez, 1937; MacLean, 1955).  Both the mouse and 
macaque exhibited significant developmental Met/MET expression in hippocampal 
efferent fibers projecting to the medial mammillary bodies, in axon terminals within the 
anteroventral thalamic nucleus, in cingulate cortex and axons within the cingulum, and in 
the hippocampal complex, effectively completing the classically defined circuit of Papez 
(Papez, 1937).  Met/MET expression also was shared in the main efferent pathway of the 
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amygdala, the stria terminalis, indicating conserved receptor function in the development 
of more broadly defined limbic circuits (MacLean, 1955).  This evolutionary 
conservation of Met/MET expression is not necessarily surprising; the limbic brain is 
phylogenetically old, and conserved expression of other molecules that participate in 
limbic circuit wiring has been reported (Horton and Levitt, 1988; Chesselet et al., 1991; 
Pimenta et al., 1996).  Approximately 50 million years of evolution has, though, allowed 
for at least some redefinition of Met/MET receptor roles in the development of limbic 
circuitry in monkeys as compared to mice.  For example, MET expression in the 
indusium griseum appeared to be a unique feature of the developing primate limbic 
system, whereas Met-labeled afferents of a presumed olfactory origin were uniquely 
detected in the nucleus of the lateral olfactory tract and posterior cortical nucleus of the 
mouse amygdala.  Additionally, MET staining in the ventromedial striatum may be 
localized in part to afferents originating in the basolateral amygdala and/or hippocampal 
formation (Friedman et al., 2002), a pattern not detected in the mouse (Judson et al., 
2009).  However, as demonstrated in the present study, the greatest interspecies 
divergence in patterns of Met/MET expression during social circuit development is at the 
level of the neocortex.   
 In the context of social circuit integration, structures such as the basolateral 
amygdala, cingulate cortex, perirhinal cortex, and entorhinal cortex are critical, because 
they are broadly interconnected with the neocortex, and thus, serve as an interface 
between the circuits required for social perception and downstream limbic circuits that 
facilitate social cognitive processes such as social recognition, arousal, and awareness 
(Adolphs, 2001; Amaral, 2003; Phelps and LeDoux, 2005).  We observed Met/MET 
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staining within the neuropil of each of these areas in the mouse and the macaque, strongly 
suggesting that this receptor is involved in establishing connections between neocortical 
and limbic circuits.  Because the neocortical expression patterns overlap functional areas 
required for the receipt of social stimuli characteristic of each species, we reason that 
Met/MET signaling may have been evolutionarily co-opted to integrate circuits 
governing social perception and social cognition. 
 In primate species such as the macaque, sensory faculties such as vision and 
audition are critically important for the perception of socially relevant stimuli, and they 
are largely rooted in neocortical areas of the temporal, occipital, and inferior parietal 
lobes.  Remarkably, during the period of social circuit wiring, we observed a nearly 
exclusive localization of MET to the axons of projection neurons within these select 
neocortical areas.  MET expression was particularly dense in the inferior temporal gyrus, 
which houses cortical areas in the ventral visual stream that facilitate the processing of 
complex socially-relevant visual features including body parts and faces (Pinsk et al., 
2005; Pinsk et al., 2009).  Because we also observed MET staining of presumed 
inferotemporocortical efferent axons within the perirhinal and entorhinal cortices of the 
hippocampal complex, we suggest that the receptor may regulate the development of 
circuits required for social recognition (Malkova et al., 1995; Thornton et al., 1997) – an 
essential cognitive process supporting social interaction among primate conspecifics.  
Additionally, staining was observed in the ventral putamen and caudate nucleus of the 
striatum, indicating that the development of circuits governing the formation of socially 
adaptive visual habits also may depend on intact MET signaling (Fernandez-Ruiz et al., 
2001). We hypothesize that genetic variation that impacts MET expression may disrupt 
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the formation of these circuits and contribute to social interaction phenotypes 
characteristic of ASD. 
 Whereas neocortical MET expression was spatially restricted in the tangential 
domain, Met expression in the mouse neocortex was broadly distributed, perhaps 
reflecting the relatively full employment by this species of its sensory faculties for social 
behavior.  Excepting sexual behavior, olfaction and somatosensation are minor tools in 
the social repertoire of the primate, but mice and other rodent species depend on these 
senses in order to communicate with conspecifics.  In fact, social recognition in mice is 
almost exclusively mediated by olfaction (Brennan and Kendrick, 2006; Spehr et al., 
2006).  Yet mice also rely on vision and audition in order to extract socially relevant 
information from their environment.  Langford and colleagues recently demonstrated that 
the visual observation of pain-related behavior in a conspecific subject can modulate pain 
responses in an observer mouse through an empathy-like process (Langford et al., 2006).  
A more recent study employed a fear-conditioning paradigm to show that auditory cues 
can also facilitate empathy-like social behavior in mice (Chen et al., 2009). Tail-rattling, 
which has been shown to be an important behavioral trait associated with mouse 
aggression (St John, 1973), also is perceived by the auditory and/or visual senses. 
 Though the present study supports our hypothesis that Met/MET signaling 
regulates the development of species-specific social circuits in the developing forebrain, 
much can be gained by further Met/MET expression studies comparing other species.  
Two specific experimental approaches may prove useful: 1) patterns of developmental 
Met/MET forebrain staining could be compared in genetically distant mammalian species 
with convergent social ethologies, and/or 2) staining patterns could be compared in 
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genetically related species with divergent social ethologies.  A comparison of 
developmental forebrain Met staining in solitary versus eusocial African naked mole rats 
(Bathyergidae) would constitute an extreme example of the second approach.  
Fortunately, such experiments are possible owing to the evolutionarily conserved 
epitopes recognized by immunohistochemistry-compatible Met/MET antibodies.     
  
MET expression patterns and circuit vulnerability in autism 
 
Recent studies have served to establish human MET gene promoter variants as 
causative risk alleles for ASD.  The MET rs1858830-C allele in particular has been 
shown to promote less efficient MET transcription in in vitro assays (Campbell et al., 
2006)), consistent with the observed 2-fold reduction in the temporal cortex of 
postmortem ASD brains (Campbell et al., 2007).  We also recently demonstrated 
presynaptically-derived alterations in forebrain circuitry in a mouse model of 
developmentally abrogated Met signaling (M. Judson, K. Eagleson, P. Levitt, 
unpublished observations), indicating a possible causal link between reduced MET 
expression and circuit malformation in ASD.  However, as indicated by the findings of 
the present study, alterations in the spatial distribution of MET expression may be as 
important to consider as absolute levels of expression in regard to the wiring of social 
circuitry and ASD risk.   
MET protein expression mapping in the developing human forebrain is currently 
the best available approach to gain knowledge of the specific social circuits that may be 
vulnerable in MET-related cases of idiopathic ASD.  Moreover, considering the 
population frequencies (.35-.55) of ASD-associated MET alleles (Campbell et al., 2006; 
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Campbell et al., 2008; Jackson et al., 2009; Sousa et al., 2009), mapping studies of brains 
with MET risk allele genotypes may help to elucidate broadly relevant etiological 
mechanisms of the disorder.  However, these studies are necessarily hindered by the 
ethical and practical considerations that are associated with any approach requiring 
postmortem human tissue of embryonic origin. Comparative analysis of conserved and 
divergent regulatory elements within the murine and primate genes may thus constitute a 
useful alternative approach.   
Considering the posterior (high) to anterior (low) neocortical gradient of 
Met/MET expression shared by the mouse and macaque, conserved Met/MET regulatory 
elements may contain binding sites for transcription factors known to exhibit anterior-
posterior gradients of expression during cortical development (Kudo et al., 2007).  
Divergent regulatory elements, on the other hand, may contribute to the remarkable areal 
restriction of MET expression within the primate neocortex.  Recombineered mice that 
carry the 5’ regulatory region of the human MET gene in place of the homologous murine 
sequence could be generated to test this possibility.  Furthermore, inclusion of the various 
single nucleotide variations that are associated with ASD risk could potentially yield 
animal models of ASD-relevant circuit vulnerability with high external validity.  Studies 
of such ―humanized‖ Met mice would, however, be limited by certain neuroanatomical 
constraints.  For example, mice possess only an evolutionary rudiment of the pulvinar, 
which receives heavily MET-labeled projections from the temporal cortex in the 
developing macaque.  
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Abstract 
             Human genetic findings and murine neuroanatomical expression mapping have 
intersected to implicate Met receptor tyrosine kinase signaling in the development of 
forebrain circuits controlling social and emotional behaviors that are atypical in autism 
spectrum disorders (ASD).  To clarify roles for Met signaling during forebrain circuit 
development in vivo, we generated mutant mice (Emx1
Cre
/Met
fx/fx
) with an Emx1-Cre-
driven deletion of signaling-competent Met in dorsal pallially-derived forebrain neurons.  
Morphometric analyses of Lucifer Yellow-injected pyramidal neurons in postnatal day 40 
anterior cingulate cortex (ACC) revealed no statistically significant changes in total 
dendritic length, but a selective reduction in apical arbor length distal to the soma in 
Emx1
Cre
/Met
fx/fx
 neurons relative to wild type, consistent with a decrease in the total 
tissue volume sampled by individual arbors in the cortex.  The effects on dendritic 
structure appear to be circuit-selective, as basal arbor length was increased in 
Emx1
Cre
/Met
fx/fx
 layer 2/3 neurons.  Spine number was not altered on Emx1
Cre
/Met
fx/fx
 
pyramidal cell populations studied, but spine head diameter was increased modestly (4-
8%).  Cell-nonautonomous, circuit-level influences of Met signaling on dendritic 
development were confirmed by studies of medium spiny neurons (MSN), which do not 
express Met, but receive Met-expressing corticostriatal afferents during development.  
Emx1
Cre
/Met
fx/fx
 MSN exhibited robust increases in total arbor length (~20%). Like in the 
neocortex, average spine head diameter increased modestly (~5%).  These data 
demonstrate that a developmental loss of presynaptic Met receptor signaling can affect 
postsynaptic morphogenesis and suggest a mechanism whereby attenuated Met signaling 
could disrupt both local and long-range connectivity within circuits relevant to ASD.  
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Introduction 
             The -heterodimeric, transmembrane Met receptor tyrosine kinase binds its 
endogenous ligand, hepatocyte growth factor (HGF), and signals to promote a variety of 
developmental processes in epithelially-derived tissues.  At the single-cell level these 
include cell proliferation, migration, differentiation, and survival (Ebens et al., 1996; 
Hamanoue et al., 1996; Caton et al., 2000; Ieraci et al., 2002; Gutierrez et al., 2004; 
Giacobini et al., 2007; Garzotto et al., 2008; Lim and Walikonis, 2008).  HGF-Met 
signaling also plays a critical role in higher-order developmental processes such as 
epithelial tubulugenesis and duct formation, which requires the organization of complex 
interactions among many polarized cells (Rosario and Birchmeier, 2003; Zhang and 
Vande Woude, 2003).     
          Circuit wiring and synaptogenesis in the nervous system also require the exquisite 
control and coordination of interactions among polarized cells.  Recent evidence indicates 
that HGF-Met signaling may help regulate these processes within specific circuits of the 
mammalian forebrain.  Met expression mapping during the period of forebrain wiring and 
synaptogenesis reveals a striking enrichment of the receptor in the neuropil and long-
projecting axons of the cerebral cortex, hippocampus and amygdala, suggesting that 
disrupted Met signaling could result in aberrant connectivity between these structures 
(Judson et al., 2009).  Such a disruption would be predicted to impact the function of 
circuits governing social and emotional dimensions of behavior, consistent with recent 
genetic findings from ours and two other laboratories that two different alleles of the 
human MET gene are associated with autism spectrum disorders (ASD) (Campbell et al., 
2006; Campbell et al., 2008; Jackson et al., 2009; Sousa et al., 2009).  One variant 
136 
 
reduces transcriptional efficiency, consistent with the reported 2-fold decrease in 
neocortical MET protein expression in ASD postmortem cases (Campbell et al., 2007).  
Moreover, further family-based analyses have revealed an enriched association of this 
same promoter variant with social and communication phenotypes of ASD (Campbell et 
al., 2009).   
           There are a number of studies of neurons in vitro that demonstrate the importance 
of Met signaling for neuronal differentiation and synapse organization (Powell et al., 
2003; Gutierrez et al., 2004; Madhavan and Peng, 2006; Tyndall and Walikonis, 2006; 
Nakano et al., 2007; David et al., 2008; Lim and Walikonis, 2008).  However, despite 
these converging lines of evidence supporting a role for Met signaling in the proper 
wiring of circuits which in human may be vulnerable in ASD, precisely how disrupted 
Met signaling might affect in vivo circuit development has yet to be addressed 
experimentally.  In the present study, we applied our neuroanatomically-based 
understanding of developmental forebrain Met expression to the study of dendritic 
morphology in neurons from wild type mice and conditional mutant mice in which Met 
receptors are functionally deleted in forebrain structures originating from the dorsal 
pallium.  Specifically, we describe the dendritic morphometry of Lucifer Yellow-injected 
wild type and mutant projection neurons in both the anterior cingulate cortex (ACC) and 
the dorsolateral striatum.  ACC pyramidal neurons are of interest due to their important 
roles in limbic circuit function and the shared expression of Met in these cells in mouse 
and primate cortex (M. Judson, D. Amaral, P. Levitt, unpublished observations).  To 
address possible non-cell autonomous effects of deleting Met, we examined medium 
spiny neurons (MSN) of the dorsolateral striatum. These neurons do not express Met 
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transcript or protein, but receive abundant Met-expressing corticostriatal afferents during 
development (Judson et al., 2009).  
 
Materials and Methods 
Breeding and genotyping mice 
Conditional Met mutant mice (Emx1
Cre
/Met
fx/fx
) were generated and genotyped using 
previously described strategies (Judson et al., 2009).  Briefly, homozygous Met floxed 
(Met
fx/fx
) mice were crossed to heterozygous Emx1-Cre knock-in mice that were also 
heterozygous for the floxed Met allele (Emx1
Cre
/ Met
fx/+
).  All resultant progeny were 
genotyped by polymerase chain reaction (PCR) using the following PCR primer sets: 
Emx1
Cre
 forward 5_-TTCGGCTATACGTAACAGGG-3_ and reverse 5_-
TCGATGCAACGAGTGATGAG-3_; Met
fx
 forward 5_-
GCAACTGTCTTTTGATCCCTGC-3_ and reverse 
5_TGTCCAGCAAAGTCCCATGATAG-3_.   Met
fx
 (Courtesy of Snorri Thorgeirsson, 
NIH/ Center for Cancer Research, Bethesda, MD) and Emx1
Cre
 breeding lines (courtesy 
of Dr. Kevin Jones, University of Colorado, Boulder, CO) were backcrossed onto the 
C57BL/6J background for greater than 10 generations.  All research procedures using 
mice were approved by the Institutional Animal Care and Use Committee at Vanderbilt 
University and conformed to NIH guidelines.  All efforts were made to minimize animal 
suffering and to reduce the number of animals used.   
Immunoprecipitation 
             The primary antibody used to immunoprecipitate (IP) the Met receptor was 
mouse anti-Met (Met, 25H2; #3127; Lot No. 3; Cell Signaling Technology, Beverly, MA; 
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immunogen: peptide corresponding to C-terminal amino acids of human Met [NCBI No. 
AAA59591]).  Control immunoprecipitation experiments were conducted using anti-
mouse IgG, whole molecule (Chroma Pure; #015000003; Lot No. 82958; Jackson 
Immunoresearch, West Grove, PA).  Each IP antibody was covalently linked to magnetic 
M-280 Tosylactivated Dynabeads (Invitrogen, Carlsbad, CA) as per manufacturer’s 
instructions. 
 Postnatal day 7 (P7) mice were deeply anesthetized with isofluorane prior to 
decapitation and brain removal.  Each brain was immediately immersed in room 
temperature Hanks’ balanced salt solution (Sigma, St. Louis, MO), and the cerebral 
cortex was rapidly dissected from each hemisphere with the aid of an MZ-6 stereozoom 
microscope (Leica, Bannockburn, IL).  Harvested cerebral cortices were immediately 
snap-frozen in liquid nitrogen and stored at -80°C to await IP analysis.  
 Lysates for IP were prepared by homogenizing frozen P7 cerebral cortices in a 
glass tissue homogenizer (Wheaton, Millville, NJ) with ice-cold IP buffer (50 mM Tris 
HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40) containing a protease inhibitor cocktail 
(Sigma), both serine/threonine and tyrosine phosphatase inhibitor cocktails (Sigma), 10 
mM activated Na3VO4, 1mM EDTA, and 1mM EGTA.  The lysates were cleared by a 
16,000g centrifugation for 20 minutes at 4°C, and protein concentrations of the 
supernatants were determined using the Dc protein assay (Bio-Rad, Hercules, CA).  Wild 
type and Emx1
Cre
/Met
fx/fx
 cortical lysates were diluted to a concentration of 2 mg/ml with 
IP buffer, and 1ml of 2 mg/ml lysate was incubated for 12 hours at 4°C with 75 l of 
either anti-Met or anti mouse IgG IP antibodies linked to magnetic beads.  Subsequently, 
the IP beads were pelleted with the application of a magnetic field, and washed 3 times 
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for 5 minutes each at 4°C in phosphate-buffered saline (PBS) containing protease and 
phosphatase inhibitors and 0.005% Nonidet P-40 detergent.  The washed IP beads were 
then resuspended in 60 ul of Laemmli buffer containing 5% 2-Mercaptoethanol and 
incubated at 75°C for 5 minutes to elute the IP complexes.  IP eluates were stored at -20C 
prior to SDS-PAGE and Western blotting.   
HGF stimulation of cortical synaptosomes 
Frozen cortices from P7 wild type and Emx1
Cre
/Met
fx/fx
 mice were thawed in ice-
cold fractionation buffer (320 mM sucrose in 7mM Tris-HCL, pH 7.5, containing 
protease inhibitors (Sigma)) and then fractionated using a glass tissue homogenizer 
(Wheaton).  One ml of fractionation buffer per whole cortex was used.  The fractionated 
samples were then centrifuged at 4°C at 900g for 15 minutes to pellet nuclei and blood 
vessels.  The nuclear pellets were discarded and the supernatants were further centrifuged 
at 14,500g for 15 minutes to yield pellets containing crude cell membranes and 
synaptosomes.  Each crude synaptosomal pellet was then resuspended in ice-cold 
artificial cerebral spinal fluid (12.4 mM NaCl, 0.4 mM KCl, 0.1 mM KH2PO4, 0.25 mM 
CaCl2, 0.1 mM MgCl2, 1 mM dextrose, and 2.6 mM NaHCO3), freshly bubbled with 95% 
O2/5% CO2.  At this stage, human recombinant HGF (R&D Systems, Minneapolis, MN) 
was added to some of the resuspended synaptosomes at a final concentration of 50 ng/ml 
to stimulate Met receptor phosphorylation.  After a 5 minute incubation on ice, both 
stimulated and unstimulated synaptosomes were centrifuged at 14,500g for 15 minutes at 
4°C, and the resulting pellets were lysed with 100 l of IP buffer and vigorous mixing.  
Synaptosomal lysates were cleared by a 16,000g centrifugation for 20 minutes at 4°C, 
and protein concentrations of the supernatants were determined using the Dc protein 
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assay (Bio-Rad).  Samples were stored at -80°C prior to SDS-PAGE and Western 
blotting.  
Western blotting   
The following primary antibodies were used in Western blotting analyses: mouse 
anti-Met (Met, B-2; sc-8057; Lot No. C2807; Santa Cruz Biotechnology, Santa Cruz, 
CA; immunogen: peptide corresponding to amino acids 1330–1379 of mouse Met [NCBI 
No. NP 032617]), rabbit anti-phosphorylated Met (pMet
Y1234/1235
, D26; #3077; Lot No. 2; 
Cell Signaling Technology; immunogen: synthetic, KLH-coupled phosphopeptide 
corresponding to C-terminal amino acids of human Met [NCBI No. AAA59591]), and 
mouse anti-phosphotyrosine (pY, 4G10; #05-321; Lot No. DAM1503375; Millipore, 
Billerica, MA; immunogen: KLH-coupled phosphotyramine).  
 Protein samples (15 l of IP eluate per lane or 20 g synaptosomal protein per 
lane) were fractionated by SDS-PAGE and transferred to supported nitrocellulose 
membranes. Western blotting was then performed as described previously (Judson et al., 
2009), using the following primary antibody dilutions: rabbit anti-pMet and mouse anti-
pY were diluted 1:1,000 in Blotto (3% Carnation dried milk in PBS) containing 0.1% 
Tween-20; mouse anti-Met was diluted 1:500 in Blotto alone.  Anti-mouse and anti-
rabbit horseradish peroxidase-conjugated secondary antibodies (Jackson 
Immunoresearch) were diluted to 1:5,000 with the same diluent as the primary antibody.   
Intracellular injections, lucifer yellow immunohistochemistry, and morphometric 
reconstructions 
 
A total of 11 P39-41 male mice (7 wild type and 4 Emx1
Cre
/Met
fx/fx
) were deeply 
anesthetized with sodium pentobarbital (60 mg/kg i.p.) prior to transcardial perfusion. To 
clear blood from the vasculature and facilitate more efficient tissue fixation, mice were 
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first perfused with ~10mls of 37°C PBS, which was immediately followed by ~100 mls 
of room-temperature phosphate-buffered 4% paraformaldehyde (pH 7.3).  Each fixed 
brain was then removed from the skull and post-fixed for 2 hours at 4°C before being 
sectioned coronally at a thickness of 200 M with a vibratome (Vibratome, Saint Louis, 
MO).  Fixed vibratome sections were then post-fixed for an additional 2 hours at 4°C 
before being rinsed and stored in cold PBS.  Sections were stored in PBS at 4°C for up to 
5 days prior to intracellular injections of Lucifer Yellow dye.  Equivalent intervals 
between post-fixation and intracellular injection were maintained across animals for each 
anatomical region of interest.   
 The cell bodies of layer 5 and layer 2/3 pyramidal neurons in anterior cingulate 
cortex (at the level of the genu of the corpus callosum) and medium spiny neurons in 
dorsolateral striatum (at the level of the body of the anterior commissure) were targeted 
for injection with the aid of an Axioskop2 microscope and 40x immersion objective 
(Zeiss, Jena, Germany).  The injected cells were within 3 focal planes of the upper 
surface of the brain section and evenly spaced from previously injected cells.  Then, a 
glass micropipette containing Lucifer Yellow dye (8% in 0.05 M Tris buffer, pH 7.4) was 
gently inserted into each targeted cell body using a micromanipulator, and a continuous 
current (5-15 nA) was applied until the tips of the most distal dendrites were brightly 
fluorescent.   
Lucifer Yellow immunohistochemistry was used to yield a more photostable 
product within injected cells.  Briefly, sections containing injected cells were placed in a 
stock solution (2% bovine serum albumin, 1% Triton X-100, and 5% sucrose in PBS) 
containing a 1:5,000 dilution of rabbit anti-Lucifer Yellow antibody (#L9163; Sigma).  
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Sections were incubated in the primary antibody solution at 4°C for 3-4 days before 
being rinsed several times in stock solution and incubated 2 hours at room-temperature in 
biotinylated anti-rabbit secondary antibody (RPN1004; GE/Amersham, Pittsburgh, PA).  
Several rinses in PBS followed, and sections were subjected to a final 2 hour room-
temperature incubation in Alexa Fluor 488-conjugated streptavidin (Invitrogen) diluted 
1:1,000 in PBS.  After several more rinses in PBS, sections were mounted on uncoated 
glass slides and coverslipped with ProLong Gold mounting medium (Invitrogen).  
An Olympus microscope with a motorized stage and Neurolucida software 
(Microbrightfield, Williston, VT) were used to three-dimensionally reconstruct the 
dendritic arbors of neurons whose dendrites were completely filled to the distal tips.  
Between 3 and 6 cells per anatomical region per animal were analyzed.  Dendrites were 
frequently transected by the coronal plane of section, which severely limited the study of 
pyramidal apical dendritic arbors whenever the primary apical dendrite was cut off 
proximal to the cell body.  Therefore, we chose to only analyze the arbors of layer 5 and 
layer 2/3 pyramidal cells with total apical dendritic lengths at least half that of their 
respective genotypic means.  Seven wild type (3 layer 5 and 4 layer 2/3) and 6 
Emx1
Cre
/Met
fx/fx
 (5 layer 2/3 and 1 layer 5) pyramidal cells were excluded from analysis 
based on this criterion.  Investigators were blind to the genotypic identities of the samples 
from the time of animal perfusion through the morphometric analysis of dendritic arbor 
structure.    
Confocal microscopy and semi-automated analysis of dendritic spines 
            Using an approach based on previously described methods (Shen et al., 2008), 
dendrites of the same neurons subjected to Neurolucida analyses were imaged by 
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confocal microscopy, and three-dimensional renderings of the images were used to 
facilitate semi-automated quantification of dendritic spine density and dendritic spine 
head diameter.  Usually 2, but occasionally 1 or 3, dendritic segments located 60-120 M 
(2
nd
, 3
rd
, or 4
th
 order) from the cell body were analyzed per cell.  Briefly, a Zeiss LSM 
510 confocal microscope (Zeiss, Jena, Germany) with 63x oil immersion objective, 4x 
digital cropping, and a frame size of 1024 x 1024 pixels was used to capture high-
resolution images of dendritic segments with 0.035 M x 0.035 M pixel dimensions.  
Segments were scanned at 0.38 M intervals along the Z axis. 
          Confocal images of dendritic segments were viewed using Imaris software 
(Version 6.3-64 bit, Bitplane, Saint Paul, MN) in the Surpass view.  The Filament module 
(Autopath, no loops), was then used to generate a three-dimensional, segmented 
rendering of each dendritic segment that was between 30 M and 35 M in length on 
average.  The minimum end-point diameter (smallest detected spine head) was set at 
0.143 M, and the fluorescence contrast threshold was set > to 3.  Renderings were 
subsequently edited for accuracy relative to the actual confocal image, and data 
concerning spine density and end-segment diameter were exported to Microsoft Excel 
2003 (Microsoft Incorporated, Redmond, WA) for summary statistical analyses.  
Investigators were unaware of sample genotypes both during the imaging and three-
dimensional rendering of dendritic segments.           
Digital illustrations 
 Optical fluorescence microscopy was performed with the aid of an Axioplan II 
microscope (Zeiss), and low-power micrographs depicting fields of Lucifer Yellow-
injected neurons were acquired with a Zeiss AxioCam HRc camera (Zeiss) in Axiovision 
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4.1 software (Zeiss).  Alterations to contrast levels in these low-power images were 
performed using Adobe Photoshop (Version 7.0, Adobe, San Jose, CA).  Figures were 
prepared digitally in Microsoft Office Powerpoint 2003 (Microsoft Incorporated).  
Statistical analyses 
All morphological data in the present study are summarized as means+SEM. 
Genotypic group differences in gross dendritic structure (e.g., total dendritic length and 
dendritic arbor volume) were assessed using the two-sample, two-tailed t-test within 
GraphPad Prism (Version 4.0, GraphPad Software, La Jolla, CA), the software program 
used for the production of all data graphs.  P-values less than 0.05 were considered 
significant.  
Sholl analysis data, which describe changes in dendritic structure that occur as a 
function of radial distance from a neuronal cell body (Sholl, 1953), were analyzed within 
SAS (version 9.1.3, SAS institute, Cary, NC) Procedure GLIMMIX.  Specifically, 
genotypic group differences within each anatomical region of interest were analyzed 
using a linear mixed model with dendritic length as the outcome, fixed effects group, 
radius, group x radius interaction, and random effects animals. The random animal 
effects, along with an autoregressive covariance structure for each neuron within an 
animal account for correlations of repeated measurements from the same animal. Because 
both fixed and random effects are included, this model is a mixed effects model.  To 
compare dendritic length at each radius for the two groups, parameters from the mixed 
model were estimated and compared.  We used the Kenward-Roger’s adjusted degrees of 
freedom solution (option DDFM=KR in Procedure GLIMMIX) for statistical inference 
(Kenward and Roger, 1997), an approach specifically proposed for small sample settings. 
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Normality of residuals from the mixed models was assessed using the Shapiro-Wilk test, 
and a Box-Cox transformed (Box and Cox, 1964) outcome variable for dendritic length 
was used when departure from normality was detected.  Owing to the relatively small 
number of animals sampled, genotypic differences at each radius were considered 
statistically significant if the raw p-value was less than 0.05.  All tests were two-tailed.  
 
Results 
Demonstration of Met signaling deficiency in the cortex of Emx1
Cre
/Met
fx/fx 
mice 
A previous study reporting a Cre recombinase-driven deletion of the Met
fx 
allele from 
heaptocytes demonstrated successful removal of the ATP-binding site from the Met 
tyrosine kinase domain, and consequently, dramatic reductions in levels of signaling-
competent Met protein, receptor activation and downstream signaling (Huh et al., 2004).  
We confirmed similar Met signaling deficiencies in forebrain tissues derived from the 
dorsal pallium in Emx1
Cre
/Met
fx/fx 
mice during the period of peak receptor expression in 
the postnatal mouse forebrain (Judson et al., 2009).  First, a dramatically reduced ratio of 
processed (140 kD), presumably signaling-competent Met to unprocessed (170 kD) 
precursor protein was immunoprecipitated from lysates of Emx1
Cre
/Met
fx/fx 
postnatal day 
(P) 7 neocortex relative to wild type (Fig. 1A).  Second, we observed a robust induction 
of Met receptor phosphorylation in HGF-stimulated synaptosomes prepared from P7 wild 
type but not Emx1
Cre
/Met
fx/fx 
synaptosomes (Fig. 1B).  Collectively, these data 
demonstrate the utility of the Emx1
Cre
/Met
fx/fx 
mouse as a model in which to study the 
consequences of Met signaling deficiency during forebrain circuit development.    
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Figure 1.  Met signaling deficiency in the Emx1
cre
/Met
fx/fx 
mouse.  A: Total Met Western blotting of Met 
and control mouse IgG immunoprecipitates from P7 wild type (WT) and Emx1
cre
/Met
fx/fx 
(-/-) cortical 
lysates.  Note the drastically reduced ratio of processed, signaling-competent Met receptor (140 kD band) 
to unprocessed receptor precursor (170 kD band) that is immunoprecipitated from the -/- lysate.  No Met 
protein of either form was immunprecipitated with control mouse pre-immune IgG.  B: Stimulation of P7 
crude cortical synaptosomes with 50 ng/ml HGF. Western blotting for phosphorylated Met (pMet) 
demonstrates that HGF induces substantial Met receptor activation in WT but not -/- synaptosomes. 
Western blotting for total tyrosine phosphorylated protein (4G10) demonstrates equivalent protein loading 
across samples.  
 
 
Met-dependent changes in layer- and compartment-specific dendritic arbors in 
pyramidal neurons of anterior cingulate cortex 
 
To begin to understand the effects of attenuated Met signaling on forebrain circuit 
development, we focused on comparisons of dendritic morphology in wild type and 
Emx1
Cre
/Met
fx/fx 
pyramidal neurons of the anterior cingulate cortex (ACC) at a time-point 
(P40) just subsequent to the most robust periods of circuit connectivity and refinement.  
ACC pyramidal neurons presented as a compelling population for study for 3 reasons: 1) 
these neurons act as key integrators and processors of limbic circuit information, 2) these 
neurons constitute a Met-expressing population shared by mouse and non-human primate 
cortex (M. Judson, D. Amaral, P. Levitt, unpublished observations ) and 3) corticocortical  
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Figure 2.  Analysis of layer 5 pyramidal cell morphometry in postnatal day 40 wild type (WT) versus 
Emx1
cre
/Met
fx/fx 
(-/-) anterior cingulate cortex (ACC).  A: Representative fluorescence micrograph of  
lucifer yellow immunoreactivity in microinjected pyramidal cells in both left and right anterior cingulate 
cortex in a coronal brain section. Pyramidal cell injections could be precisely targeted within Layer 5 
(arrow, left hemisphere).  The dashed lines represent the anatomical boundary between ACC and primary 
motor cortex (M1) in each hemisphere. The median fissure (mf, double arrows) marks the boundary 
between hemispheres.  B: Representative Neurolucida traces of layer 5 WT and -/- ACC pyramidal 
neurons.  The neurons depicted have dendritic arbor morphometries approximate to the mean values of 
their genotypic group. C-H: Dendritic morphometry summary statistics.  Though the average total dendritic 
arbor lengths are statistically equivalent (C), -/- arbors exhibit reduced dendritic length distal to the cell 
body (D). Sholl analysis indicates a corroborating reduction in -/- branching complexity in the same distal 
arbor regions (E). Subcomponent analyses for arbor length indicate that reductions in distal length in -/- 
layer 5 neurons are due to changes in the apical (G) but not the basilar (F) arbor.  Three-dimensional 
convex hull analysis shows that reduced apical arbor length translates into reduced arbor volume in -/- layer 
5 pyramidal neurons (H).  Scale bar = 275 M for A and 100 M for B. *p < 0.05.    
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afferents to ACC pyramidal neurons express abundant levels of Met during limbic circuit 
formation, raising the possibility that dendritic morphologies of these neurons in 
Emx1
Cre
/Met
fx/fx 
mice would reflect both cell-autonomous and circuit-level effects of Met 
signaling disruption.  To visualize and study ACC pyramidal dendrites, we employed the 
Lucifer Yellow microinjection technique, which allowed for the reliable sampling of both 
layer 5 and layer 2/3 pyramidals (Figs. 2A and 3A) as well as the faithful three-
dimensional (3D) reconstruction of dendritic arbors and analysis of several morphometric 
parameters. 
 Contrary to the reported growth-promoting effects of HGF-signaling in vitro, but 
consistent with grossly normal ACC cytoarchitecture and histology (Judson et al., 2009), 
no statistically significant difference was found in either the number of primary dendrites 
(Suppl. Fig. 1A,B) or total dendritic arbor length (Figs. 2C, 3C) between wild type and 
Emx1
Cre
/Met
fx/fx 
ACC pyramidal neurons.  However, both qualitative (Figs. 2B, 3B) and 
quantitative (Figs. 2D, 3D) comparisons revealed altered distributions of dendritic length 
within the arbors of layer 5 and layer 2/3 Emx1
Cre
/Met
fx/fx 
pyramidal neurons as 
compared to wild type.  The reduction in distal arbor length was shared by layer 5 and 
layer 2/3 Emx1
Cre
/Met
fx/fx 
pyramidal neurons, and was corroborated by decreases in 
branching complexity in the same distal arbor regions (Figs. 2E, 3E).  Moreover, these 
changes were specific to the apical dendritic compartment (Figs. 2G, 3G).  Finally, as 
demonstrated by 3D convex hull analysis, which measures the volume contained within 
the arbor’s most outward lying dendritic end-points (Suppl. Fig. 2A-D), the loss in distal 
apical length translated into an approximate 20% reduction in the average cortical volume 
sampled by Emx1
Cre
/Met
fx/fx 
ACC pyramidal neurons (Figs. 2H, 3H).  Interestingly,   
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Figure 3.  Analysis of layer 2/3 pyramidal cell morphometry in postnatal day 40 wild type (WT) versus 
Emx1
cre
/Met
fx/fx 
(-/-) anterior cingulate cortex (ACC).  A: Representative fluorescence micrograph of 
lucifer yellow immunoreactivity in microinjected pyramidal cells in both left and right anterior cingulate 
cortex in a coronal brain section. Injections of Layer 2/3 pyramidal cells (arrow, left hemisphere) were 
highly reproducible across animals in terms of radial distance from the pial surface/median fissure (mf). 
The dashed lines represent the anatomical boundary between ACC and primary motor cortex (M1) in each 
hemisphere.  B: Representative Neurolucida traces of layer 2/3 WT and -/- ACC pyramidal neurons.  The 
neurons depicted have dendritic arbor morphometries approximate to the mean values of their genotypic 
group. C-H: Dendritic morphometry summary statistics.  Though the average total dendritic arbor lengths 
are statistically equivalent (C), -/- arbors exhibit increased dendritic length proximal to, but decreased 
dendritic length distal to, the cell body (D). Sholl analysis shows that changes in branching complexity in   
-/- arbors mirror changes in dendritic length as a function of distance from the cell body (E). Subcomponent 
analyses for arbor length indicate that proximal increases in -/- arbor length reflect changes in the basilar 
arbor (F), while the apical arbor (G) accounts for decreases in distal arbor length.  Three-dimensional 
convex hull analysis reveals a strong trend toward reduced arbor volume in -/- layer 2/3 pyramidal neurons 
(H), consistent with reduced apical arbor length distal to the cell body.  Scale bar = 275 M for A and 100 
M for B. *p < 0.05.    
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Supplementary Figure 1.  Comparison of average primary dendrite number between postnatal day 40 wild 
type (WT) and Emx1
cre
/Met
fx/fx 
(-/-) neurons.  No genotypic difference in primary dendrite number was 
detected within the basilar dendritic arbors of either layer 5 (A) or layer 2/3 (B) pyramidal neurons in 
anterior cingulate cortex.  The number of primary dendrites within the arbors of medium spiny neurons was 
also equivalent between the WT and -/- groups (C).  
 
 
despite these broad phenotypic similarities, there were different causes underlying the 
apical arbor deficits in these two groups of Emx1
Cre
/Met
fx/fx 
ACC pyramidal neurons.  
Specifically, the reduction in apical arbor length in layer 5 mutant
 
pyramidal neurons 
were primarily a function of reduced dendritic segment length (Suppl. Fig. 3A,C), 
wheseas those in layer 2/3 pyramidal neurons were caused by reduced branching in select 
regions of the apical arbor (Suppl. Fig. 4A,C). 
Emx1
Cre
/Met
fx/fx 
layer 5 and layer 2/3 ACC pyramidal neurons differed with 
regard to dendritic length proximal to the cell body (Figs. 2D, 3D).  Proximal dendritic 
length and branching complexity (Fig. 3D,E) was significantly increased in 
Emx1
Cre
/Met
fx/fx 
layer 2/3 pyramidal neurons due to robust increases in branching.  This 
occurred despite a trend toward modestly reduced dendritic segment length in the basal 
arbors of these cells (Fig. 3F; Suppl. Fig. 4A,B).  The distribution of dendritic length 
both proximal to the cell body and within the basal arbors of Emx1
Cre
/Met
fx/fx 
layer 5 
pyramidal neurons was statistically indistinguishable from that in wild type neurons (Fig. 
2D,F).  There was, however, a trend toward reduced basal dendritic segment length in   
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Supplementary Figure 2.  Explanation of 3-dimensional (3D) convex hull analysis of dendritic arbor 
structures.  First, the distal most dendritic end-points of a 3D reconstructed dendritic arbor (A) are 
identified (B, red circles).  These distal end-points are then connected with line segments (C) to form a 3D 
polyhedron, or “convex hull”, which bounds the extremities of the dendritic arbor.  The volume contained 
within the convex hull (D) is the morphometric parameter of interest.  This analysis is automatically 
performed within Neurolucida (Microbrightfield).           
 
 
these cells (Suppl. Fig. 3B).  These data suggest that in the absence of Met signaling, 
there are different adaptive changes in distinct neuronal compartments that may reflect 
circuit-specific influences.    
 
Met-dependent changes in spine head size on ACC pyramidal neurons 
 Changes in the dendritic morphology of Emx1
Cre
/Met
fx/fx 
ACC pyramidal neurons 
were layer-specific in nature, prompting us to determine whether or not dendritic spine 
morphology across layers might also be differentially susceptible to Met signaling 
deficiency.  Using high resolution 3D-renderings of confocal image stacks, we quantified  
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Supplementary Figure 3.  Branching details of postnatal day 40 wild type (WT) and Emx1
cre
/Met
fx/fx 
(-/-) 
layer 5 pyramidal neurons in anterior cingulate cortex.  Analysis of branch number as a function of distance 
from the cell body reveals equivalent branching between genotypic groups proximal to the cell body and a 
modest decrease in branching in distal regions of -/- dendritic arbors (A).  Measures of dendritic length per 
branch node in layer 5 basilar arbors are not statistically different between WT and -/- groups (B).  
However, similar analyses in layer 5 apical arbors reveal an ~20% decrease in dendritic segment length in -
/- neurons (C).  *p < 0.05.       
 
 
 
 
Supplementary Figure 4.  Branching details of postnatal day 40 wild type (WT) and Emx1
cre
/Met
fx/fx 
(-/-) 
layer 2/3 pyramidal neurons in anterior cingulate cortex.  Analysis of branch number as a function of 
distance from the cell body reveals increased branching in -/- neurons proximal to the cell body but a 
decrease in branching in more distal dendritic regions in these same cells (A).  Measures of dendritic length 
per branch node show a trend toward modestly reduced dendritic length in the basilar dendritic segments of 
-/- layer 2/3 neurons (B), but there is no statistically significant difference between genotypic groups in 
regard to the length of apical dendritic segments (C). 
 
 
dendritic spine density and spine head diameter within dendritic segments from the basal 
arbors of layer 5 and layer 2/3 ACC pyramidal neurons.  Neither layer 5 (Fig. 4A) nor 
layer 2/3 (Fig. 5A) neurons exhibited changes in basal dendritic spine density in the  
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Figure 4.  Analysis of basilar dendritic spines in P40 wild type (WT) versus Emx1
cre
/Met
fx/fx 
(-/-) layer 5 
pyramidal cells.  Confocal projection images of WT and -/- layer 5 pyramidal basilar dendritic segments 
(top row) and associated three-dimensional (3-D) segmented renderings shown in overlay (middle row) and 
apart (bottom row).  The images depict portions of analyzed full-length segments with spine density and 
spine head diameter values similar to the mean values of their genotypic group.  A-C:  Quantification of 
spine density and spine head diameter based on 3-D renderings.  No difference in spine density was 
observed between genotypic groups (A), but an ~8% increase in average spine head diameter was found for 
-/- layer 5 basilar dendritic segments as compared with WT (B).  The frequency distribution of spine head 
diameters reveals greater numbers of larger spines and fewer thinner spines in -/- layer 5 basilar dendritic 
segments (C).  Scale bar = 4 M for all images.  *p < 0.05.         
 
 
Emx1
Cre
/Met
fx/fx 
as compared to wild type ACC.  However, modest, but statistically 
significant, increases in basal dendritic spine head diameter were detected in both 
populations of Emx1
Cre
/Met
fx/fx 
cells (Figs. 4B, 5B).  The data also revealed a leftward 
shift in the frequency distribution of Emx1
Cre
/Met
fx/fx 
versus wild type layer 5 basal 
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Figure 5.  Analysis of basilar dendritic spines in P40 wild type (WT) versus Emx1
cre
/Met
fx/fx 
(-/-) layer 2/3 
pyramidal cells.  Confocal projection images of WT and -/- layer 2/3 pyramidal basilar dendritic segments 
(top row) and associated three-dimensional (3-D) segmented renderings shown in overlay (middle row) and 
apart (bottom row).  The images depict portions of analyzed full-length segments with spine density and 
spine head diameter values similar to the mean values of their genotypic group.  A-C:  Quantification of 
spine density and spine head diameter based on 3-D renderings.  No difference in spine density was 
observed between genotypic groups (A), but an ~5% increase in average spine head diameter was found for 
-/- layer 2/3 basilar dendritic segments as compared with WT (B).  The frequency distribution of spine head 
diameters reveals a rightward shift toward larger spines in -/- layer 2/3 basilar dendritic segments (C).  
Scale bar = 4 M for all images.  *p < 0.05.          
 
 
dendritic spine head diameters (Fig. 4C).  Whereas an analysis of layer 2/3 pyramidal 
neurons revealed a similar increase in the frequency of larger basal dendritic spine head 
diameters, there was no obvious reduction in the frequency of thinner spines (Fig. 5C).  
Collectively, these data demonstrate similar alterations in dendritic spine morphology on 
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arbors whose branching morphologies are differentially affected by disrupted Met 
signaling.  
 
Met-dependent changes in dendritic arbors and spine morphology in striatal medium 
spiny neurons  
 
We analyzed the dendritic morphology of Lucifer Yellow-injected dorsolateral 
MSNs from the same wild type and Emx1
Cre
/Met
fx/fx 
mice used to study the morphology 
of ACC pyramidal neurons.  Measures of total dendritic length revealed an approximate 
20% increase in the dendritic arbors of MSNs in Emx1
Cre
/Met
fx/fx 
mice compared to wild 
type (Fig. 6C).  This difference in dendritic growth is robust and readily appreciated 
qualitatively in two-dimensional projections of Neurolucida tracings (Fig. 6B).  Sholl 
analysis of the distribution of dendritic length (Fig. 6D) revealed increases in the 
Emx1
Cre
/Met
fx/fx 
arbors beginning approximately 50 M from the cell body and spanning 
the extent of the arbor.  This finding is consistent with there being equivalent numbers of 
primary dendrites (Suppl. Fig. 1C), but increased branching (Fig. 6F) and branching 
complexity (Fig 6E) of higher order dendrites, in the Emx1
Cre
/Met
fx/fx 
arbors relative to 
wild type.  Furthermore, we found that the approximate 20% increase in Emx1
Cre
/Met
fx/fx 
MSN dendritic arbor volume (Fig. 6H) was related to increased branching, and not from 
an increase in average length of dendritic segments (Fig. 6G).   
 At the level of the dendritic spine, we detected morphological differences 
in the Emx1
Cre
/Met
fx/fx 
MSN arbors that were more modest in nature.  Relative to wild 
type MSN dendrites, MSN dendritic spine density was normal (Fig. 7A).  Average spine 
head diameter was increased by approximately 5% (Fig. 7B).  The frequency distribution 
of spine head size revealed reductions in thinner spines and extremely large spines in the 
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Figure 6.  Analysis of medium spiny neuron (MSN) morphometry in the dorsolateral caudate putamen 
(CPu) of postnatal day 40 wild type (WT) versus Emx1
cre
/Met
fx/fx 
(-/-) mice.  A: Representative 
fluorescence micrograph of lucifer yellow immunoreactivity in microinjected medium spiny neurons in 
dorsolateral CPu in a coronal section. The dashed line represents the white matter boundary between 
striatum and overlying somatosensory barrel cortex (S1BF).  B: Representative Neurolucida traces of 
MSNs.  The neurons depicted have dendritic arbor morphometries approximate to the mean values of their 
genotypic group.  C-H: Dendritic morphometry summary statistics.  -/- MSNs exhibit an ~25% increase in 
total dendritic arbor length relative to their WT counterparts (C).  Further analyses shows that increases in   
-/- dendritic length (D) and branching complexity (E) are distributed throughout the arbor and are due to 
increases in the number of dendritic branches (F) rather than an increase in the length of each branch 
segment (G).  Three-dimensional convex hull analysis indicates an ~20% increase in -/- MSN arbor volume 
(H).  Scale bar = 275 M for A and 167 M for B. **p < 0.01, *p < 0.05.      
 
 
Emx1
Cre
/Met
fx/fx 
arbors, whereas the frequency of intermediately sized spines was 
increased (Fig. 7C).  Consequently, the overall dendritic phenotype of Emx1
Cre
/Met
fx/fx 
MSNs, which do not express Met, is reminiscent of the basal dendrites of layer 2/3 ACC 
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Figure 7.  Analysis of dendritic spines in P40 wild type (WT) versus Emx1
cre
/Met
fx/fx 
(-/-) dorsolateral 
medium spiny neurons (MSNs).  Confocal projection images of WT and -/- MSN dendritic segments (top 
row) and associated three-dimensional (3-D) segmented renderings shown in overlay (middle row) and 
apart (bottom row).  The images depict portions of analyzed full-length segments with spine density and 
spine head diameter values similar to the mean values of their genotypic group.  A-C:  Quantification of 
spine density and spine head diameter based on 3-D renderings.  No difference in spine density was 
observed between genotypic groups (A), but an ~4% increase in average spine head diameter was found for 
-/- MSN dendritic segments as compared with WT (B).  The frequency distribution of spine head diameters 
reveals an increase in larger spines and a decrease in thinner spines in -/- MSN dendritic segments (C).  
Scale bar = 4 M for all images.  *p < 0.05.            
 
 
pyramidal neurons.  The collective data from neocortex and striatum suggest that 
disruption of Met signaling influences developing forebrain neurons in a circuit-
dependent fashion.  
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Discussion 
The major finding of this study is that the constitutive elimination of Met receptor 
tyrosine kinase signaling during development in vivo results in modest cell-
nonautonomous changes in dendrite and dendritic spine morphology in forebrain 
neurons.  Two critical features of our experimental approach allowed us to dissociate 
these changes from cell-autonomous effects on dendritic structure- a considerable 
challenge considering the well-documented roles for Met signaling in dendritic (Gutierrez 
et al., 2004; Tyndall et al., 2007; Lim and Walikonis, 2008) and axonal outgrowth in vitro 
(Ebens et al., 1996; David et al., 2008) as well as the localization of Met to both dendritic 
and axonal compartments in vivo (Tyndall and Walikonis, 2006; Judson et al., 2009).  
First, based on transcript and protein expression, Met expression is absent or expressed at 
very low levels in medium spiny neurons (MSN) in the developing pre- and postnatal 
striatum (Judson et al., 2009), suggesting that any alterations in their dendritic 
morphology subsequent to an ablation of Met signaling is not cell-autonomous in nature.  
Second, in the Emx1
Cre
/Met
fx/fx 
mouse, Met signaling is ablated from nearly all Met-
expressing MSN afferents during development (Judson et al., 2009), rendering these cells 
vulnerable to cell-nonautonomous, presynaptically-derived changes in dendritic 
morphology. We documented such changes in Emx1
Cre
/Met
fx/fx 
MSN dendritic 
morphology using the Lucifer Yellow microinjection technique to visualize and assess 
dendritic morphology.  Specifically, we detected a marked increase in dendritic 
branching and total dendritic length and a small, statistically significant increase in 
dendritic spine head diameter in Emx1
Cre
/Met
fx/fx 
MSN neurons relative to their wild type 
counterparts.  Because similar changes in dendritic morphology were detected in the 
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basal arbors of Emx1
Cre
/Met
fx/fx 
ACC pyramidal neurons, it is possible that these circuit-
level influences affect all dendritic compartments that receive Met-expressing axonal 
afferents.  
 
Mechanisms of altered dendrite and dendritic spine morphology in the Emx1
Cre
/Met
fx/fx 
forebrain 
 
This study provides, to our knowledge, the first evidence that Met signaling can 
influence the development of dendrites on select forebrain neurons in a circuit-related 
fashion.  However, the mechanistic nature of the influences is unclear.  One possibility is 
that Met signals directly within the developing preterminal axon to impact postsynaptic 
neuronal development.  Though this signaling capacity has yet to be directly 
demonstrated, its potential is supported by observations of upregulated Met expression in 
the terminal fields of forebrain axons during, but not prior to, robust periods of axon 
collateralization and the beginning of synaptogenesis (Judson et al., 2009).  Recently, an 
absence of presynaptically localized Met receptor was reported in the rat via immuno-
electron microscopy (Tyndall and Walikonis, 2006), but this finding was limited to 
circumscribed regions of the hippocampus in adult animals.  Assuming that Met signals 
within presynaptic compartments, elucidating its role in regulating presynaptic function 
will require additional morphological and electrophysiological analyses.   
There are examples in the literature that would be consistent with the resultant 
MSN adaptive changes due to either increased or reduced presynaptic signaling.  For 
example, both broad (Dierssen et al., 2003; Gelfo et al., 2009) and focal (Russell and 
Moore, 1999; Sorensen and Rubel, 2006) manipulations of afferent activity have been 
shown to positively correlate with changes in dendritic structure, suggesting that the 
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enhanced branching in Emx1
Cre
/Met
fx/fx 
MSN dendritic arbors could result from increased 
corticostriatal afferent activity.  This would imply that Met signaling normally serves to 
limit corticostriatal activity and neurotransmitter release.  Alternatively, reduced afferent 
activity or a mistargeting of presynaptic elements can sometimes evoke paradoxical 
increases in dendritic growth (Lund et al., 1991; McAllister et al., 1996; Tripodi et al., 
2008).  Such a scenario would require Met signaling to potentiate corticostriatal activity,  
perhaps during earlier developmental periods when pre- and postsynaptic elements are 
establishing initial contact (McAllister, 2000).  Presynaptic roles for Met signaling are 
similarly difficult to predict from changes in Emx1
Cre
/Met
fx/fx 
MSN dendritic spine 
morphology.  Larger spine heads predict stronger synapses (Schikorski and Stevens, 
1997; Murthy et al., 2001), which could have been sculpted by modest increases in 
corticostriatal afferent activity and trophic support in Emx1
Cre
/Met
fx/fx 
mice.  
Alternatively, increased spine size may reflect a homeostatic scaling up of 
Emx1
Cre
/Met
fx/fx 
MSN excitability in response to decreased excitatory drive from 
corticostriatal afferents.  Complimentary morphometric and electrophysiological studies 
of corticostriatal connectivity in the Emx1
Cre
/Met
fx/fx 
mouse are ongoing, and will clarify 
Met signaling roles in axonal and presynaptic development. 
 The distinct laminar- and compartment-specific changes expressed by ACC 
pyramidal neurons following disruption of Met signaling suggest circuit-level influences 
on dendritic growth.  Because cortical afferents, efferents and intrinsic neurons express 
Met, however, distinguishing between cell-autonomous and presynaptically-driven 
effects of Met signaling will be challenging.  There is additional complexity concerning 
these mechanisms in cortical neurons.  For instance, it is known that other growth factor 
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receptors (McAllister et al., 1997) and distinct intracellular signaling pathways (Chow et 
al., 2009) can either promote or inhibit pyramidal dendritic growth in a layer- and/or 
compartment-specific manner.  In addition, Met-expressing, corticocortically projecting 
afferents likely target different dendritic compartments within each ACC pyramidal 
neuron, depending on the radial position of its cell body within the cortex (Petreanu et al., 
2009).  That stated, reductions in tissue volume occupied by Emx1
Cre
/Met
fx/fx 
ACC apical 
arbors are most consistent with cell-autonomous effects of attenuated Met signaling on 
pyramidal dendritic growth as defined in vitro (Gutierrez et al., 2004).  In contrast, the 
phenotypes of ACC basal pyramidal and MSN dendrites are similar to each other in 
Emx1
Cre
/Met
fx/fx 
mice, consistent with cell-nonautonomous influences. 
 
Implications of Emx1
Cre
/Met
fx/fx 
dendrite and dendritic spine phenotypes for cellular 
and circuit function 
 
The dendritic phenotypes of the Emx1
Cre
/Met
fx/fx 
neurons offer insight regarding 
the effects of Met signaling disruptions at the single cell- and circuit-levels.  Rightward 
shifted frequency distributions of dendritic spine head diameter were observed for both 
ACC pyramidal and striatal MSN dendrites, indicating a gain of large, stable spines at the 
expense of thinner, more labile varieties.  This is consistent with a possible impact on 
neuronal plasticity.  Increases in dendritic spine size accompany the induction of long-
term potentiation (LTP) (Engert and Bonhoeffer, 1999; Park et al., 2006; Roberts et al., 
2009).  In Emx1
Cre
/Met
fx/fx 
neurons, in which spine size is already shifted toward 
maximal levels, there may be a reduced potential to induce, or further increase, LTP.  In 
fact, this is consistent with preliminary findings in hippocampal slices from 
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Emx1
Cre
/Met
fx/fx
 mice in which the induction and sustainability of LTP is reduced (S. Qiu 
and P. Levitt, unpublished observations).   
Developmentally, Met expression begins to decline during the second postnatal 
week (Judson et al., 2009), coinciding with changes in presynaptic release probability 
(Bolshakov and Siegelbaum, 1995; Chavis and Westbrook, 2001) and postsynaptic 
excitability (Sheng et al., 1994; Petralia et al., 1999; Elias et al., 2008).  This raises the 
possibility that Met signals to maintain developing synapses in an immature, labile state 
and that the ablation of Met signaling in Emx1
Cre
/Met
fx/fx 
mice might result in a 
precocious maturation of synaptic connections- a postulate tentatively supported by our 
observation of modestly increased spine head diameters in the dendrites of P40 
Emx1
Cre
/Met
fx/fx 
neurons.  An early onset of robust LTP induction (Harris and Teyler, 
1984; Muller et al., 1989), premature gains in postsynaptic density size and thickness 
(Welch et al., 2007; Hung et al., 2008; Roberts et al., 2009), and shifts in NMDAR 
subunit composition (Sheng et al., 1994; Flint et al., 1997; Roberts et al., 2009) constitute 
logical phenotypic predictions for these mice if they indeed mature precociously.  Of 
course, considering the potential for Met to signal in both postsynaptic and presynaptic 
compartments, these hypotheses will be addressed best by electrophysiological and 
biochemical studies of corticocortical as well as corticostriatal synapses. 
 The approximate 20% reduction in Emx1
Cre
/Met
fx/fx 
ACC pyramidal dendritic 
arbor volume indicates potentially significant alterations in information processing at the 
circuit-level.  This reduction was due to decreases in dendritic length at approximately 
150-175 M in radial distance from the cell body, changes that were restricted to the 
apical arbor.  Importantly, in layer 5 Emx1
Cre
/Met
fx/fx 
ACC pyramidal neurons, this 
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phenotype is explained entirely by shorter oblique apical branches, because the apical 
dendrite of these neurons was always transected before the bifurcation node and apical 
tuft.  This change could be functionally significant for several reasons.  For example, 
topographical mapping of inputs to layer 5 neurons in somatosensory cortex suggests that 
oblique branches of the apical arbor are an important convergence point of ascending 
thalamic and descending cortical information (Petreanu et al., 2009).  In addition, in 
general terms, a loss of distal relative to proximal dendritic length should restrict the 
cortical territory sampled by a pyramidal neuron, which could limit the integration of 
information across the tangential domain.  This functional consequence would be most 
relevant to the apical dendritic tuft, which receives highly convergent inputs from both 
the cortex (Kuhn et al., 2008; Petreanu et al., 2009) and the thalamus (Jones, 2002; 
Rubio-Garrido et al., 2009) that facilitate attention and associative processing. 
Contrary to ACC pyramidal neurons, striatal MSNs exhibited an approximate 
25% increase in dendrite arbor volume in Emx1
Cre
/Met
fx/fx 
mice, implying that they are 
capable of receiving more broadly distributed striatal afferents.  Considering the patch-
matrix compartmental organization of the striatum, this change could affect the quality of 
discrete information processing.  MSN dendritic arbors are largely confined to the 
compartment of their cell body of origin (Gerfen, 1992), so without concomitant 
decreases in striatal cell density, the larger arbors of Emx1
Cre
/Met
fx/fx 
MSNs would be 
expected to extend beyond their compartmental boundaries.  This might result in an 
atypical mixing of afferent sensorimotor and limbic information that usually is routed 
through the matrix and patch compartments, respectively (Gerfen, 1992). 
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Relevance of Met signaling disruptions to circuit vulnerability in ASD 
Neurobiological hypotheses of ASD pathophysiology propose that forebrain 
connectivity is altered fundamentally, impacting the quality of simple and complex 
information processing (Frith, 2004; Geschwind and Levitt, 2007; Levy, 2007).   These 
concepts have emerged primarily from anatomical and functional studies demonstrating 
the potential for, or examples of, local hyper-connectivity and global hypo-connectivity 
in forebrain circuits.  For example, functional magnetic resonance imaging during either 
face processing or sentence comprehension tasks revealed reduced prefrontal activation 
relative to other cortical areas in the brains of individuals with autism (Just et al., 2004; 
Koshino et al., 2008).  More recent magnetoencephalographic analyses of high-
functioning children with ASD showed enhanced parietal lobe synchrony and decreased 
prefrontal lobe synchrony relative to typically developing children during the 
performance of tasks probing executive function (Perez Velazquez et al., 2009).  
Collectively, these and other studies indicate that long-range circuits between the 
neocortex and other brain regions are functionally disconnected.  Evidence for local 
circuit abnormalities in ASD has come from post mortem anatomical studies, which show 
minicolumns to be narrower and more numerous in several cortical areas from subjects 
with ASD (Casanova et al., 2002).  Interestingly, a bias toward an increased spread in 
local activation has been predicted from this pathological feature (Casanova, 2006). 
Here, we present evidence that the mouse homologue of the ASD-associated MET 
gene can impact the development of both local and long-range forebrain circuits, 
consistent with connectivity-based theories of the disorder.  Importantly, we wish to 
emphasize that the constitutive deletion in mice does not phenocopy the human clinical 
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findings of altered transcriptional regulation of MET due to the ASD-associated allele 
(Campbell et al., 2006).  Thus, the moderate circuit-level phenotypes in the 
Emx1
Cre
/Met
fx/fx 
forebrain may be even less pronounced in the heterozygous condition, 
which is probably more relevant to ASD etiology.   We suggest that even mild 
disruptions in Met signaling may render select forebrain circuits vulnerable to further 
genetic and environmental insults that would otherwise more broadly impact connectivity 
(Campbell et al., 2008; Bill and Geschwind, 2009; Judson et al., 2009).  Behavioral 
analyses of Emx1
Cre
/Met
fx/+
 mice in compound genetic and/or environmental models of 
forebrain circuit disruption will constitute a useful, further test of this hypothesis.  
Additionally, mapping the expression of MET during the development of the human and 
nonhuman primate forebrain may promote a further understanding of the specific circuits 
that are vulnerable in ASD.  
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CHAPTER V 
 
 
 
FUTURE DIRECTIONS 
 
Following strong leads provided by human genetic studies of autism spectrum 
disorders (ASD), the overarching goal of this research project was to clarify the 
relationship of MET receptor tyrosine kinase function to the development of forebrain 
circuits which govern socioemotional dimensions of behavior.  On two distinct fronts, our 
developmental Met/MET expression mapping studies in the mouse and nonhuman 
primate macaque forebrain (Judson et al., 2009; M. Judson, K. Eagleson, D. Amaral, P. 
Levitt, unpublished observations) provided the first real progress toward this end: 1) in 
both species, the temporal and subcellular profiles of expression were highly consistent 
with a preferential role for this pleiotropic receptor in axon outgrowth, collateralization 
and otherwise presynaptically-derived elements of circuit wiring, and 2) spatial patterns 
of Met/MET expression during forebrain development overlapped circuits involved in 
species-appropriate social behavior.  Together, these findings support the idea that this 
receptor plays an evolutionarily conserved role in wiring socioemotionally-relevant 
forebrain circuits.  They are also consistent with the recent human genetic finding that the 
rs1858830-C allele variant of the MET promoter exhibits an enriched association with 
social and communication phenotypes of ASD (Campbell et al., 2009).  
 Functional in vitro studies indicate that the rs1858830-C allele, as opposed to the 
ASD-protective rs1858830-G allele, reduces transcriptional efficiency from the MET 
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promoter (Campbell et al., 2006), which is consistent with the finding of 2-fold 
reductions in neocortical MET protein expression in postmortem ASD cases.  Therefore, 
our studies of dendritic morphology in mice with forebrain-specific Met signaling 
deficiency may provide insight into the etiology of MET-associated cases of ASD.  For 
example, through these studies, we revealed firm evidence that Met signaling influences 
both local and long-range circuit development through axonal, presynaptically-derived 
mechanisms (M. Judson, K. Eagleson, P. Levitt, unpublished observations).  This finding 
relates to the local and global information processing deficits that characterize ASD 
(Frith, 2004; Levy, 2007; Levitt and Geschwind, 2007).    
 These considerable gains in relating the neurodevelopmental function of 
Met/MET signaling to the wiring of socially-relevant circuits have led to two immediate 
questions of further interest at the cellular and molecular levels: 1) Considering that this 
receptor may be expressed in both the axonal and dendritic compartments of forebrain 
projection neurons, are there cell-nonautonomous (i.e., axonal) as well as cell 
autonomous (i.e., dendritic) consequences of Met/MET signaling disruption for the 
development of forebrain circuit architecture?, and  2) how does the Met/MET receptor 
signal to regulate aspects of forebrain circuit wiring? 
   
Strategies to distinguish cell-autonomous versus cell-nonautonomous influences of 
Met signaling during forebrain circuit development 
 
A multitude of  in vitro studies have implicated murine Met signaling in both 
axonal (Ebens et al., 1996; Powell et al., 2003; David et al., 2008) and dendritic 
(Gutierrez et al., 2004; Tyndall et al., 2007; Lim and Walikonis, 2008) development or 
growth, and evidence that this receptor is localized to both axonal and dendritic 
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compartments in vivo has recently emerged (Tyndall and Walikonis, 2006; Judson et al., 
2009).  Therefore, attributing cellular phenotypes to the influence of Met signaling in one 
neuronal compartment or the other is an unavoidable challenge- especially within an 
intact circuit where presynaptic and postsynaptic elements influence each other 
throughout development.  We recently encountered this obstacle in our studies of 
dendritic morphology in the Emx1
cre
/Met
fx/fx 
mouse, a model of developmental, 
forebrain-specific Met signaling disruption.   
In Emx1
cre
/Met
fx/fx 
mouse, we could reliably determine if alterations in dendritic 
structure were of a presynaptically-derived, cell-nonautonomous origin if they occurred 
in cell populations such as striatal medium spiny neurons, which do not express Met but 
receive Met-expressing axonal afferents during development (M. Judson, K. Eagleson, P. 
Levitt, unpublished observations).  Conversely, pyramidal neurons of the anterior 
cingulate cortex (ACC) express Met and are contacted extensively by Met-expressing 
corticocortically projecting axons throughout the early postnatal period.  Thus, it was 
impossible to determine if the dendritic phenotypes that we observed in Emx1
cre
/Met
fx/fx 
ACC pyramidal neurons were due to cell autonomous and/or cell-nonautonomous effects 
of disrupted Met signaling.  Further confusing the issue is the fact that we observed both 
layer- and compartment-specific changes in the dendritic morphology of this pyramidal 
cell population in Emx1
cre
/Met
fx/fx 
mice (M. Judson, K. Eagleson, P. Levitt, unpublished 
observations).   
Neurobiological precedent dictates that both cell-autonomous and cell-
nonautonomous effects of developmental Met signaling disruption could contribute to the 
layer- and compartment-specific changes in dendritic morphology that we observe in 
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Emx1
cre
/Met
fx/fx 
ACC pyramidal neurons.  First, cell-autonomous dendritic growth in 
layer 5 and layer 2/3 ACC pyramidal neurons may be differentially regulated by Met 
signaling, perhaps due to unique subcellular distributions of the receptor and its signaling 
partners.  Consistent with this, McAllister and colleagues previously demonstrated that 
neurotrophin receptor signaling influences the dendritic growth of pyramidal neurons 
differentially in layers 4 and 6 of the developing visual cortex (McAllister et al., 1997).  
Also, forebrain-specific deletion of the gene encoding the signaling phosphatase PTEN 
results in a dramatic induction of dendritic growth that is restricted to the apical 
compartment of layer 2/3, but not layer 5, pyramidal neurons (Chow et al., 2009).  
Second, attenuated Met signaling within axonal compartments may compromise 
presynaptic integrity and induce compensatory changes in dendritic development that, 
within the ACC, reflect layer- and compartment-specific projection topographies of Met-
expressing cortico-cortical afferents (Petreanu et al., 2009). 
Advances in technology that allow for subcellular, compartment-specific 
manipulations of Met signaling will prove invaluable in dissecting these complex 
phenotypes within intact circuits.  In the meantime, cell autonomous effects could be 
specifically dissected with the use of genetic approaches such as SLICK (Single-neuron 
Labeling with Inducible Cre-mediated Knockout) (Young et al., 2008) and MADM 
(Mosaic Analysis with Double Markers) (Zong et al., 2005) to disrupt Met signaling in 
just a few neurons within a typically developing cortical milieu.  Conversely, a lentiviral-
mediated mosaic rescue of Met signaling within select pyramidal cells of the 
Emx1
cre
/Met
fx/fx 
cortex could further our understanding of circuit-level, cell-
nonautonomous influences of Met signaling on the development of pyramidal cell 
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dendritic morphology.   Finally, it will be essential to directly determine the nature of 
aberrant axonal development in Emx1
cre
/Met
fx/fx 
forebrain.  Considering the layer- and 
compartment-specific dendritic phenotypes of Emx1
cre
/Met
fx/fx 
ACC pyramidal neurons, 
determining whether the corticocortical afferents therein conform to typical 
compartmental and topographical input patterns is of the utmost importance.  Subcellular 
channelrhodopsin-2 (ChR2)-assisted circuit mapping (Petreanu et al., 2007; Petreanu et 
al., 2009) is a cutting-edge technique that is suited to compare the topographies of local 
circuit connections made by long-projecting corticocortical axons in wild type and 
Emx1
cre
/Met
fx/fx 
mice.  
 
Elucidating molecular mechanisms of Met signaling during forebrain circuit 
development 
 
From the simple observation that Met is an extremely pleiotropic signaling 
molecule it can be inferred that this receptor is capable of engaging a variety downstream 
signaling pathways upon binding its constitutive endogenous ligand, hepatocyte growth 
factor (HGF).  The specific pathways that are engaged as well as the amplitude and 
kinetics of the downstream signaling are likely to dictate the specific developmental 
response that HGF/Met signaling will mediate in a given context.  For example, 
HGF/Met-mediated enhancement of nasopharyngeal cancer cell invasiveness has been 
shown to depend on downstream activation of the PI3K and JNK pathways but not the 
erk 1/2 or p38 MAPK pathways (Zhou et al., 2008), whereas the migration of rat 
mammary fibroblasts in response to HGF stimulation is dependent on the mutual 
activation of both the erk 1/2 and PI3K pathways (Delehedde et al., 2001).  How an 
activated Met receptor engages one downstream signaling cascade versus another is an 
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important mechanistic question concerning any developmental process in which Met 
signaling plays a part.      
What signaling pathways are engaged downstream of HGF/Met signaling in the 
context of forebrain circuit development?  To our knowledge, this question had yet to be  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  HGF stimulation of Met signaling ex vivo.  Immunoblotting for Met and relevant Met signaling 
pathway proteins in lysates prepared from P7 wild type mouse cortical synaptosomes that were treated with 
50 ng/ml HGF at sub-physiologic  (4C) or physiologic temperature (37C) for periods of variable duration.  
A: Immunoblotting for phosphorylated (p-Met) and total Met receptor indicates that robust receptor 
phosphorylation occurs even at sub-physiologic temperature.  Progressively decreased levels of total Met 
and especially p-Met are observed as the duration of HGF stimulation at physiologic temperature increases, 
consistent with energy-dependent mechanisms of receptor desensitization.  B:  Immunoblotting for 
phosphorylated erk 1/2 (p-erk 1/2) demonstrates that HGF stimulation of Met for as little as 5 minutes at 
37C results in a dramatic increase in MAPK pathway signaling as compared to sub-physiologic baseline 
(see red bracket).  MAPK signaling is only slightly attenuated over time as shown out to 30 minutes at 37C.  
C: Immunoblotting for phosphorylated Akt (p-Akt
Thr308
 and p-Akt
Ser473
) demonstrates a surprising decrease 
in PI3K pathway stimulation downstream of HGF-stimulated Met receptor activation.  Note that the levels 
of p-Akt
Thr308
 seem to decrease much more rapidly (blue bracket) than the levels of p-Akt
Ser473 
(green 
bracket).   
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addressed by any study employing native forebrain tissues.  Therefore, we recently 
developed an ex vivo system to evaluate Met signaling in suspensions of crude 
synaptosomes prepared from postnatal day (P) 7 mouse neocortex  subsequent to 
stimulation with physiologic concentrations of HGF (i.e., 50 ng/ml) (see Chapter IV 
Materials and Methods for protocol details).  Using this system, we discovered two 
surprising features of HGF-stimulated Met signaling, which may be relevant to forebrain 
circuit wiring in vivo: 1) though downstream signaling is only engaged at physiologic 
temperature, Met receptor phosphorylation occurs robustly in the presence of HGF, even 
at sub-physiologic temperature (Fig. 1A), and 2) Met signals downstream to robustly 
potentiate the MAPK pathway but inhibit the PI3K pathway subsequent to HGF 
stimulation as evidenced by immunoblotting for phosphorylated erk 1/2 (Fig. 1B) and 
Akt proteins (Fig. 1C), respectively.  We hypothesize that this opposing influence of Met 
signaling on downstream MAPK and PI3K pathway activation, which, to our knowledge, 
is a phenomenon unique to the Met receptor in this specific context, results from 
interactions with specific co-receptors and signaling adaptor proteins.  Below, briefly 
outline and discuss a tandem immunoprecipitation/mass spectrometry approach designed 
to determine the identity of interacting proteins that facilitate the role of Met in forebrain 
circuit wiring.   
Though conceptually straightforward, tandem immunoprecipitation/mass 
spectrometry experiments are technically challenging, and whether or not they are 
successful largely depends on the development of an optimized immunoprecipitation 
protocol and the availability of appropriate negative controls.  Using a paramagnetic 
bead-based approach (see Chapter IV Materials and Methods for protocol details), 
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which is schematized in Figure 2, we have optimized an immunoprecipitation protocol 
that is suitable for purifying Met and associated proteins from native forebrain lysates.  
Moreover, the monoclonal Met antibody used in this protocol is capable of purifying 
HGF-stimulated, tyrosine-phosphoryalated forms of the Met receptor as well (Fig. 3), 
which will serve our ultimate goal of identifying the protein partners that facilitate Met 
signaling during forebrain circuit development.       
 However, the capacity to immunoprecipitate phosphorylated Met receptors 
alone will not ensure our success in purifying signaling partners of Met.  Protein-protein 
interactions can be fleeting and of low affinity, especially when they pertain to signaling 
mechanisms with rapid on/off kinetics.  Furthermore, even when immunoprecipitation 
conditions permit the co-purification of transient or weakly interacting proteins, at later  
steps in the process, such as washing (Fig. 2, step 4), the loss of these interactions may 
equate to the price of eliminating background.  We plan to employ two general, non-
mutually exclusive experimental strategies to maximize the chance of trapping weak or 
transient Met interactions with protein signaling partners.  The first strategy requires that 
Met and phosphorylated Met be immunoprecipitated at multiple time-points subsequent 
to HGF-stimulation; increased experimental sampling should increase the chance of 
catching transient protein-protein interactions.  The second strategy would incorporate 
the use of a chemical such as dithiobis-succinimidylpropionate to covalently cross-link 
Met to its directly and indirectly interacting signaling partners at pre-determined intervals 
following HGF-stimulation.  This method succeeds in effectively cementing weak                           
protein-protein interactions into place, and it has been used to identify weakly interacting 
TrkB signaling partners subsequent to stimulation with BDNF (Arevalo et al., 2004).  
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However, a potential pitfall of this approach is that cross-linking can change epitope 
structures and thus reduce or eliminate the affinity of the immunoprecipitation antibody 
for the target protein.  
 
Figure 2.  General Met immunoprecipitation approach.  Step1: solubilized protein lysates are prepared 
from native forebrain tissues of interest.  These include Met receptors (red circles), direct Met binding 
partner proteins (green squares), and indirect Met binding partner proteins (purple circles).  All non-partner 
proteins are represented by yellow triangles.  Step 2: Soluble Met protein complexes are made insoluble by 
the addition of high-affinity Met antibodies that have been covalently linked to insoluble paramagnetic 
beads.  Step 3: The now insoluble Met protein complexes are precipitated out of solution by the application 
of a magnetic field.  Step 4: The immunoprecipitated (IP’d) Met protein complexes are washed repeatedly 
to remove background, non-partner proteins.  Step 5: Met protein complexes are removed from the beads, 
and thus resolubilized, in a reducing elution buffer.  Step 6: Met partner proteins within the IP’d complexes 
can be identified via mass spectrometric analysis.  
 
 
179 
 
Figure 3.  Immunoprecipitation of phosphorylated (p-Met) and total Met protein.  Input lysates (left 3 
lanes) were prepared from P7 wild type mouse cortical synaptosomes that were unstimulated (--, far left 
lane) or stimulated (+, right two lanes) with 50 ng/ml HGF for 5 minutes at 37C.  As per immunoblotting, 
p-Met bands were only detected in the input lysates prepared from HGF-stimulated synaptosomes.  
Immunoprecipitation (IP) was performed using each of the 3 input lysate samples (right 3 lanes).  As per 
immunoblotting, total Met protein was clearly detected in both Met IP (Met, left two lanes) samples, but p-
Met was only detected in the Met IP sample prepared using HGF-stimulated input lysate (middle lane).  No 
p-Met or Met was detected in the control (ctrl) IP sample prepared using HGF-stimulated input lysate (far 
right lane).  
 
 
 No amount of optimization will ever result in an immunoprecipitation protocol 
that allows for the perfect co-purification of a target protein and its interacting partners.  
Some amount of background protein will always co-elute with the protein complexes of 
interest, and, unfortunately, a mass spectrometer cannot tell the difference between them.  
Therefore, the implementation of appropriate negative controls is an important safeguard 
against excessive false-positive identifications of candidate partner proteins in any 
tandem immunoprecipitation/mass spectrometry approach.  Succinctly, if the 
experimental and negative control immunoprecipitates are analyzed in the same mass 
spectrometer run, any identified proteins that they share in common can be eliminated 
from consideration as candidate partner proteins.   
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 To reliably identify protein partners of the Met receptor in both signaling and 
non-signaling states, we plan to perform Met and control IgG antibody precipitations of 
lysates prepared from P7 wild type mouse cortical synaptosomes that have either been 
untreated or stimulated with HGF.  Parallel mass spectrometric analyses comparing the 
control immunoprecipitates with either Met immunoprecipitation sample should allow for 
a broad identification of Met-specific protein partner candidates.  Further comparisons 
between the unstimulated and HGF-stimulated Met immunoprecipitates may reveal 
protein interactions that are gained and/or lost subsequent to Met receptor activation.  An 
even more sophisticated level of analysis would involve the mass spectrometric 
comparison of Met immunoprecipitates prepared from synaptosomes that have been 
HGF-treated at sub-physiologic versus physiologic temperatures.  In the former  
condition, Met receptors are phosphorylated but apparently not engaging downstream 
signaling pathways (Fig. 1A), which could reflect an intermediate or incomplete 
recruitment of signaling adaptor proteins at this stage.  A basic outline of our 
immunoprecipitation strategy to identify signaling Met signaling partners that are 
relevant to forebrain circuit development can be viewed in Figure 4.  We have chosen to 
experiment initially with synaptosomes prepared from wild type P7 mouse cortex, 
primarily because Met is robustly expressed in cortical neuropil compartments during this 
early period of forebrain circuit wiring (Judson et al., 2009).  Additionally, because the 
cortex is the largest forebrain structure, fewer animals will be required to satisfy these 
preliminary experimental aims.  Pending the satisfactory identification of Met signaling 
partners within the P7 cortical neuropil, subsequent experiments will seek to determine if 
Met signaling complexes are differentially composed in forebrain structures such as the 
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Figure 4.  Immunoprecipitation strategy to identify Met signaling partners during forebrain circuit 
development.  Top row: P7 wild type mouse cortical synaptosomes are treated with 0 (left column) or 50 
(middle and right columns) ng/ml HGF.  Colored shapes represent cortical synaptosomal proteins.  All 
columns: inactive Met (red circle) interacts with a constitutive partner (green square) and its inactive state 
partner (purple circle).  Middle and right columns: active, phosphorylated Met (p-Met, blue circle) still 
interacts with the green square but ceases interacting with the purple circle.  p-Met also gains interactions 
with two new partners (yellow triangle, strong interaction; olive square, weak interaction).  Middle row: 
DSP cross-linker (red bar) is added to all synaptosomal samples in order to trap weakly associated Met 
signaling partners (red bar now connects olive square to p-Met complexes).  Lysis follows to solubilize all 
Figure 4—cont.  synaptosomal proteins.  Bottow row: lysed synaptosomal proteins are incubated with 
either specific Met immunoprecipitation antibodies (left and middle columns, black Fab region) or control 
antibodies (right column, red Fab region).  Met-associated proteins are immunoprecipitated only by Met 
antibodies (left and middle columns), and p-Met-associated proteins are immunoprecipitated only by Met 
antibodies incubated lysates prepared from HGF-stimulated synaptosomes (middle column).  
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P7 striatum where the subcellular localization of Met is exclusively axonal (Judson et al., 
2009).  Temporal comparisons of immunoprecipitates prepared from corresponding 
forebrain structures at P7 and P21 will also be informative considering the evidence for a 
subcellular shift in Met localization that occurs between these ages (Judson et al., 2009).    
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